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1 Abstract 
 
The remarkable technical development over the last decade allowed the generation of 
genetic data in a high-throughput manner, challenging scientists with enormous amounts 
of data to be stored and analyzed. The functional attribution of genetic data remains the 
key task and turned out to be particularly provoking in the field of affective disorders. 
Being aware that the behavior of an individual is determined by a variety of factors – 
genes, epigenetic modifications, environment, experiences, and interactions of all these 
components – the attribution of the functional impact of genetic data depicts a 
challenging, but inevitable task, as the molecular underpinning of depression and 
associated diseases are still largely unknown, although the incidences of these 
psychiatric diseases are alarming. 
Animal models based on selective breeding approaches, such as the HAB/LAB mice 
representing extremes in anxiety-related behavior and HR/LR mice representing 
extremes in stress reactivity, serve as model organisms, which are providing both distinct 
quantitative traits at the behavioral level and an accumulated and conserved pool of 
genomic features determining quantitative traits at a genetic level.  
Therefore, as a first attempt towards the genetic characterization of the stress reactivity 
mouse model, the transcriptome of HR vs. LR mice was investigated combining 
microarray-based and serial analysis of gene expression (SAGE) experiments. The 
detected pool of differentially expressed genes in the hippocampus of HR vs. LR mice 
was further characterized via bioinformatical analyses, the phenotypic characterization of 
heterozygous Cofilin-1 knockout mice, and a neurodevelopmental follow-up study. All 
these attempts clearly indicated the mitochondria as the origin of the differences in stress 
reactivity and HPA axis dysfunction in HR vs. LR mice. More precisely, evidence for a 
disturbed energy metabolism was collected, potentially generating different levels of 
reactive oxygen species and determining different apoptosis rates between the lines. To 
that effect, extremes in stress reactivity seem to show similarities to the growing list of 
neurodegenerative disorders with a known mitochondrial impact. Furthermore, an 
anxiety-related, depression-like, and stress reactivity phenotype was attributed to 
heterozygous Cofilin-1 knockout mice giving rise to the hypothesis that Cofilin-1 dose-
dependently influences the respective quantitative traits in a U-shaped manner. 
In addition, in analogy to the founder populations of the inbred mouse models, an 
outbred population of CD-1 mice was phenotypically characterized in respect to anxiety-
related and depression-like behaviors as well as stress reactivity. From these CD-1 mice, 
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32 animals were selected to represent the continuum of quantitative traits of the inbred 
mouse models, and were subsequently genotyped for more than 620,000 SNP loci 
genome-wide. Based on these genotypes, the first CD-1 specific haplotype map was 
calculated and, furthermore, preliminary associations were calculated resulting in the 
identification of several loci, which were already reported in a broader neurobiological 
context, but not directly in relation to affective disorders so far. The haplotype map allows 
the genome-wide selection of tag-SNPs in accordance to the linkage disequilibrium 
clustering of CD-1 mice and might serve as the basis for a future development of a 
customized tag-SNP assay to test for associations in the entire CD-1 population. As the 
overall coverage and reliability of this tag-SNP approach seems questionable, a high 
throughput-SNP-screening will alternatively be considered.  
In either case, the availability of the inbred mouse models provides the unique 
opportunity to test associations detected in the extended approach. A possible first 
attempt to assess the functional impact of an associated locus on the quantitative traits 
of the inbred mouse models could be the pharmacological manipulation of the protein 
product encoded by the detected locus.  
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2 Introduction 
 
One of the oldest medical recordings is an approximately 3,600 years old Egyptian 
papyrus which Georg Ebers, a German Egyptologist and author, bought in 1872 in 
Thebes, Egypt. Ebers translated the 108 papyrus columns into German and found 
among several chapters the probably first description of what today is called 
´depression`. The nameless editor of the papyrus described a ´weakness in the head` 
which was translated as pathological exhaustion and debility (Joachim, 1890).  
Roughly 3,600 years after this presumably first description of symptoms shown by 
depressed patients, this phenomenon is on the way to becoming a major health and 
socioeconomic issue of our time.  
 
 
 
2.1 The current concept of depression scale disorders 
Depression according to today´s concept is a disease of the central nervous system 
(CNS) (Insel and Charney, 2003) comprising distinct disease patterns with similar 
symptoms. The World Health Organization (WHO) defined depression as a mental state 
characterized by depressed mood, a general loss of interest, feelings of guilt, low self-
esteem, the inability to feel pleasure, disturbed sleep and appetite, poor energy, and 
concentration levels. Depression is a recurrent and chronic state and is therefore 
followed by impairment in accomplishing the everyday life. The personal burden for the 
patient coming along with the symptomatology culminates in roughly 850,000 cases of 
suicide world-wide every year (http://www.who.int/mentalhealth/management/ 
depression/definition/en/index.html).  
Depressive disorders are highly prevalent diseases. The lifetime prevalence for women 
was estimated with 25%, for men with 12%, though these estimations differ depending 
on the source. Depressions are therefore becoming an increasingly large problem to the 
public health systems. The recurrent and chronic course of the disease made it a 
frequent cause for permanent impairment, hence making it a worldwide source for 
disability (Cassano and Fava, 2002; Cryan and Holmes, 2005; Gelenberg, 2010; Hamet 
and Tremblay, 2005; Lohoff, 2010). The WHO estimates that by the year 2020 
depression will be the second most prominent cause for disability in the world (Williams 
et al., 2009a). Furthermore, according to a calculation of the German Federal Office of 
Statistics, the costs in Germany caused by depression in the year 2008 were 5.2 billion 
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Euros, which made a 32% cost increase from 2002 to 2008 for dementia and depression 
(press release Statistisches Bundesamt, no. 280, 11.08.2010). The increasing number of 
patients entailing raising costs sensitized politics and society for this topic.  
The term depression encompasses a group of related, but still distinct forms of the 
disease. Major depressive disorder (MDD; also called melancholic, typical or 
endogenous depression) is characterized by melancholic episodes of anxiety, insomnia, 
loss of appetite, fear of the future, and seems to be associated with increased activity of 
the hypothalamic-pituitary-adrenal (HPA) axis (Gold and Chrousos, 2002; Gold et al., 
1988). MDD can be sub-classified into two prominent forms of the disease which are 
unipolar and bipolar courses. In unipolar depression the patient´s constitution remains in 
the melancholic phase, whereas a bipolar course of the disease is characterized by 
bimodality with alternating maniac and hypomaniac phases (Parker et al., 2011). The 
second most prominent form next to MDD is atypical depression. Patients suffering from 
atypical depressions show to a certain extent reverse symptoms of MDD, like for 
example lethargy, fatigue, hypersomnia, and hyperphagia (Gold and Chrousos, 1999; 
Gold and Chrousos, 2002).  
Depressive disorders are multifactorial and heterogeneous diseases (Gold and 
Chrousos, 2002) and precise understanding of the etiology remains elusive (Colman and 
Ataullahjan, 2010; Jacobson and Cryan, 2007). Comprehension of the multidimensional 
interplay between genetic, epigenetic, environmental and psychosocial components 
(Freeborough and Kimpton, 2011; Tarantino et al., 2011) finally determining the 
individual susceptibility for depressive disorders is a complex but unavoidable challenge 
necessary to counter the current advance of depressive disorders.  
2.2  Comorbidity of depression 
Depressive disorders are strongly associated with anxiety disorders, such as panic 
disorders or generalized anxiety disorder (GAD), with substance abuse, and impulse-
control disorders, like for example bulimia or antisocial personality disorder (Kessler et 
al., 2003). As mentioned above, depressions are further known to be accompanied by 
alternations of physiological stress hormone systems. The sympathetic nervous system 
and the HPA axis are dysregulated during the course of depressive disorders linking 
disturbed stress reactivity and depression. Both, HPA axis hypo- and hyperactivity and 
increased sympathetic vs. parasympathetic tone were reported in this context (Muller 
and Holsboer, 2006; Nosjean et al., 1995; Touma et al., 2008). In addition, 
cardiovascular diseases, stress reactivity, and depression share numerous 
neurobiological features strongly implying an association of cardiovascular and affective 
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disorders (Grippo and Johnson, 2009). Neither surprising, co-occurrence of depression 
and neurodegenerative disorders, such as Parkinson´s or Alzheimer´s disease, is a 
widely known phenomenon. One the one hand, this comorbidity could be explained by 
the personal burden coming along with neurodegenerative diseases, but on the other 
hand, crucial neurotransmitter and neuropeptide systems, for example, the dopaminergic 
system and the arginine vasopressin (AVP) system, are impaired in either illness. This 
common ground of impaired neurobiological mechanisms between affective disorders 
and neurodegenerative disease seems an obvious basis of comorbidity between them 
(Anisman et al., 2008). 
2.3 Generalized anxiety disorder 
GAD is defined as “an uncontrollable disposition to worry about one's welfare and that of 
one's immediate kin” (Akiskal, 1998). It is the most prevalent anxiety disorder and is very 
often associated with psychiatric diseases, in particular with MDD (Simon, 2009). Even 
more, it seems like GAD could be a prodrome for MDD, as in a study by Kessler and 
colleagues it was shown that the probability of MDD onset is increased within the first 
year of an initial period of GAD (Kessler et al., 1996). Others reported about 
simultaneous onset of GAD and MDD being as frequent as GAD onset prior to MDD or 
vice versa (Moffitt et al., 2007). However, there is consensus regarding the highly 
comorbid nature of GAD and MDD and GAD can be considered both, a risk factor as 
well as a biological marker for the development of other affective disorders later in 
lifetime. It was hypothesized that GAD might act as biological stressor and, hence, 
trigger a subliminal predisposition for MDD via dys-regulation of affected 
neurotransmitter systems, such as the serotonergic system or of the HPA axis. 
Furthermore, accumulated evidence points towards shared genetic risk factors for GAD 
and depression, in particular for GAD and MDD (Cerda et al., 2010; Simon, 2009). For 
example, Hettema and colleagues demonstrated a pronounced genetic correlation (R2 = 
0.98) between GAD and MDD after examination of more than 9,000 twins from the 
Virginia Adult Twin Study of Psychiatric and Substance Abuse Disorders (Hettema et al., 
2006). 
2.4 Stress and reactivity of the hypothalamic-pituitary-adrenal axis  
The hypothalamic-pituitary-adrenal (HPA) axis is a major part of the body´s 
neuroendocrine system and involves the paraventricular nucleus (PVN) of the 
hypothalamus, the anterior lobe of the pituitary gland, and the adrenal cortices of the 
adrenal glands (Figure 1). It contributes on a regulatory level to a variety of physiological 
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functions, such as developmental, immunological, metabolic and cardiovascular 
processes and, in particular, to stress response. It is liable to a pulsatile rhythmicity with 
in humans highest activity shortly before awakening under baseline conditions.  
Briefly, the signaling cascade of the HPA axis includes the release of corticotropin-
releasing hormone (CRH) and AVP from a sub-fraction of parvocellular neurons of the 
PVN as a primary reaction to stress. CRH stimulates, among others, the anterior pituitary 
which, in turn, secretes the adrenocorticotropin hormone (ACTH). This release of ACTH 
is synergistically supported by AVP. ACTH is transported by the systemic blood stream 
to the zona fasciculata of the adrenal cortex prompting glucocorticoid release. 
Glucocorticoids, which are the target effectors in the signaling cascade of the HPA axis, 
in turn are involved in a multiplicity of physiological and pathophysiological processes. 
The most prominent glucocorticoid is cortisol in humans and corticosterone in mice, 
respectively (Melmed et al., 2011). They execute their pleiotropic functions via the 
ubiquitously expressed glucocorticoid receptor. Upon activation, this cytoplasmic 
receptor diffuses from binding proteins, homodimerizes and translocates into the nucleus 
acting as transcription factor via binding to glucocorticoid responsive elements on 
genomic DNA. In addition, transrepressive effects of glucocorticoid receptor signaling 
which does not necessarily involve binding to DNA and fast mediated glucocorticoid 
signaling via membrane-associated effector molecules were reported. Glucocorticoids 
also initiate the negative feedback mechanism of the HPA axis limiting CRH and ACTH 
secretion (Charmandari et al., 2005; Groeneweg et al., 2011a; Groeneweg et al., 2011b; 
Heitzer et al., 2007; Lightman and Conway-Campbell, 2010; Mormede et al., 2011; 
Silberstein et al., 2009). 
Dysregulation of the HPA axis in depressed patients is often associated with constantly 
increased levels of cortisol. The reversibility of this hypercortisolemia by application of 
antidepressant agents was known (Holsboer, 2001; Sterner and Kalynchuk, 2010; 
Vreeburg et al., 2009). Furthermore, an increase in anxiety-related behavior upon 
exogenous corticosterone application has also repeatedly been reported (Murray et al., 
2008; Pego et al., 2008).  
Importantly, a high degree of heritability was shown for components along the HPA axis, 
which strongly suggests a genetic determination of stress response and therefore, stress 
pathology. The genetic influence ranges from HPA axis functionality itself to the mode of 
stress physiological adaptation to environmental stimuli (Franz et al., 2010; Mormede et 
al., 2011; Wust et al., 2004).  
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Figure 1: Schematic illustration of HPA axis components. Stimulation of the PVN, either 
by stressors conciliated from the central nervous system or circadian information from 
the suprachiasmatic nucleus (SCN) induces CRH and AVP secretion. Thus, the anterior 
pituitary secretes ACTH which triggers the release of glucocorticoids from the adrenal 
cortices. In addition to manifold physiological and pathophysiological processes, 
glucocorticoids limit HPA axis activation via initiation of the negative feedback 
mechanism. (Figure adopted from Lightman and Conway-Campbell, 2010.) 
 
2.5 Genetics of depression and associated diseases 
Besides various circuits in the CNS, the genetic underpinning of depression is one 
component among a variety of determinants entailing the development of depression 
and associated diseases.  
Although twin-studies suggest a heritability of up to 50% for MDD and family studies 
showed a clearly increased risk for first-degree relatives to also develop MDD (Lohoff, 
2010), the identification of genetic risk factors for depression was – like for other complex 
diseases, too – accompanied by obstacles. The reasons therefore are multifold. First, 
depression is a multigenic disease determined by the interplay of several genetic factors. 
Second, the contribution of each single gene can presumably be disregarded (Lohoff, 
2010). The assumption of a multitude of genetic risk factors determines the susceptibility 
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for depression. And third, this multitude of genetic risk factors is heterogeneous (Lohoff, 
2010). To a certain degree, there might be an overlap of risk factors between one 
individual and the other, but the other fraction of this factor allocation differs from one 
individual to the other. Based on the individual assembly of genetic risk factors, 
epigenetic and environmental influences differ, too (Lohoff, 2010). Along these lines, the 
term of “multigenic composite inheritance theory” was formed to “define inheritance of a 
finite group of seemingly unrelated genes”. The idea behind is that depression and 
associated diseases are determined by a genetic interplay comprising differential gene 
expression, polymorphic differences in contributing clusters of genes which are not 
obviously related, as well as environmental adaptations which could appear in the 
epistatic modification of genes, post-transcriptional and post-translational modulation, 
and also spontaneous mutations (Raymer et al., 2005).  
A further and only very recently developing idea in the field of molecular genomics is the 
potential influence of structural changes in the DNA, namely segmental copy number 
variants. It was shown that CNVs might influence expressional activity of genes encoded 
by the respective multiplied sequence. This contributes to both, physiological genomic 
variability as well as disease susceptibility. For schizophrenia, for example, it was shown 
that structural changes can enhance the risk for the disease by about 25-fold (Murphy et 
al., 1999).  
The presumable interaction of all those genetic parameters highlights the complexity of 
depression and associated diseases on a genetic level and clarifies the hurdles genetic 
research of the field encountered so far. In this context, to some extent the disappointing 
balance of genome-wide association studies (GWAS) (Bondy, 2011) appears self-
evident. The successful identification of susceptibility loci making use of GWAS can 
though not be contradicted (Schulze, 2010). Further approaches typically conducted in 
order to reveal genetic underpinnings of complex disorders, such as linkage studies and 
candidate gene analyses (Lohoff, 2010), appear appropriate to an even lesser extent. In 
fact, integrative approaches embracing the multi-faceted components of genetic 
participation to susceptibility for depression and associated diseases are required. The 
embedding of GWAS into integrative approaches provides a promising tool to further 
progress in the identification of susceptibility loci for these diseases (Schulze, 2010). 
2.6 Genome-wide association studies 
GWAS involve the significant co-occurrence of genotypic characteristics with phenotypic 
traits in case vs. control groups. Unlike linkage studies, GWAS are usually performed 
based on unrelated populations (Craddock et al., 2008).  
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As depression and associated diseases are complex diseases and a variety of genetic 
loci with individual markers contributing to a small effect size only, GWAS can provide an 
adequate tool for the detection of genetic determinants of affective disorders. A 
reasonable high marker density throughout the genome, which means 500,000 to one 
million markers, makes prior gene selection dispensable (Craddock et al., 2008; Lohoff, 
2010) and enables the detection of novel candidates beyond “usual suspect” 
components (Schulze, 2010), such as the serotonin or the dopaminergic system.  
In commercial single nucleotide polymorphism (SNP) assays, these polymorphic markers 
are typically positioned in genomic regions with minor allele frequencies above 5%, 
which results in unequal marker distribution throughout the genome and in disrespect of 
low-frequency alleles (Craddock et al., 2008). Tagging designs, which comprise the 
selection of informative SNPs representative for the respective linkage disequilibrium 
(LD) mapping, are an option to systematically cover the genome with SNP markers, 
though the detection of minor allele frequencies based on tag-SNP approaches was 
recently shown to not be improved (Siu et al., 2011).  
GWAS, on the one hand, harbor considerable pitfalls, such as a locus detected to not be 
significantly associated cannot per se be considered as uninvolved in respect to the 
respective trait (Craddock et al., 2008). In fact, positive results might require confirmation 
in form of repeated detection in independent cohorts, meta-analysis, or biological 
relevance of a locus detected as significantly associated (Cichon et al., 2009; Levinson, 
2005; Lydall et al., 2011; Shyn et al., 2011). This also means, that massive amounts of 
data need to be produced entailing expenses and statistical issues (Lohoff, 2010). On 
the other hand, GWAS constitute an unbiased approach, which allows the identification 
of causative factors (Cichon et al., 2009). Considering the multi-faceted etiology of 
depression and associated diseased, alternative methods can hardly be considered.  
Along this line, a Psychiatric GWAS Consortium (PGC) was recently initiated aimed to 
consolidate GWAS meta-analyses for major psychiatric disorders (attention deficit 
hyperactivity disorder, autism, bipolar disorder, MDD, and schizophrenia). PGC 
comprises GWAS conducted in the field and conveys these data sets to meta-analyses 
with the expectation to maximize the performance of separate association studies in this 
collaborative intent (Sullivan, 2010).  
2.7 Pharmacological therapy options for depression and associated diseases  
Antidepressant drugs are, in general, supposed to alleviate mood and depressive 
symptoms and are therefore applied against depressions and anxiety disorders. The 
most established groups are selective serotonin reuptake inhibitors (SSRIs), serotonin-
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norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), and 
tricyclic antidepressants (TCAs).  
Current first-line treatment for psychiatric disorders is the application of SSRIs. These 
drugs execute their psychotropic effect via the inhibition of neuronal uptake pumps for 
serotonin (5-hydroxytryptamine, 5-HT). This property they share with TCAs and SNRIs, 
but with the distinction to specifically inhibit serotonin reuptake pumps and no further 
neuronal receptors or central potassium and fast sodium channels. This specificity 
explains the increased compliance of SSRIs in contrast to neuropsycho-pharmacological 
treatment options developed earlier.  
The mechanism via SSRIs exert their therapeutic effect is the increase of 5-HT levels in 
the synaptic cleft of serotonergic neurons by blocking its uptake into the post-synapse 
and, therefore, rendering 5-HT in its active state and side. They are influencing the 5-HT 
system, which does not remain free of unfavorable side effects. The antagonism of the 
5-HT reuptake pump goes along with negative allosteric modulation of the 5-HT receptor 
which is probably the cause of side effects, such as for example gastrointestinal and 
neurological side effects. A further flaw is the delayed onset of the entire efficacy 
spectrum. In the initial 14 days of treatment, the increased 5-HT level in the synaptic cleft 
induces desensitization of the respective receptors. Only after this initial period, the 
serotonergic excretion is stimulated resulting in an increased serotonergic 
neurotransmission, finally relieving the patient from symptoms (Pacher and Kecskemeti, 
2004; Vaswani et al., 2003). Data regarding the remission rate after SSRI treatment 
depend on study set-up, but however, remission rates are clearly below 50% (Maoz, 
2007; Trivedi et al., 2006). In the case of therapy failure, dosage augmentation or 
switching to other pharmacological agents is an option (Connolly and Thase, 2011). On 
the long run, the development of novel antidepressant agents is the attempt of basic 
research and pharmaceutical industry, and the perspective for the rising number of 
patients suffering from depression and anxiety-disorders. Furthermore, the question, why 
established psychopharmacological agents achieve remission in one patient but not in 
the other, the issue of genomic variability in depression and associated diseases needs 
to be addressed anew.  
2.8 Psychopharmacotherapy of the future – a step towards personalized 
medicine? 
Treatment success after application of well established psychopharmacological agents 
was shown to be influenced by SNPs in genes contributing to biological circuitries which 
are known to be involved in depression and anxiety disorders. Binder and colleagues 
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reported that a SNP within the gene encoding for the human corticotropin releasing 
hormone binding protein (CRHBP) is significantly influencing both, remission as well as 
improvement of depressive symptoms in response to citalopram application, though in 
an ethnicity-dependent manner (Binder et al., 2010). Based on findings like this, allelic 
genotypes can be attributed to poorer or advantageous treatment response. SNP 
genotyping prior to treatment initiation might support the selection of the 
psychopharmacological agent best suiting the patient and, hence, serve as prognostic 
tool to therapy success.  
2.9 The use of animal models to unravel neurobiological underpinnings of 
depression and associated diseases 
With the objective to unravel neurobiological underpinnings of depression and 
associated diseases, animal models have long been used. Complex human diseases 
and, in particular, affective disorders are though not to be captured in their entity of 
aspects, but the modeling of precise neurobiological and pathophysiological features 
was done successfully in the past (Matthews et al., 2005). Independent of the 
pathobiological feature, which is mimicked by the model, there are three general criteria 
animal models are expected to fulfill, namely face-, construct- and predictive validity. 
Face validity is given if the animal phenotype resembles the human phenotype which is 
aimed to me modeled. Construct validity stipulates pathobiological parallels between 
humans and the animal model. The criterion of predictive validity is fulfilled if 
manipulation of the model organism, for example via pharmacological application, 
achieves similar results than in humans (Neumann et al., 2011).  
In the field of psychiatric science and, in particular for genetic approaches, the mouse 
approved to be a favorable model organism. This is, one the one hand, based on the 
pronounced genomic homology between men and mice. On the other hand, in 
anatomical and physiological features of the brain as well as in the response to 
pharmacological treatment mice show similarity to humans. And last but not least, 
despite the obvious physiognomic differences between the species, the behavioral 
characteristics are similar, too (Tecott, 2003). The explicit advantage coming along with 
the mouse as a model organism is the almost infinite opportunity to manipulate the 
mouse genome. This can either be done by alteration of a specific locus of interest 
(transgenic, knockout, knockin mice) or via selective breeding approaches focusing on a 
trait of interest. Inbreeding strategies, on the one hand, reduce genetic heterogeneity 
and, on the other hand, accumulate and conserve genetic characteristics which 
determine the trait of interest (Cryan and Holmes, 2005; Phillips et al., 2002; Tecott, 
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2003). This enrichment of trait relevant alleles facilitates investigation and most 
importantly, allows bridging the gap between genetic features and phenotypic traits. Two 
mouse models of affective disorders, which were generated based on selective and 
bidirectional breeding approaches, were used in the context of this study and will be 
described as follows.  
2.9.1 The HAB/LAB mouse model reflecting extremes in trait anxiety 
Using a strictly selective and bidirectional mating protocol, a mouse model reflecting 
extremes in trait anxiety was generated. It comprises three mouse lines which, 
independent of gender, display either high anxiety-related behavior (HAB), normal 
(intermediate) anxiety-related behavior (NAB) or low anxiety-related behavior (LAB). The 
breeding paradigm is based on the degree of avoidance of the unprotected, aversive 
environment presented by the open arm of the elevated plus-maze (EPM) (Kromer et al., 
2005). HAB mice spend only about 10% of their time on the open arm, reflecting the 
highly anxiety-related behavioral trait of this line. LAB mice, on the contrary, spend more 
than 50% of their time of the open arm showing a particular low degree of avoidance 
behavior towards the aversive environment (Kromer et al., 2005).  
For this mouse model, more than 250 outbred Swiss CD-1 mice (CD-1 mice) descending 
from than 25 litters served as founder population. These mice were behaviorally 
characterized on the EPM and subsequently classified in lines spending the lowest and 
the most time on the open arm of the EPM, respectively. For the first eight generations, 
an outbreeding protocol was conducted by selectively mating mice of different litters but 
identical lines with each other. This initial outbreeding was performed to enhance the 
genomic pool of alleles determining the extremes in trait anxiety and reducing the risk of 
genetic drift. After generation eight, more than 40 generations of mice were selectively 
inbred according to their anxiety-related behavior, which involves every animal being 
classified at the age of seven weeks regarding its behavior on the EPM. Animals not 
fulfilling the breeding criterion are eliminated from the mouse model. Starting after 23 
generations of HAB/LAB breeding, an intermediate control line, namely NAB mice, were 
generated spending about 35% of the testing time on the EPM on the open arm (Kromer 
et al., 2005). Figure 2 displays the development of the anxiety-related behavior of 
particular lines over the generations.  
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Figure 2: Graphic illustration of the development of trait anxiety over 40 generations of 
selective breeding of HAB and LAB mice. Trait anxiety is reflected by the percentage 
time animals spent on the open arm of the EPM, the parameter which served as 
selection criterion for selective mating. Initial differences in trait anxiety deviated further 
over the generations reaching kind of a steady state after about ten generations.  
 
 
The HAB/LAB mouse model was used for extensive studies regarding behavioral, 
genetic, proteomic, cognitive, and brain physiological correlates of extremes in anxiety-
related behavior. The extremes in trait anxiety were not only detected in EPM testing, but 
also in further behavioral paradigms testing anxiety-related behavior, like for example 
dark-light box tests (Kromer et al., 2005). Furthermore, HAB animals display increased 
levels in depression-like behavior, which was shown in increased degrees of passive 
stress coping styles in forced swim (FST) and tail suspension (TST) tests. This co-
occurrence of increased levels of anxiety-related with increased levels of depression-like 
behavior models the comorbidity of depressive with anxiety disorders. One major finding 
based on this mouse model was, for example, the identification of Glyoxalase I as a 
potential protein marker for trait anxiety (Hambsch et al., 2010; Kromer et al., 2005). 
Recently, combined metabolic and proteomics analyses indicated the contribution of 
diverging mitochondrial pathways to extremes in trait anxiety (Filiou et al., 2011). As the 
selective breeding paradigm ensured an accumulation of genetic characteristics 
determining extremes in trait anxiety (Phillips et al., 2002), and therefore the pronounced 
genetic predisposition of HAB and LAB mice towards extremes in anxiety-related 
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behavior predestines this model to extensively study the genetic differences between the 
lines in order to unravel genetic underpinnings of trait anxiety. In the study presented 
here, these animals were used for sequence-based analysis of loci presumably 
determining extremes in trait anxiety. 
2.9.2 The stress reactivity mouse model  
The second mouse model used in this study was the stress reactivity (SR) mouse model 
(Touma et al., 2008). The selective breeding paradigm of the SR mouse model is based 
on the plasma corticosterone increase after subjecting the animals to a restraint stressor, 
which reflects extremes in the dysregulation of the HPA axis. HPA axis dysregulation, in 
turn, is a key phenotype in modeling endophenotypes of MDD. In similarity to the 
HAB/LAB mouse model, this model consists of three separate breeding lines with 
distinctively different HPA axis reactivity in response to stress. The high reactivity (HR) 
mouse line displaying an excessive corticosterone increase and hence, a hyperreactivity 
of the HPA axis, the intermediate reactivity (IR) mice which, serve as standard control for 
physiological HPA axis reactivity, and the low reactivity (LR) mice showing sub-standard 
corticosterone increase caused by HPA axis hyporeactivity. In either case, two sublines 
were generated. In similarity to the HAB/LAB model, this mouse model was generated 
based on a founder population of 200 CD-1 mice. The selective and bidirectional 
breeding protocol was started from the first generation, but ensuring interfamilial 
breeding to reduce the risk of genetic drift. Figure 3 shows the development of the 
corticosterone increase for male and female HR, IR, and LR mice, respectively, over the 
first six generations. In addition to corticosterone increases after SR testing, it was found 
that further HPA axis parameters differed between the lines. For example, ACTH 
concentrations under basal conditions differed significantly between HR and LR mice 
with HRs showing elevated measures. Furthermore, similar to the HAB/LAB mouse 
model, behavioral phenotypes were investigated. In general, HR mice displayed a more 
active coping style when being subjected to stressful and aversive situations, whereas 
LR mice showed a rather passive stress coping strategy. Along this line, depression-like 
and anxiety-related behavioral features were observed in these animals. In summary, 
HR mice resembled a melancholic sub-type of depression, whereas LR mice revealed 
characteristics associated with atypical depression (Touma et al., 2008). Furthermore, 
studies investigating cognitive abilities of HR, IR, and LR mice revealed memory deficits 
in hippocampus-dependent tasks in HRs, comprising reduced hippocampal levels of 
brain-derived neurotrophic factor (Knapman et al., 2010a; Touma et al., 2008). In 
addition, HRs were further shown to perform poorly in reversal learning tasks and to 
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display disrupted latent inhibition (Knapman et al., 2010b). This seems not surprising as 
it is known that exposure to elevated levels of glucocorticoids is associated with cognitive 
impairment (McCormick and Mathews, 2010). 
The heritability for this mouse model was estimated to be 40%, which is in accordance 
with earlier findings regarding the heritability of glucocorticoid release upon exposure to 
stressors in a variety of species (Touma et al., 2008).  
 
 
Figure 3: Graphic illustration of the corticosterone increase in male (a) and female (b) 
HR, IR, and LR mice after exposure to a 15 min restrain stressor. After generation four, 
the average corticosterone increase in males was >200 ng/ml in HRs, around 150 ng/ml 
in IRs, and <100 ng/ml in LRs. The corticosterone increase in HR males deviated even 
further in the following generations to an approximate average value of 350 ng/ml in 
generation twelve. In female mice, the detected corticosterone increases were generally 
higher compared to male mice. The corticosterone increase in HR females was 
measured with >400 ng/ml, in IRs around 300 ng/ml, and <200 ng/ml in LRs. (Figure 
adopted from Touma et al., 2008.)  
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2.10 Technical progress in methods applied for the generation of transcriptome- 
and sequence-based genomic data 
In the last years, the generation of genetic data, no matter if transcriptome- or sequence-
based, was eased in many ways.  
To visualize this development, the generation of the first ´whole` genome sequence 
(whole meaning about 99% of the gene-containing regions of the human genome) was 
finished 2003. This ´Human Genome Project` was conducted with international scientific 
efforts, took about 13 years and did cost about 2.7 billion US Dollar. This was, by the 
way, faster and cheaper than originally expected (http://www.genome.gov/ 11006929). 
Today, about eight years later, the generation of a whole genome sequence via next-
generation sequencing (NGS) can be achieved by one technically skilled person within 
two weeks for approximately 8,000 US Dollar (Peter Weber, personal communication). 
This comparison might appear striking, but it underlines the almost inflationary technical 
progress in the field.  
The challenge in the field of psychiatric research is therefore not the generation of 
genetic data. The challenge is the attribution of functional relevance to sequence- and 
transcriptome-based genomic findings. The question in how far expressional profiles and 
variable sequences detectably infiltrate the behavioral level and determine 
endophenotypes needs to be answered in order to understand the multilevel and 
complex underpinnings of depression and associated diseases.  
The contribution of both expressional differences and of sequence variations to 
neurobiological diseases was proven sufficiently. In this aspect, Alzheimer´s disease 
seems like a good example. It was shown, that a mutation in the amyloid precursor 
protein can cause early onset of Alzheimer´s disease and furthermore (Goate et al., 
1991), apolipoprotein E type 4 can influence the risk of late onset Alzheimer´s disease in 
a gene dose-dependent manner (Corder et al., 1993).  
2.11 Aim and scope of this study 
The major and comprehensive aim of this study was to unravel genetic underpinnings of 
depression and associated diseases. The attribution of functional relevance at behavioral 
level to genetic data gained from two mouse models of affective disorders was intended 
applying a heterogeneous variety of techniques. Thereby, the impact of transcriptome- 
and sequence-based characteristics on behavioral endophenotypes displayed by 
HAB/LAB and HR/LR mice were investigated.  
First, gene expressional profiling approaches were aimed to identify the pool of 
differentially regulated genes in the hippocampus of HR vs. LR mice. Furthermore, the 
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functional relevance of selected genes, detected to be differentially expressed in respect 
to extremes in stress reactivity of HR and LR mice, were intended to be characterized.  
Second, in order to be able to identify genetic markers determining the endophenotypes 
of HAB/LAB and HR/LR mice, a primary genome-wide association study in an outbred 
population of CD-1 mice was performed to detect loci associated with depression-like 
and anxiety-related behaviors, as well as with extremes in stress-reactivity. It was further 
targeted to provide the basis for the extension of this association study to a larger 
population of outbred CD-1 mice.  
 
24 
 
Animals, materials, and methods 
25 
 
3 Animals, materials, and methods 
3.1 Experimental animals 
All experimental animals used for the experiments described in this thesis were kept in 
type-2 Makrolon standard cages with access to food (no. 1314; Altromin GmbH, Lage) 
and tap water ad libitum in the animal facilities of the Max Planck Institute of Psychiatry. 
Standard housing conditions included equipment of cages with nesting and bedding 
material, standardized room temperature and humidity (23 ±2 °C, 60%), and a 12-hour 
light/dark cycle (beginning light phase at 8 am). Before any behavioral test, a 1-hour 
adaptation to the light phase was allowed; behavioral tests and collection of tissue were 
finished the latest at 1 pm. Mice were either single or group-housed (three to five mice 
per cage), depending on the respective scientific context. If not indicated otherwise, mice 
were aged between 12 - 20 weeks when used for behavioral testing or tissue collection.  
In this thesis, animals of the following mouse models and mouse strains, respectively, 
were used: HAB/LAB mice, HR/LR mice, heterozygous Cofilin-1 knockout mice, C57BL/6 
and CD-1 wild-type mice.  
3.1.1 Inbred mouse models 
As described in the introduction, HAB and LAB mice, as well as HR and LR mice, were 
generated applying bidirectional and selective breeding approaches (see 2.9.1 and 2.9.2; 
for details see Kromer et al., 2005 (HAB/LAB) and Touma et al., 2008 (HR/LR)).   
3.1.2 Heterozygous Cofilin-1 knockout mice 
Heterozygous Cofilin-1 knockout (Cfl-1+/-) mice (2 females, 1 male) were kindly provided 
by Prof. Dr. Walter Witke from the Institute of Genetics at the University of Bonn and 
bred with C57BL/6 wild-type mice. The breeding resulted in offspring either carrying 
heterozygous deletions at the Cofilin-1 (Cfl-1) locus or WT animals. The generation of 
the Cfl-1+/- line was described earlier (Gurniak et al., 2005). Briefly, two loxP sites, both 
flanking exon 2 of the Cfl-1 gene, were introduced. By excision of the lox responsive 
elements, the deletion of the genomic sequence enclosed by the two loxP sites was 
achieved, resulting in a complete deletion of exon 2 and, in addition, a frame shift 
mutation and a translational termination for the remaining Cfl-1 sequence.  
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3.1.3 C57BL/6 wild-type mice 
Male and female C57BL/6 wild-type mice (WT), provided from the animal facility at the 
Max Planck Institute for Neurobiology in Martinsried, were used for breeding with Cfl-1+/- 
mice. 
3.1.4 CD-1 mice 
Male outbred CD-1 mice were purchased from Charles River Laboratories (Sulzfeld) at 
the age of eight weeks. In this study, CD-1 mice were used for the so-called ´CD-1 
panel`, which involved phenotypic and genotypic characterization of mice.  
3.2 Behavioral experiments 
All behavioral experiments were conducted with authorization of the local authorities and 
according to the current directives of the European Union (86/609/EEC) for animal 
experimentation in vertebrates.    
3.2.1 Assessment of anxiety-related behavior 
The main principle of testing anxiety-related behavior in mice is based on subjecting 
animals to an approach-avoidance conflict (Bailey and Crawley, 2009). Mice have an 
innate exploratory drive and tend to investigate unknown territory, but at the same time 
they prefer a protective and familiar environment. The repellent stimulus in the 
unprotected environment is typically increased by illumination (Bailey and Crawley, 2009; 
Crawley, 1999). In the three following tests, mice were exposed to potentially challenging 
situations, but as well given the choice to retract to a secure environment while tracking 
their behavior. Mice were subjected to these tests for 5 min. In between testing animals, 
the apparatus was cleaned using soap water and 70% ethanol (Pharmacy Schwabinger 
Krankenhaus, Munich). Video tracking of animal´s behavior during the test situation was 
done using Stoelting Any-maze software version 4.72 (Stoelting Co. West Lane, IL, 
USA). 
3.2.1.1 Open field test  
The apparatus of the open field (OF) test consisted of a round PVC barrier with a 
diameter of 60 cm and a height of 40 cm (Figure 4). In general, the illumination in the 
inner zone of the OF was brighter compared to the illumination in the outer zone creating 
an aversive area in the inner and a less challenging area close to the barrier. Depending 
on the differences in illumination between the inner and the outer zone, the OF test could 
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either serve as a classical test for anxiety-like behavior or, like in the context of this work, 
as a test to primarily assess the animals locomotion and exploratory behavior (Prut and 
Belzung, 2003; Walsh and Cummins, 1976); hence, the light intensity did slightly differ 
between the central part and the periphery of the OF arena (approximately 15 lx). The 
key criterion in the OF test was therefore the total distance animals travelled in the 
apparatus and not primarily a differentiation between the distances travelled in the inner 
vs. the outer zones which would have allowed a conclusion regarding the anxiety-like 
behavior of the animals (Crawley, 1999). Another important parameter in the OF test was 
the number of rearings as an indicator for the animal´s explorative drive, hereby 
differentiating between free and wall rearings. In the beginning of a testing period, 
animals were placed in the center of the arena.  
 
 
 
Figure 4: OF test apparatus with a brighter illuminated inner zone than outer zone. The 
inner zone, therefore, constitutes a more aversive environment compared to the outer 
zone.      
3.2.1.2 Elevated plus-maze test 
The elevated plus-maze (EPM) was a cross-shaped maze consisting of two closed and 
two open arms, which were connected via a neutral zone (Lister, 1987; Pellow et al., 
1985). The PVC maze was elevated by 40 cm, open arms were 30 x 5 cm, closed arms 
were 30 x 5 x 15 cm, and the neutral zone had an extension of 5 x 5 cm (Figure 5). The 
weakly illuminated closed arms (10 lx) of the maze reflected a protected environment, 
whereas the brighter illuminated open arms (300 lx) constituted an aversive environment 
for the animals (Hogg, 1996). In summary, the more time animals spent in the closed 
area of the EPM, the more anxious their behavior was considered. In contrary, the more 
time animals spend in the aversive open area of the EPM and hence followed their 
exploratory drive, the less anxiety-related the behavior was rated. The number of full or 
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partial entries into the different arms was also taken into account. In addition, the total 
distance travelled on the maze was considered a locomotion parameter and also 
contributed to the estimation of the animal´s behavior. At the beginning of the EPM test, 
animals were placed in the neutral zone facing a closed arm. 
 
 
 
Figure 5: Elevated plus-maze apparatus, consisting of two closed and two open arms, 
which are connected via a quadratic neutral zone.  
3.2.1.3 Dark-light box test 
The apparatus of the dark-light (DL) box was a rectangular PVC box with a smaller black 
compartment (15 x 20 x 25 cm), and a larger white compartment (30 x 20 x 25 cm; 
Figure 6). The two compartments were connected via a tunnel of 5 cm length. The 
illumination of the two compartments differed clearly, thereby creating an explicitly 
aversive environment in the light compartment and a secure compartment in the dark 
part of the box (Bourin and Hascoet, 2003; Crawley and Goodwin, 1980). The 
illumination of the light compartment depended on the gender of animals. Female mice 
were subjected to 700 lx in the light compartment, male mice to 400 lx. The illumination 
for mice of both genders in the dark compartment was 15 lx. Initially, animals were 
placed in the dark compartment of the DL box (Costall et al., 1989). 
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Figure 6: DL box apparatus existing of a light (larger, higher illuminated) and a dark 
compartment (smaller, marginally illuminated).  
3.2.2 Assessment of depression-like behavior 
The conceptual basis for the assessment of depression-like behavior in mice is the 
comparison of an active vs. passive coping style which animals display when being 
exposed to a desperate, inescapable and unpredictable situation (Cryan and Holmes, 
2005; Jacobson and Cryan, 2007). An animal´s behavior was evaluated as depression-
like when the animal showed a passive coping style in a way that it appeared to accept 
the desperate situation without major attempts to escape the unpleasant state. An active 
coping style was characterized by intensive physical efforts to get away from the 
desperate situation. The duration of the tests for the detection of depression-like 
behavior was 6 min. During testing, animals were video-tracked; the subsequent analysis 
of video-material was done using Eventlog 1.0 software (EMCO) by a person being blind 
to the experimental group of the test animal.   
3.2.2.1 Tail suspension test  
The tail suspension test (TST) executes a haemodynamic stress to the animals (Cryan et 
al., 2005; Steru et al., 1985). Four animals at a time were subjected to the TST by 
suspending them at their tail tips to a metal framework (Figure 7). Their coping styles 
during this inescapable situation were evaluated by differentiating between mobile 
(active coping style) and immobile phases (passive coping style). The more immobile 
periods an animal displayed during this test, the more depression-like the behavior of the 
respective animal was rated. 
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Figure 7: During the TST procedure mice are suspended by their tail tips from a lever of 
a metal framework.  
 
3.2.2.2 Forced swim test 
The “Porsolt`s” forced swim test (FST) was originally published as “a primary screening 
test for antidepressants”, and in this way was also widely used for the screening of 
depression-like behavior. In the FST, a physically and mentally highly aversive stressor 
was provided to the animals (El Yacoubi and Vaugeois, 2007; Petit-Demouliere et al., 
2005; Porsolt et al., 1977; Porsolt et al., 1978). Mice were placed into 2 l glass cylinders 
which were filled with 1.75 l tempered water (23 °C). It was excluded that mice could 
touch the beaker´s ground with their tails, neither could they escape from the glass 
cylinder by climbing (Figure 8). The behavior mice showed during the test period was 
differentiated between struggling, swimming, floating (Steiner et al., 2008; Varadarajulu 
et al., 2011), and freezing behavior (Crawford and Masterson, 1982; Gross et al., 2000). 
An absolute rigor, usually occurring immediately after placing the mouse mice into the 
water, was scored as freezing behavior. Struggling involved vehement movements of all 
four limbs with mostly fore-paws above the water surface. The animal´s body axis was 
almost horizontal during struggling periods. Swimming was scored when the mouse 
showed coordinated movements with all four paws under the water surface. The body 
axis was horizontal and the animal covered a distance when swimming. Passive periods 
with no movements or slight balancing movements in order to maintain the passive 
condition were scored as floating. Typically, in the beginning of the testing period the 
animals showed active coping strategies, starting with vigorously struggling and 
swimming, followed by passive periods of floating behavior. The total time spent floating 
was considered as the main parameter of the FST indicating depression-like behavior.  
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Figure 8: Experimental set-up of FST experiments displaying the inescapable situation 
for testing animals in a 2 l glass cylinder.  
 
3.2.3 Assessment of stress reactivity 
In order to test an animal`s stress reactivity, the so-called stress reactivity test (SRT) was 
conducted (Touma et al., 2008). This test involved the collection of an initial blood 
sample from the animal´s tail vessel, followed by the animal´s subjection to a 15 min 
period of a restraint stressor and the subsequent collection of a reaction blood sample, 
again from the tail vessel. The initial blood sample reflected the resting condition as it 
was taken right after removing the mouse out the home cage. Directly after blood 
sampling, the mouse was placed into a 50 ml Falcon tube (Sarstedt, Nümbrecht), 
equipped with a hole in the ground allowing ventilation and a hole for the tail in the cap of 
the tube (Figure 9). After 15 min, the mouse was removed from the tube, the reaction 
blood sample was immediately taken and the animal was put back into the home cage. 
The SRT of Cfl1+/- and WT control mice was conducted with slight modifications, as in 
addition to the standard procedure described above recovery samples were collected 60 
min after the reaction blood samples.  
Blood samples (in each case approximately 50 µl) were collected using heparinized 
capillaries (Micro haematocrit tubes, Brand GmbH and Co KG, Wertheim). Capillaries 
were sealed using a Haematocrit sealing compound (Brand GmbH and Co KG, 
Wertheim) and centrifuged for 5 min at 14,800 g to separate cellular and plasma 
components of the blood. Plasma was collected and stored at -20 °C for further 
analyses. 
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Figure 9: The restraint stressor mice are subjected to during the SRT is presented by 
tubing animals into a 50 ml Falcon tube. The test procedure also involves the covering of 
the tube with a lid. 
 
3.2.4 Behavioral test batteries performed in this study 
3.2.4.1 Behavioral test battery conducted for phenotypic characterization of Cfl-1+/- 
vs. WT mice 
At the age of eight to twelve weeks, male and female Cfl-1+/- and WT mice were 
separately subjected to a behavioral test battery. In this behavioral test battery (Figure 
10), the OF was primarily chosen as a test for locomotion, followed by two paradigms for 
the testing of anxiety-related behavior, the FST for monitoring depression-like features, 
and finally the SRT to test the animal´s stress reactivity. In all behavioral tests, WT 
littermates served as control animals.  
 
 
 
Figure 10: Illustration of the behavioral test battery Cfl-1+/- and WT mice were subjected 
to. The order of behavioral tests was arranged according to an increase of stress 
intensity. (Illustrations of behavioral test apparatuses were adopted from Lynn Talton 
available at http://btc.bol.ucla.edu/neuroscreen.htm.)   
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3.2.4.2 Behavioral test battery conducted for phenotypic characterization of an 
outbred population of CD-1 mice 
384 male CD-1 mice were subjected to the ´CD-1 panel` behavioral test battery 
assessing locomotion, anxiety-related and depression-like behavior, as well as stress 
reactivity of the animals. Animals were subjected to this test battery in eight separate 
batches of 48 mice. After arriving from Charles River Laboratories, mice were allowed to 
habituate for four days before 24 mice (half the animals of a batch) were tested on the 
EPM and the other half in the OF. Two days later, animals, which were EPM tested 
already, were subjected to the OF and vice versa. After the FST, which followed again 
two days later, mice were allowed to rest for four days before they were subjected to the 
physically and mentally stressful SRT. The final test of the test battery was the TST. 
After this, mice were sacrificed and tail tips were collected for DNA extraction. The time 
course of the test battery is shown in Figure 11.  
 
 
Figure 11: Graphic illustration of behavioral test battery animals of the ´CD-1 panel` were 
subjected to. (Illustrations of behavioral test apparatuses were adopted from Lynn Talton 
available at http://btc.bol.ucla.edu/ neuroscreen.htm.)   
 
3.3 Sacrifice of animals 
Animals were sacrificed after administration of anesthesia. Mice were therefore placed 
into an inhalation chamber saturated with Isoflurane (Curamed Pharma, Karlsruhe). The 
anesthetized animal was immediately killed by decapitation. 
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3.4 Dissection of embryos 
Pregnant females were sacrificed on day 18 of pregnancy (ED 18). Immediately, the 
uterus was opened and embryos were extracted from the amniotic sacs. Embryos were 
promptly sacrificed by decapitation and the heads were collected in ice cold PBS (Table 
3) for further extraction of the hippocampus.  
3.5 Collection of brain and hippocampal tissue from embryonic and adult mice  
Brains were gained immediately after sacrificing the animal by opening the cranial bones 
along the sagittal suture, laterally removing the cranial bones and raising the brain from 
the base of the skull. Hippocampal tissue was collected separating the two hemispheres 
with a scalpel. The hemisphere was fixed at the cerebellum and the cerebrum was 
removed with a sliding movement using a spatula, thereby exposing the hippocampus. 
Hippocampal tissue was displaced from the cerebrum using curved forceps. The 
procedure was conducted on an iced surface. Hippocampal tissue, as well as rest brain 
tissue, was frozen at -80 °C for further analyses. Hippocampal tissue of embryos was 
collected in a cell culture plate (5 cm diameter; Nunc A/S, Roskilde, Denmark) filled with 
iced dissection medium containing HBSS medium, Pen/Strep, 1M HEPES, and 200 mM 
L-Glutamine (all from Invitrogen, Darmstadt) using a binocular microscope (Olympus U-
TV0.5XC-3, Hamburg).   
3.6 Nucleic acid based methods 
3.6.1 RNA based methods 
Whenever processing RNA, protocols were conducted under a fume cupboard 
(Köttermann Systemlabor type 2-453-DAHD, Uetze-Hänigsen) to prevent contamination 
with RNAses. In addition, surfaces and equipment were treated with 0.1M NaOH (Merck, 
Darmstadt), followed by 70% ethanol, and pipette tips with a special security standard 
(Sarstedt, Nümbrecht) were used.  
3.6.1.1 Extraction of total RNA from hippocampal tissue 
Hippocampal tissue was thawed on ice and immediately homogenized using a pestle, 
fitting the conical shape of 1.5 ml Eppendorf tubes (Eppendorf, Hamburg). 1 ml TRIzol 
(Invitrogen) was added stepwise (Chomczynski and Sacchi, 1987). After vortexing 
vigorously, the homogenate was incubated at RT for 5 min. 0.2 ml chloroform (Sigma-
Aldrich, Taufkirchen) per ml TRIzol were added, mixed vigorously and again incubated at 
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RT for 3 min. After a centrifugation step for 15 min at 21,000 g and 4 °C, the clear 
supernatant was transferred into a clean Eppendorf tube. 0.5 ml ice cold isopropanol 
(Sigma-Aldrich) per ml TRIzol were added, the sample was vortexed and incubated 
at -20 °C overnight. The day after, the extraction process was continued by 
centrifugation for 10 min at 21,000 g and 4 °C. The supernatant was discarded and 1 ml 
ice cold ethanol 70% per ml TRIzol was added to precipitate RNA. After vortexing and 
centrifuging for 5 min at 10,000 g and 4 °C, the supernatant was again discarded and the 
RNA pellet was air-dried for approximately 20 min. After complete vaporization of the 
alcohol, the RNA pellet was dissolved in 50 µl RNAse-free water (Ambion, Austin, TX, 
USA). The amounts of this protocol were used for RNA extraction of hippocampal tissue 
from adult animals. If hippocampal RNA was extracted from younger mice, the 
measurements were adapted. For example, for the RNA extraction of hippocampi from 
ED 18 mice 300 µl TRIzol were used, and further amounts were reduced accordingly.  
3.6.1.2 Control measures of RNA quality and determination of RNA concentration 
RNA was quality checked by using Agilent RNA NanoChips and the Agilent 2100 
Bioanalyzer (Agilent Technologies, Böblingen). The RNA integrity number (RIN factor) 
was measured and taken as standard measure for RNA quality. RIN factors >7.15 were 
considered showing satisfactory RNA quality (Kiewe et al., 2009). If RNA samples were 
used for microarray purposes, probes were quality checked twice, before and after 
amplification. Using the Bioanalyzer, concentration of RNA probes was determined 
simultaneously.  
Alternatively, RNA concentration was detected using an Implen NanoPhotometer 
(Implen, München). Usually, lidfactor 50 was chosen for the determination of RNA 
concentrations. In case of low RNA yields, lidfactor 10 was used. The absorption ratio 
detected at 260 and 280 nm (A260/A280) which was automatically detected by the 
NanoPhotometer served as control parameter. A ratio of about 1.8 was considered 
showing satisfactory RNA quality. Likewise, the NanoPhotometer was also used for the 
determination of DNA concentrations and A260/A280 ratios. 
3.6.1.3 Reverse transcription of RNA into cDNA 
RNA was reversely transcribed into cDNA using the High-Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems, Darmstadt) strictly following the manufacturer´s 
instructions. Briefly, 2.0 ml 10x RT buffer, 0.8 µl 25x dNTP mix (100 mM), 2.0 µl 10x RT 
random primers, 1.0 µl Multiscribe Reverse Transcriptase, 4.2 µl nuclease-free water 
and a total volume of 10 µl RNA were mixed on ice. A 4-step program was run (25 °C 
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10 min, 37 °C 120 min, 85 °C 5 min, 4 °C ad infinitum) in a thermal cycler (Peqlab primus 
96 advanced PCR machine; Peqlab, Erlangen). 
3.6.1.4 RNA amplification for array analysis 
Total RNA from seven HR, and eight LR mice was processed for array analysis strictly 
following the instructions of the Illumina TotalPrep RNA Amplification Kit (part number 
AMIL1791; Ambion). In short, 250 ng total RNA were reversely transcribed into first 
strand cDNA using T7 oligo (dT) primers. Incubation for first strand cDNA synthesis at 
42 °C and for second strand cDNA synthesis at 16 °C was done in the thermal cycler. 
Newly synthesized dsDNA transcription templates were purified and subsequently 
processed into cRNA. Therefore, incubation at 37 °C was done for 14 h in a 37 °C 
incubation chamber. Subsequent cRNA purification was performed using a PHMT Grant-
bio thermo-shaker (Keison, Essex, UK). Assessment of purified biotin-labeled cRNA 
yield and quality was done via bioanalyzer analysis (see 3.6.1.2). In a direct hybridization 
assay, an Illumina gene expression beadchip array (type MouseWG-
6_V2_0_R2_11278593_A; Illumina, San Diego, CA, USA) was chosen for expressional 
profiling of cRNA. Hybridization was performed strictly following the manufacturer´s 
instructions and using the equipment recommended by Illumina. The fluorescence based 
hybridization signals were detected using a BeadStation scanner and BeadStudio Gene 
Expression Analysis Module 3.4.0 software, both by Illumina. Statistical analysis of the 
microarray experiment was described under points 3.8.1.1 and 3.8.1.2.  
3.6.1.5 Serial analysis of gene expression  
A serial analysis of gene expression (SAGE) was conducted as an alternative 
transcriptome analysis. Here, pooled samples of total RNA from HR and LR animals 
were used for expressional profiling. The HR RNA-pool consisted of total RNA from 
seven HR animals in equal shares; the LR RNA-pool was prepared from eight animals 
accordingly.   
The library was prepared following the manufacturer´s instructions in the standard 
protocol of the Applied Biosystems SOLiD 3 System kit (Invitrogen, Paisley, UK). In 
short, each RNA pool contained 1 µg total RNA as starting material. The poly(A) tail of 
the total RNA was bound to magnetic beads and first- and second strand cDNA 
synthesis from the RNA-magnetic bead-hybrid was done using SuperScript III Reverse 
Transcriptase provided in the kit. A Nla III digestion step was conducted cleaving the 
cDNA approximately every 250 bp, providing complementary binding sequences for 
Adapter A ligation. The Adapter A provided a 3-terminal EcoP15l restriction site, and the 
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first priming site for later PCR amplification. Afterwards, an EcoP15l digestion step was 
carried out, as this type III restriction endonuclease served as tagging enzyme. The 
resulting 60 bp tag consisted of approximately 33 bp adapter sequence plus 27 bp of a 
specific sequence unit from a RNA transcript. The subsequent Adapter B ligation 
delivered the SOLiD sequencing initiation site, plus the second PCR amplification site.   
Template beads were prepared according to the SOLiD 3 Systems Templated Bead 
Preparation full-scale protocol starting with an upscale PCR (95 °C 2 min; 95 °C 30 s, 
55 °C 1 min, 72 °C 1 min, 10 cycles; 72 °C 5 min). Upscale PCR products were run on a 
4% agarose gel for size separation and quality control. SAGE tag templates appeared in 
a 100 bp fragment, which was extracted from the gel and purified via micro columns 
provided with the kit. In addition, product quality was checked using High Sensitivity DNA 
chips (Agilent Technologies) in the Agilent 2100 Bioanalyzer. 500 pmol of the purified 
and controlled product were used as template in the emulsion PCR (95 °C 5 min; 93 °C 
15 s, 62 °C 30 s, 72 °C 75 s, 40 cycles; 72 °C 7 min) amplifying tag library onto beads 
and thus preparing the clonal bead population. According to the protocol, beads were 
purified, enriched and modified at the 3´ terminal ends.  
41 million beads per pool were deposited as octets on the slide and sequenced 
accordingly using the Applied Biosystems SOLiD Analysis Tool (SAT) v3.5 (Applied 
Biosystems, Carlsbad, CA, USA). The statistical analysis of the SAGE experiment was 
described under point 3.8.2. 
3.6.2 DNA based methods 
3.6.2.1 DNA extraction from mouse tissue 
Genomic DNA was extracted from either tail tips or brain tissue using the Genomic DNA 
from Tissue Nucleospin Tissue kit (Machery-Nagel, Düren). DNA extraction from brain 
tissue was carried out following the manufacturer´s instructions of the standard protocol 
for human or animal tissue and cultured cells. Briefly, around 25 mg homogenized brain 
tissue was incubated in 180 µl buffer T1 and 25 µl Proteinase K at 56 °C overnight to 
digest and lyse the tissue using a thermo-shaker (Thermomixer 5436, Eppendorf, 
Hamburg). The day after, 200 µl lysis buffer B3 were added, and DNA was precipitated 
by adding 210 µl ethanol 96%. Further on, samples were loaded onto a Nucleospin 
tissue column and DNA was collected in the silica membrane of the column by 
centrifugation for 1 min at 11,000 rpm. After a first washing step with 500 µl buffer BW, 
followed by centrifugation for 1 min at 11,000 rpm and a second wash step with 600 µl 
buffer B5 and again centrifugation for 1 min at 11,000 rpm, the silica membrane was 
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dried, and DNA was eluted in 100 µl pre-warmed elution buffer. Extraction of genomic 
DNA from tail tips was performed according to the support protocol for mouse or rat tails 
which requires an extra centrifugation step after the overnight incubation. Here, samples 
were centrifuged for 5 min at high speed to pellet undigested tissue. 200 µl of the clear 
supernatant were collected and the protocol was continued as described above. 
Determination of DNA concentration and quality was done in analogy to the 
determination of RNA concentration and quality as described under point 3.6.1.2. 
3.6.2.2 Polymerase-chain reactions and gel electrophoresis 
Polymerase-chain reactions (PCRs) were performed to amplify a DNA fragment of 
interest and subsequently visualize the amplicon in a gel electrophoresis. PCRs were 
conducted to genotype embryos regarding gender and to differentiate between mice 
being either heterozygous knockout or WT at the Cfl-1 locus. All PCRs were prepared n 
ice and were run using a thermal cycler. 
PCR for specific amplification of the Sry locus 
A PCR specifically amplifying the Sry locus (Sry PCR) on chromosome Y was conducted 
to distinguish between male and female mice gained at ED 18. The detection of the Sry 
gene in this PCR was taken as a marker for a male genotype, whereas the absence of 
the Sry gene displayed a female genotype. The PCR mix for one sample contained 5 µl 
10x DreamTaq buffer, 5 µl dNTP mix (2 mM each), 1 µM upstream primer, 1 µM 
downstream primer, 1 µg genomic DNA, 1.25 u DreamTaq DNA polymerase and 
nuclease-free water up to a total volume of 50 µl (Fermentas, St. Leon-Rot; 
oligonucleotide sequences see Table 1). DNA of adult male and female mice served as 
positive and negative controls, respectively. In addition, water controls containing water 
instead of DNA were prepared. The PCR was run in a touch-down program (95 °C 4 min; 
95 °C 1 min, 66 °C 1 min, 72 °C 1 min, 5 repeats; 95 °C 1 min, 64 °C 1 min, 72 °C 1 min, 
5 repeats; 95 °C 1 min, 62 °C 1 min, 72 °C 1 min, 5 repeats; 72 °C 10 min). 
PCR for genotyping of the Cfl-1 locus 
The genotyping of the Cfl-1 locus was done by PCR (Cfl-1 PCR) using a set of three 
primers (A, B, and C primer; oligonucleotide sequences see Table 1). Amplification of 
DNA from mice carrying two WT alleles at the Cfl-1 locus resulted in one distinct 
amplicon with a fragment size of 380 bp. DNA of mice carrying a heterozygous knockout 
at the Cfl-1 locus showed one WT amplicon and, in addition, a 170 bp fragment, which is 
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the PCR product of the truncated Cfl-1 allele. The PCR reaction for one sample 
contained 10 µl 5x Colorless GoTaq reaction buffer, 5 µl MgCl2 25 nM, PCR Nucleotide 
Mix 10 mM 1 µl, 1 µM of each primer, GoTaq DNA polymerase (5u/µl) 0.25 µl, 1 µg 
genomic DNA and nuclease-free water up to 50 µl (Promega, Madison, WI, USA). 
Genotyping strategy, primer sequences and PCR conditions (94 °C 2 min; 94 °C 30 s, 
58 °C 30 s, 68 °C 40 s, 35 repetitions; 68 °C 5 min) were kindly provided by Christine 
Gurniak (Gurniak et al., 2005).  
3.6.2.3 Gel electrophoresis 
PCR products were controlled and visualized via gel electrophoresis. Therefore, 1.5% 
agarose (UltraPure, Invitrogen) in TAE buffer (10.8 g TRIS (Roth, Karlsruhe), 5.5 g boric 
acid (Sigma, Taufkirchen), 0.7 g EDTA (Sigma), ddH2O ad 1 l; pH = 8.0) were microwave 
heated until all solid particles were dissolved. 5 µl ethidiumbromide (Roth) per 100 ml gel 
were added. After gel polymerization, 12 µl PCR product together with 2 µl 6x DNA 
loading dye (Fermentas) were loaded. ZipRuler Express DNA ladder 1 (Fermentas) 
served as DNA standard ladder. The gels were run at 110 V for 1 h in TAE buffer. After 
gel electrophoresis, DNA signals were visualized under UV light (BioDoc II 
Transilluminator; UVP, Upland, CA, USA) and documented using a digital graphic printer 
(UP-D860E; Sony, New York, NY, USA).  
3.6.2.4 Precipitation of cDNA 
After reverse transcription of RNA into cDNA, genomic DNA fragments were precipitated 
via ethanol-based precipitation. Therefore, 20 µl cDNA were mixed with 2 µl sodium 
acetate 3 M (Sigma), 40 µl ethanol 96%, and 2 µl glycogen 10 mg/ml (Roth). The 
samples were vortexed and shock frozen in liquid nitrogen (Air Liquide, München). After 
centrifugation for 30 min at 21,000 g and 4 °C, supernatant was discarded and 300 µl 
ethanol 70% were added. After a second centrifugation step for 5 min at 21,000 g and 
4 °C, the supernatant was again discarded and the samples were dried at 65 °C in the 
thermo block for 15 min, followed by 20 min at room temperature. cDNA pellets were 
dissolved in the appropriate volume of nuclease-free water; for example, 50 µl nuclease-
free water were used for dissolving of cDNA from a whole hippocampus of an adult 
animal.  
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3.6.2.5 Quantitative real-time PCR 
 
The principle behind quantitative real-time PCR (qPCR) analysis is a simultaneous 
amplification and quantification of PCR products allowing quantitative conclusions 
regarding a target gene´s expressional activity (Higuchi et al., 1993). Sybr Green was 
used as a fluorescent reporter signal. The fluorescence signal of a target gene was 
standardized to the fluorescence signal of a housekeeping gene and the result was seen 
as a relative expression value of the target vs. the housekeeping gene. The 
housekeeping gene used for qPCRs presented in this study was beta-2 microglobulin 
(B2m, Becker et al., 2004). qPCR runs were analyzed using the absolute quantification 
fit point function of the LightCycler Software 4.05 and the LightCycler 2.0 instrument 
(Roche Diagnostics, Mannheim), thereby standardizing thresholds and noise bands of 
target and housekeeping genes to equal values. Crossing points (CPs) were transformed 
into fold changes (FCs) using the 2-∆∆CT algorithm (Livak and Schmittgen, 2001). As 
internal control, a pooled standard dilution series was prepared. Error rates below 0.05 
and efficiencies of 2.0 were aimed. Samples as well as standards were measured in 
duplicates. CPs of duplicates deviating more than one CP were excluded from the 
analyses. Water controls (containing water instead of cDNA) and RT controls (containing 
negative sample of the RT instead of cDNA) were measured as well. The melting 
temperature (Tm) of the amplicon was detected and equal Tms were taken as a control 
measure for primer specificity.  
qPCR primers were designed to be intron-spanning to guarantee the amplification of 
cDNA only (oligonucleotide sequences see Table 1). Primer pairs not fulfilling control 
parameters were discarded and redesigned.  
Samples were prepared using QuantiFast Sybr Green PCR mastermix (Qiagen, Hilden) 
containing 5 µl QuantiFast Sybr Green, 1 µl forward primer 10 pM, 1 µl reverse 
complementary primer 10 pM, 2 µl cDNA and 1 µl nuclease-free water. The conditions of 
the LightCycler program (95 °C 10 min; 95 °C 10 s, 60 °C 30 s, 40 repetitions; generation 
of melting curve: 50 - 95 °C with 0.1 °C/s temperature increase) were adjusted to the 
recommendations of the QuantiFast Sybr Green PCR mastermix.  
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3.6.2.6 Table of oligonucleotides 
Table 1: List of oligonucleotids (´primers`) used for experiments presented in this study. 
All primers were purchased from Sigma Aldrich. 
 
 
Primer Table 
 
 
I. qPCR Primer 
 
Target  
gene 
Forward   
sequence 
Tm 
[°C] 
Reverse 
complementary 
sequence 
Tm 
[°C] 
Product 
length 
[bp] 
Accn2 
AGT GCT ACA CAT 
TCA ACT CGG 
61.72 
CTC GTC CTG ACT 
GTG GAT CT 
61.93 185 
Acot1 
AAG AAG CCG TGA 
ACT ACC TG 
60.85 
CTC ATC CTT GTA 
GGA GAT GGT 
59.56 185 
Acot11 
ACA GCC TCT ATG 
GAT GAC ATC 
60.53 
CTG CTT CTC AGA 
GCA CAG AT 
59.89 147 
Acot13 
AGA GTT CAT TCT 
CGC AGA GC 
61.28 
CTT CCA CCT TCA 
TCT CAC AGA 
61.85 180 
Adam11 
CAG TGT CAC CTT 
CTA CCA CCA 
62.64 
AGA TCC TTC GCT 
CTC CAC TT 
61.89 197 
Adam22 
CAC CCA CTT TCC 
TCA CAA T 
59.96 
TTC CTA AGA TGA 
GGG CCA G 
61.72 128 
Aldh1l1 
GCT GGC TGG TGT 
GAT AAG AT 
61.67 
TTC CAG GAC AGC 
ATC ATT AAG 
61.58 149 
Ash1l 
TTC AGA ACA TAA 
GAA GGG GGT 
61.25 
AGC ACA GGT TGC 
AAG GTA TT 
61.12 195 
B2m 
CTA TAT CCT GGC 
TCA CAC TGA 
59.30 
CAT CAT GAT GCT 
TGA TCA CAT 
60.96 130 
Bdnf 
TTC CAC CAG GTG 
AGA AGA GT 
61.30 
CAT TCA CGC TCT 
CCA GAG T 
60.60 163 
Cfl-1 
ATG ATC TAT GCC 
AGC TCC AAG 
63.01 
CGC TGC CAC CTA 
GTT TCT CT 
63.38 127 
Cntn6 
GAA TGC ATC GCA 
GGT AAC C 
63.04 
GTG TTG AGA CGT 
TGA CCA TTC 
62.02 194 
Crtac1 
ATC TAC AGA TGA 
GTG CTC ACG 
59.48 
TTC TGT AGG CAA 
TGT TGT TGA 
60.72 150 
Cyp4f13 
ATG TTC TCT TGA 
TGG CTG AG 
59.39 
TCG CCA GGT TGT 
AGA GAA T 
59.82 138 
Cyp4f14 
ATA GCA CCA ACA 
TCA TGC AC 
61.01 
CCA GGA TGG CAG 
CAA TAT AT 
61.25 174 
Cyp4f15 
ACA TCA TTC GAT 
CTG TTC TCA 
59.67 
CTC CAC TTG TCA 
CCA TCA CT 
60.18 121 
Cyp4f16 
ATG TGC ATC AAG 
GAG AGT CTG 
61.88 
GATGCTGATGACA
CAGATGTT 
60.16 126 
Dap3 
GAG CTT CTG GGC 
TAC CTG A 
62.11 
AGC ATC TGG GAT 
ATG CAG AAT 
62.31 156 
Fam116b 
AAC TCA TGC TTC 
TTG GGG A 
62.22 
GCT CCT TGA ACT 
CAC TGT CAT 
60.89 156 
Fam123a 
ACA GGT GAC GTT 
CCG ATA AA 
61.92 
TTC AGT GAA GTC 
ACG TCA GAA 
61.08 155 
Gabrg2 
TGC TCC TGC TAT 
CGC TCT A 
61.40 
TTG TCA TAC CCT 
TCC AGC A 
61.7 184 
Hmgn3 
AGG TGC TAA GGG 
GAA GAA GG 
63.30 
GTC CCG AGA GGT 
ACG TGA AA 
64.00 171 
Hsp90ab1 CCT GAG GAA GTG 61.34 CAA TTT TCA GCT 62.42 217 
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CAC CAT CTT TCC CAC 
Mthfd1 
AAG ACT GCC AAT 
CTG GAC AAG 
63.13 
CTG GAA CAT AAT 
TGA TCC CAC A 
63.34 136 
Prodh 
ACA ATG TGA CCT 
TGG ATA TGG 
61.06 
ACA TAG TTA AGG 
CAC CTG TGG T 
61.23 181 
Pvalb 
ACA TCA AGA AGG 
CGA TAG GA 
61.18 
GAG GAG AAG 
CCC TTC AGA AT 
61.28 187 
Rgl1 
ACA CAC AGT CAG 
TCA GTA CGA G 
59.46 
AGC TCC AGC ACT 
TCC TTA GT 
59.64 171 
Rps6ka5 
CGG TCT GAG TAA 
GGA GTT TGT 
59.79 
AAC ACC TAA GCT 
CCA CCA GT 
60.19 142 
Sh3gl2 
ATG ATT GCA ACT 
TTG GTC CT 
60.93 
CAG ATC CTT GTC 
ATG AAG ATT CT 
61.03 137 
Ssh1 
CAA GTG ATG ATC 
AAC CTC CT 
59.08 
GTC AAC TCC CAG 
CAG AAT ATT 
59.59 150 
Tesk1 
GAG ACC TCA CAT 
CCA AGA ACT 
59.72 
GCC TTC TCA TCA 
TAC AGC TCT 
60.01 193 
Timp4 
TCC AGT GAG AAG 
GTA GTC CCT 
61.64 
ATA CTG CTT GTG 
ACT GTT GGT TT 
61.38 188 
Tmem106c 
ACC GCG GTA TAA 
ACA TTG AG 
61.30 
CTT CAC TGC TAA 
CCA ATC CAT 
60.54 178 
Tmem132d 
CAT CCC TTC TTC 
AGC CAG AG 
63.80 
AGT GAG AAC CGC 
TGA ATG CT 
63.90 187 
Ttbk1 
ATC AGT GTG TCC 
ATG CCT GT 
63.20 
ACT GTT TGG GAC 
GGA GGT C 
64.00 148 
Usp38 
ACT GGC AGC TGT 
TCA GAA G 
60.79 
GCA GCA TAT GAG 
AGA GGA CTG 
61.55 128 
 
II. Sry PCR 
 
Sry 
TGT TTC TCT TTG 
CAT CAC ATC TCT 
GTC 
68.22 
GTC CCA CTG CAG 
AAG GTT GTA CA 
67.22 482 
 
III. Cfl-1 PCR 
 
deleted 
Cfl-1 allele 
(A and B 
primer) 
 
Cfl-1 WT 
allele       
(C and B 
primer) 
CGC TGG ACC AGA 
GCA CGC GGC ATC 
 
 
CAT GAA GGT TCG 
CAA GTC CTC AAC 
 
82.31 
 
 
 
69.63 
 
CTG GAA GGG TTG 
TTA CAA CCC TGG 
 
 
CTG GAA GGG TTG 
TTA CAA CCC TGG 
 
70.00 
 
 
 
70.00 
 
 
170  
 
 
 
380  
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3.7 Protein based methods 
3.7.1 Mitochondrial proteomics 
3.7.1.1 Preparation of mitochondrial protein lysates 
 
Mitochondrial protein lysates from hippocampal tissue of adult HR and LR mice were 
gained according to the subcellular fractionation and protein extraction protocol 
described by Cox and Emili in Nature Protocols (Cox and Emili, 2006). According to this, 
hippocampal tissue (around 30 mg) was slowly thawed from -80 °C and homogenized on 
ice using a plastic pestle tightly fitting a 1.5 ml Eppendorf tube. After homogenization, 
180 µl 250-STMDPS buffer (Table 2) were added to the hippocampal tissue and the 
tissue homogenate was dissolved in the buffer by slightly grinding for 3 min. The 
completely dissolved homogenate was centrifuged for 15 min at 80 g, supernatant was 
collected and stored on ice. The pellet (volume around 80 µl) was dissolved in 640 µl 
250-STMDPS buffer and rehomogenized for 1 min using the plastic pestle. A second 
centrifugation step for 15 min at 80 g followed and the supernatant was collected again, 
the pellet was discarded. To pellet the mitochondrial protein fraction, the first and the 
second supernatant from one hippocampal tissue sample were collected and centrifuged 
in separate tubes for 15 min at 4,500 g. The mitochondrial pellets from one sample were 
resuspended in 100 µl 250-STMDPS buffer, centrifuged for 15 min at 4,500 g to repellet 
the mitochondrial fraction. After resuspension of the pellet in 100 µl HDP buffer (Table 2), 
the suspension was incubated on ice for 30 min. Samples were sonicated on ice 
usingfive bursts each of the Branson Sonifier Cell Disruptor B15 (Hielscher Ultrasonics, 
Teltow) to support protein lyses. After spinning the samples for 30 min at 10,000 g, the 
supernatant containing the soluble fraction of the mitochondrial matrix proteins was 
collected. In order to achieve an extraction of mitochondrial membrane proteins, the 
pellet was resuspended in 100 µl ME buffer (Table 2) and incubated for 30 min at 4 °C 
while gently rocking the samples using an Elmi Rotamix RM1 (ELMI, Riga, Latvia). A 
final centrifugation step was conducted for 30 min at 10,000 g. The resulting supernatant 
contained the fraction of mitochondrial membrane proteins. Both mitochondrial proteins 
fractions, the matrix protein fraction and the mitochondrial membrane proteins, were 
merged and protein concentration was determined via a Bradford assay. 
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3.7.1.2 Bradford assay 
5 µl of the mitochondrial protein sample were mixed with 795 µl ddH2O. A standard curve 
consisting of a BSA dilution series (2, 4, 6, 8, and 10 µg/ml) was pipetted, and both the 
diluted protein samples and the BSA standards were mixed with 200 µl Bradford reagent 
(Bio-Rad Laboratories, München). Absorption was detected within 30 min at 595 nm 
using a Beckman DV640 Spectrophotometer (Beckman Coulter, Krefeld). Samples as 
well as standards were measured in duplicated and mean values were used for further 
calculations.  
3.7.1.3 Two-dimensional gel electrophoresis 
After determination of protein concentrations, 200 µg mitochondrial protein lysates were 
diluted in IEF buffer (Table 2) to a total volume of 250 µl. The mitochondrial protein 
samples were centrifuged for 20 min at 24,000 g and subsequently loaded on a 
ReadyStrip IPG Strip (Bio-Rad Laboratories, Hercules, CA, USA). 200 µl of the samples 
were loaded on an IPG strip and incubated for 1 h before overlaying it with 3 ml mineral 
oil (Bio-Rad). After rehydrating the IPG strips in the IEF-tray (Bio-Rad) for 12 h, wicks 
(Bio-Rad), which were humidified with 20 µl ddH2O, were placed between IPG strips and 
electrodes to absorb excess salt. The first dimension, which separates the proteins 
contained in the lysate according to the isoelectric point of the proteins, was run for 8 -
9 h with a final voltage of 8,000 V.  
In the second dimension, the proteins already separated along the isoelectric gradient, 
were additionally segregated along a size gradient. One criterion gel per sample was 
therefore prepared using a 12% separating gel consisting of 12 ml acrylamide/bis-
acrylamide (37.5:1; Serva Electrophoresis, Heidelberg), 1.5 M Tris-HCl 7.5 ml, 10% SDS 
300 µl, Temed 15 µl, 10% APS 150 µl (all Bio-Rad), 10.06 ml ddH2O and a 4% stacking 
gel consisting of acrylamide/bis-acrylamide (37.5:1) 1.98 ml, 0.5 M Tris-HCl 3.78 ml, 10% 
SDS 150 µl, Temed 15 µl, 10% APS 75 µl and 9 ml ddH2O. During polymerization of 
criterion gels, IPG strips were equilibrated for 15 min in equilibration buffer I and 
subsequently for 10 min in equilibration buffer II. After equilibration, IPG strips were 
overlaid with running buffer, inserted between the spacer glass plates above the stacking 
phase of the criterion gel, and additionally covered with pre-warmed 0.5% low-melting 
agarose solution (Bio-Rad). A placeholder for the protein ladder (Precision Plus Protein 
Standard; Bio-Rad) was formed. The gel was initially run at 80 V, voltage was increased 
to 120 V after 10 min for approximately 1.5 h.   
For protein staining in colloidal coomassie, the gel was fixed in 100 ml 30% ethanol 
containing 2% phosphoric acid (Merck) overnight and afterwards washed in ddH2O three 
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times for 1 h, and incubated in 120 ml staining solution for 1 h. The two-dimensional (2D) 
gels were left in the colloidal coomassie staining solution (Table 2) rocking for three days 
on a Rotamax 120 shaker (Heidolph Instruments, Schwabach).  
 
Table 2: List of buffers and staining solutions used for protein based protocols. 
 
Buffer Function 
Composition                        
(filter-sterilized, stored at 4 °C) 
250-STMDPS Initial homogenization 
1 mM DTT (Bio-Rad) 
25 µg ml-1 spermine (Sigma) 
25 µg ml-1 spermidine (Sigma)  
PMSF as per manufacturer´s 
specifications (Sigma) 
Complete Protease Inhibitor Cocktail 
Tablets (Roche) according to 
manufacturer´s instructions 
HDP 
Extraction of soluble 
mitochondrial proteins 
10 mM HEPES (pH = 7.9; Sigma) 
1 mM DTT 
1 mM PMSF 
ME 
Extraction of mitochondrial 
membrane proteins 
20 mM Tris-HCl (pH 7.8; Bio-Rad)  
0.4 M NaCl (Merck)  
15% glycerol (Merck) 
1 mM DTT  
1 mM PMSF              
1.5% Triton-X-100 (Sigma) 
Rehydration 
buffer 
Rehydration of IPG strips 
7 M urea (Bio-Rad) 
2 M thiourea (Sigma) 
0.2% biolytes 3 - 10 (Bio-Rad) 
2% CHAPS (Bio-Rad) 
100 mM DTT 
IEF 
Sample buffer during first 
dimension 
Rehydration buffer including 25x 
Complete Protease Inhibitor (Roche) 
100 mM PMSF    
100x Pepstatin (Roche) 
2D running 
buffer 
Running buffer during 
electrophoresis 
10 x TGS (Bio-Rad) 
ddH2O 
Equilibration 
buffer I 
First equilibration of IPG strip 
180 g urea  
20% SDS 50 ml (Bio-Rad) 
1.5 M Tris (pH 8.8; Bio-Rad)  
87% glycerol 115 ml (Merck) 
2% DTT  
ddH2O up to 500 ml 
Equilibration 
buffer II 
Second equilibration of IPG 
strip 
180 g urea  
20% SDS 50 ml  
1.5 M Tris (pH = 8.8)  
87% glycerol 115 ml  
2.5% IAA (Bio-Rad) 
ddH2O up to 500 ml 
Colloidal 
coomassie 
Gel staining solution 
17% ammonium sulfate (Merck) 
2% phosphoric acid  
34% methanol (Merck) 
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Destaining was done by washing the 2D gels in ddH2O for 1 h until background signals 
were minimal and protein signals were precise. Finally, gels were scanned using a gel 
scanner (GS-800 Calibrated Densitometer; Bio-Rad).  
3.7.2 Cytochrome c immunoassay 
The release of cytochrome c from the mitochondrial membrane into the cytoplasm was 
considered a marker for apoptotic activity in the cell (Huttemann et al., 2011). To 
determine potential differences in apoptotis between HR and LR mice, a Quantikine 
rat/mouse cytochrome c Immunoassay (R&D Systems, Abingdon, UK) was performed. 
The protein extraction from hippocampal tissue was conducted as described in a 
publication of Carboni and colleagues (Carboni et al., 2005). Therefore, hippocampi were 
homogenized in a 1.5 ml Eppendorf tube using a tightly fitting plastic pestle. 1 ml of ice-
cold lysis buffer containing 210 mM mannose (Merck), 250 mM sucrose (Sigma), 10 mM 
Hepes-NaOH (pH = 7.4), 10 mM KCl (Merck), 1.5 mM MgCl2 (Merck), 1 mM EDTA, 
1 mM EGTA (both Sigma), 1 mM DTT and Complete Protease Inhibitor (Roche) was 
added. Homogenized lysates were centrifuged for 10 min at 60 g and 4 °C, supernatant 
was collected and recentrifuged for 30 min at 1,100 g and 4 °C. After recentrifugation, 
the supernatant was collected as the cytosolic protein phase, the pellet as the 
mitochondrial protein fraction. The pellet was resuspended in 100 µl lysis buffer and 
stored at -80 °C for further analyses. The concentration of the cytosolic protein fraction 
was determined by a Bradford-Assay and subsequently standardized to 0.3 µg cytosolic 
protein per µl lysate. Following, lysates were 1:10 diluted with PBS to decrease the DTT 
concentration of the samples below 0.1 mM, and then to a final dilution factor of 1:30 
with RD5-18 calibrator diluent to ensure that the absorption values of the cytosolic 
protein samples were within the same range than the absorption values of the standard 
curve.  
The Quantikine assay is a sandwich enzyme immunoassay which allows the quantitative 
determination of rat/mouse cytochrome c concentrations in lysates of whole cells and 
subcellular fractions. It was conducted according to the manufacturer´s instructions, 
which was in short the application of 75 µl rat/mouse cytochrome c conjugate to each 
well of a 96-well plate, followed by the application of 50 µl cytosolic protein lysate, 
standard sample or control probe. The solutions were mixed by gently rocking the plate 
for 1 min and incubation for 2 h at room temperature. Following the incubation period, 
the plate was emptied and washed five times with 400 µl wash buffer per well and per 
wash step. 100 µl substrate solution per well were added and the plate was incubated for 
30 min at room temperature while protecting it from light. The reaction was stopped by 
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adding 100 µl stop solution per well and gentle mixing of the reagents. The optical 
density of the assay was determined at 450 nm using an absorbance reader (GENios 
Pro; Tecan, Crailsheim). Wavelength correction was set to 540 nm. All standard and 
cytosolic protein samples were measured in triplicates. Mean values of the three 
absorption values were calculated and a standard curve was generated based on the 
absorption values of the standard dilution series. The cytochrome c concentration of the 
cytosolic protein lysates were calculated based on the equation of the standard line.   
3.7.3 Cytochrome c oxidase staining 
Cytochrome c oxidase (CO) staining was performed as a marker staining for neuronal 
and metabolic activity (Hu et al., 2005). Therefore, dissected brains of HR and LR female 
mice were sliced into 20 µm thick coronal brain slices using a Microm HM 560 cryostat 
(Thermo Fisher Scientific, Schwerte) and mounted on Superfrost Plus microscope slides 
(Gerhard Menzel, Braunschweig). Brains were collected beginning approximately 
100 µm anterior of the hypothalamic paraventricular nucleus and ending directly 
posterior of the ventral hippocampus. Immediately after slicing, slides were heated up to 
60 °C for 1 min and afterwards stored at -20 °C until CO staining was carried out.  
As a standard, liver tissue was homogenized as previously described with slight 
modifications (Riddle and Forbes, 2005). Approximately 2 ml of the liver homogenate 
were centrifuged at 8 g to remove residual air bubbles and frozen at -20 °C in cubic 
plastic gauges. Frozen homogenates were sliced, heated, and stained like brain slices.  
CO staining was carried out in glass staining chambers while gently rocking during the 
whole protocol. The staining solution was required to be freshly prepared immediately 
before the staining by tempering the solution to 40 °C for 30 min and filtering before use. 
Each staining chamber contained next to the brain slices two slides with liver 
homogenates. The staining protocol started with tissue fixation for 5 min in acetone 
(Sigma-Aldrich) and washing in 0.1 M sodium phosphate buffer three times for 5 min, 
both at 4 °C. After this, slices were incubated in CO staining solution for 20 min at 37 °C, 
staining was stopped by transferring the slides in 0.1 M sodium phosphate buffer at 4 °C, 
followed by two washing steps in 0.1 M sodium phosphate buffer for 5 min. Post-fixation 
was achieved by incubation of the stained slices in 4% PFA for 30 min. The washing 
step in 0.1 M sodium phosphate buffer was repeated twice before drying the tissue 
sections in an ethanol dilution series of 70%, 80%, and 99% ethanol (5 min each), 
followed by 2 min in isopropanol. Finally, slides were cover-slipped with Roti Histokitt 
(Carl Roth, Karlsruhe). 
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Digitalization of stained tissue sections was done using an AxioCam MR05 (Leica 
Camera, Solms). Regions of interests were marked using a Bamboo paint tablet 
(Wacom, Krefeld) and subsequent densiometric quantification was done via ImageJ 
(version 1.43u) freeware.  
For standardization, densiometric values of brain tissue slices were normalized to 
densiometric values of simultaneously stained of liver homogenates.    
 
Table 3: Composition of buffers and solutions used for the CO staining protocol. 
 
Buffer Function Composition 
0.1 M Sodium 
phosphate solution 
Wash buffer 
10.6 g Na2HPO4 x 2 H2O (Merck) 
56 g K2HPO4 (Merck) 
ddH2O up to 1 l (pH = 7.2) 
CO staining solution 
Cytochrome c 
oxidation 
45 g sucrose 
3% DAB (Sigma) 
50 mg cytochrome c (Sigma)  
100 mg Ni(NH4)2(SO4)2 x 6 H2O 0.1 M (Merck) 
sodium phosphate solution up to 1 l 
4% PFA  Post-fixation 
2 g paraformaldehyde (Roth)   
0.1 M PBS (pH = 7.2) up to 1 l 
0.1 M PBS 
 
Preparation of 
4% PFA 
14.4 g NaCl  
0.1 M sodium phosphate solution 400 ml, 
ddH2O 1.2 l (pH = 7.2) 
 
3.7.4 Quantification of plasma corticosterone via radioimmunoassays 
Plasma corticosterone values of SRT blood samples were measured via corticosterone 
(rat/mouse) radioimmunoassays (RIAs; DRG Instruments, Marburg) according to the 
manufacturer´s instructions but with slight modifications. In this competitive binding 
assay the quantitation of corticosterone molecules in the plasma was achieved using 
radioactively labeled corticosterone and an antibody-based detection of bound 
radioisotopes.    
Initial plasma samples were diluted 1:13.5, reaction and recovery plasma samples 1:100, 
other than recommended in the kit. Initial plasma samples were measured once, reaction 
and recovery blood samples were detected in duplicates. In case the detected 
concentrations of the duplicate samples deviated more than 10%, the plasma of the 
respective sample was rediluted and measured again. Mean values from double 
detections were used for further calculations. The difference between the corticosterone 
concentration of a reaction and an initial sample was considered the corticosterone 
increase during the SRT, the difference between a reaction and a recovery sample was 
regarded the corticosterone decrease. Pooled plasma samples with a corticosterone 
concentration in the average range of an initial and of a reaction corticosterone 
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concentration were prepared and placed in the beginning and at the end of the assay to 
exclude intra-assay variations. A 6-fold standard dilution series with known 
corticosterone concentrations was used to calculate the corticosterone concentration of 
the probes accordingly. 
3.8 Statistical and bioinformatical methods 
3.8.1 Statistical analyses of microarray experiment  
3.8.1.1 Univariate analysis 
The raw fluorescence data or signal intensities, based on the degree of hybridization of 
cRNA to beads with the corresponding probe sequences, was exported by the Illumina 
BeadStudio software (version 3.4.0), based on the optical scan signals from the arrays. 
These data were further processed using various functions of the R; for example, the vsn 
function was used for data normalization, and the LIMMA package was applied for 
differential expression analyses. The ranking of significantly different expressed genes 
was achieved via an empirical Bayes method considering the correlation structure within 
the samples, and therefore increasing the validity of analysis. Genes not showing any 
expression signal were excluded from further evaluation to not fail the variances in the 
Bayesian correlation. These expression values were assorted according to the 
respective line of the animals which resulted in a design matrix. A false discovery rate 
approach was employed to correct for multiple testing, yielding adjusted p-values of 
differential expression.  
3.8.1.2 Multivariate analysis 
Based on normalized microarray raw data of HR and LR animals, multivariate analyses 
using support vector machines with recursive feature elimination (SVM-RFE) and 
random forest (RF) classifiers were performed in addition to the univariate analysis.  
For SVM-RFE, the algorithm developed by Augustin and colleagues according to Zhou 
was applied (Augustin et al., 2011; Trumbach et al., 2010; Zhou and Tuck, 2007), at 
which for SVM prediction the svm function from the e1071 package in R statistical 
software (http://www.r-project.org/) was used. The function svm was used with default 
settings except the parameters type = ‘C-classification’, kernel = ‘linear’, cost = 0.1. 
SVM-RFE algorithm was applied 40 times on different subsets of the original dataset and 
finally 40 different gene selections, each consisting of the best 1,000 genes for 
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classifying according to the cost function of the SVM classifier, were obtained. The 
frequency of each gene occurring in all the gene selections was computed to identify the 
most important genes. Finally, genes persisting more than 30 recursive feature 
eliminations were considered significantly different regulated. 
Supervised clustering with the ensemble classifier RF was performed 50 times 
(Trumbach et al., 2010); candidates occurring among the top 200 after ranking according 
to the mean decrease accuracy in each analysis were considered significantly differential 
expressed between the lines. For RF analysis, the function randomForest in R was 
applied by setting the number of trees ntree = 15,000, the number of input variables tried 
at each split mtry = 500 and otherwise default parameters. The candidate gene 
expressions were compared between the SVM-RFE and the RF method. 
3.8.2 Statistical analyses of the SAGE experiment  
The pre-processing of the reads prior to quality controls involved the removal of the first 
primer base (T) which occurred as an adapter artifact and the first color. The actual 
quality control step was based on the phred-like scores for each color which was 
provided by the ABI SOLiD sequencer. More precisely, the quality control was done by 
computing a linear function of the phred scores of the complete read as well as the 
scores of the first 20 colors of the read. As a next step, identification of the adaptor 
sequence and the restriction enzyme binding site was carried out via dynamic 
programming allowing a maximum of two color mismatches to the standardized color 
sequence. Identifiable patterns were trimmed after identification of the target sequence 
(CAGT) representing the restriction enzyme binding site. Terminating element was the 
adapter sequence. Reads were standardized to a length of 23 colors if this sequence 
element could not be identified. Computation of the alignments was done using the BWA 
algorithm allowing a maximum of two color mismatches (Li and Durbin, 2009). The 
UCSC mRNA database served as a reference sequence for the alignment of remaining 
reads. In order to increase accuracy of the alignments, the mRNA reference sequences 
were trimmed to the fragments that can theoretically be produced by the 3´ SAGE 
protocol. Following the alignment step, the mRNA reference IDs were mapped to gene 
symbols. 
For the comparison of expressional profiles Z-scores were calculated based on the 
logarithm of the HR vs. LR counts for each gene symbol. Z-score values ≥2 were 
indicative for significantly differential expression. 
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3.8.3 Cluster analyses of differentially regulated genes  
3.8.3.1 Database for annotation, visualization, and integrated discovery  
Cluster analyses with candidate genes detected as differentially expressed in the 
hippocampus of HR vs. LR animals by microarray and SAGE experiments were done to 
systematically screen the set of regulated genes for functional enrichment. The database 
for annotation, visualization, and integrated discovery (DAVID), an integrative tool for the 
analysis of large sets of gene and protein lists, was employed for mapping of regulated 
genes to associated biological annotations and for subsequent statistical analyses of 
enriched gene sets (http://david.abcc.ncifcrf.gov/). Thereby, the protocol for the analyses 
of large gene lists described in the publication of Huang et al. was strictly followed 
(Huang da et al., 2009). In short, the lists of regulated genes, detected in the microarray 
and in the SAGE experiments, were submitted to DAVID bioinformatics tool. Functional 
annotation clustering, chart and table were generated applying medium classification 
stringency. Detected clusters with enrichment scores ≥1.3 were considered reflecting 
functional clusters indicating a significant biological impact in the sets of regulated 
genes. Benjamini correction was applied to correct for multiple testing.  
3.8.3.2 Gene ontology analyses 
Pathway studio (version 8.0) was used to perform gene ontology (GO) analysis of genes 
found to be regulated in hippocampal tissue of HR and LR mice by means of the 
microarray study. The set of genes which was detected in the SVM-RFE evaluation to 
differ the most in the expression was used for these additional annotation analyses 
regarding common biological processes, common cellular components, and common 
molecular functions. The resulting adjusted p-values were corrected for multiple testing 
according to Benjamini-Hochberg (Benjamini et al., 2001).  
3.8.4 High-density screening for single-nucleotide polymorphisms and detection 
of segmental copy number variants by means of the Jax Mouse Diversity 
Genotyping array  
The Jax Mouse Diversity Genotyping array is a high-through-put genotyping array for the 
mouse simultaneously detecting 623,124 single-nucleotide polymorphisms (SNPs) and 
916,269 invariant genomic probes. It resembles therefore the Affymetrix Human 6.0 
array. The invariant genomic probes were targeted to functional elements and regions 
known to harbor segmental duplications (Yang et al., 2009). The Mouse Diversity 
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Genotyping array was built on an Affymetrix platform and contains SNPs from either 
source, mice derived from the wild and known inbred-strains commonly used in 
research.  
The performance of the assay was offered by The Jackson Laboratories (Bar Harbor, 
ME, USA) as a service feature, beginning with the extraction of high-molecular weight 
DNA from tail tip tissue via computational analyses of raw data until customized analyses 
adapted to individual scientific demands. Therefore, roughly 0.5 cm of tail tip tissue from 
CD-1 mice were sent to The Jackson Laboratories. After processing of the assay, data 
from basic analyses as well as from custom analyses were submitted via Accellion 
Secure File Transfer. 
3.8.4.1 Detection of segmental copy number variation based on data from Jax 
Mouse Diversity Genotyping array  
Segmental duplications and copy number variants (CNVs) were identified in HAB vs. 
LAB and HR vs. LR animals based on invariant genomic probes of the JAX Mouse 
Diversity Genotyping array following the ´Simple CNV` instructions of the MouseDivGeno 
Vignette (version 1.0.0) by Yang and Sheppard (obtained from http://genomedynamics. 
org/tools/MouseDivGeno). Therefore, the MouseDivGeno together with the 
HiddenMarkov R packages were installed. One animal from each mouse model was 
needed to be defined as ´reference animal`. Hence, invariant genomic probes raw data 
of the other animal from the same mouse model were analyzed in respect to the data of 
the ´reference animal`. For the HAB/LAB comparison, data gained from the LAB mouse 
served as reference; in case of the HR/LR comparison, sequences obtained from the LR 
mouse were chosen as reference. As a consequence, ´gains` and ´losses` detected in 
HAB and HR mice, respectively, were ´gains` and ´losses` in respect to the particular 
reference sequences.  
3.8.5 Principle component analyses of phenotypic features 
Principal component analyses (PCA) were conducted to structure phenotypes collected 
in the behavioral test battery of the so-called ´CD-1 panel`. Detected behavioral variables 
were condensed and arranged in a multidimensional scaling following an orthogonal 
varimax rotation maintaining variables with an eigenvalue >1 (Henderson et al., 2004). 
The PCA and the varimax rotation were accomplished using the open-source statistical 
software package R. 
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3.8.6 Calculation of association via WG-Permer     
Associations between genotypes resulting from the Jax Mouse Diversity Genotyping 
array and phenotypes detected in the behavioral test battery of the ´CD-1 panel` were 
tested using WG-Permer freeware (version 0.9.9; obtained from http://www.wg-
permer.org/). Settings were defined as follows. The level of significance was set to 
nominal p-values <0.05, Chi-square-test was performed for quality controls, the number 
of permutations was set to 10,000, the permutated Fisher product-combination-method 
was applied over all selected models, and point-wise empirical p-values were calculated 
accordingly. Correction for permutation-based multiple testing was done via the minP 
method of Westfall and Young (WY-corrections).  
3.8.7 Generation of CD-1 strain-specific haplotype map 
Genotypes gained from high-throughput SNP screening of 32 CD1 mice were used for 
the generation of a strain-specific haplotype map. Therefore, genotypes of heterozygous 
and opposite homozygous SNPs were transferred into a PLINK file using PLINK 
freeware (version 1.07; http://pngu.mgh.harvard.edu/~purcell/plink/). Linkage 
disequilibrium (LD) parameters were calculated for every possible SNP combination 
(conservative clustering) within a sliding window of 5 mb applying a greedy algorithm. 
The maximal marker density within a sliding window was set to 1,000 SNPs. This 
iterative tagging resulted in the calculation of a correlation coefficient (R2) for every 
potential marker combination. R2 values ≥0.8 within a sliding window were filtered and 
considered reflecting strong LD clustering. The SNP with the highest R2 value which is 
thus predicting the most genotypes of SNPs within the sliding window was considered 
the tagging SNP of the respective LD cluster.    
3.8.8 Statistical data analyses, graphical illustration, and common bioinformatical 
processes 
Statistical calculations for two or more group comparisons were done using SPSS 
software (version 16.0). Converging normal distribution, behavioral data sets were 
analyzed via parametric statistics (independent samples T-test; IST); non-parametric 
statistics (Mann-Whitney-U test; MWU) was applied for statistical analyses of molecular 
biological data sets. For statistical analysis of qPCR data, prior to MWU testing 
descriptive statistics was applied and separate values in the range of upper and lower 
whiskers were considered methodological artifacts rather than reflecting biological 
variance and were, therefore, excluded from the analysis.  
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Comparative illustrations of data were created by the use of SigmaPlot 16.0. Respective 
data are provided in box plots showing medians as lines in the boxes and 25% and 75% 
percentiles (boxes). 10% and 90% percentiles are shown by the whiskers.  
Common bioinformatical processes, such as comparison of large data tables, were 
conducted by making use of the open-source statistical software package R 
(http://www.r-project.org/). Furthermore, diverse functions of the Microsoft Office 2007 
package were employed. 
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4 Results 
4.1 Gene expressional profiling of the SR mouse model 
4.1.1 Differentially expressed genes according to univariate analysis of the 
microarray experiment 
Applying univariate analysis, microarray-based gene expression profiling of hippocampal 
tissue from HR and LR animals revealed 330 probes to be significantly different 
regulated (adjusted p-values ≤0.05), identifying a total of 297 differentially regulated 
genes between the lines. Out of these 297 differentially regulated genes, 27 candidates 
were detected with more than one hybridization probe. Tpmt was identified with two 
different probes showing contradictory fold changes; the gene was therefore not 
considered for further analysis. Minor discrepancies in the number of regulated genes 
noted in further analyses appeared due to variations in genome build and gene 
alignment versions. Identified candidates are listed in Table S1 of the supplementary 
data.  
Supplementary data are provided on the external data source which was attached to the 
thesis; respective Tables and Figures were marked with ´S` before serial numbers.   
4.1.2 Genes detected as differentially expressed in the SAGE experiment 
A total of 709 genes were identified to differ significantly in their expression in the 
hippocampus of HR vs. LR mice (Z-score ≥2). Detected candidates, respective fold 
changes, and Z-scores are summarized in Table S2. 
4.1.3 Overlapping pool of genes detected as differentially expressed in both gene 
expression profiling approaches 
Combining the gene pools detected in the microarray and in the SAGE experiment, a 
total number of 1,007 genes was found to differ significantly in hippocampal expression. 
25 genes (2.48%) were detected by either approach (Table 4). The resulting combined 
gene pool, therefore, consists of 982 genes.   
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Table 4: Combined pool of 25 genes detected as differentially expressed in the 
microarray and in the SAGE experiment. Genes are listed in alphabetical order. 
Respective significance values are shown (adjusted p-value for microarray candidates, 
Z-score for SAGE candidates). In either case, positive fold change values indicate higher 
expression in HR, negative fold changes higher expression in LR mice.  
 
 
Gene 
symbol 
Fold changes in 
 Microarray SAGE 
Aars2 -1.303 -2.565 
Abcb1b 1.926 6.939 
Acot1 1.283 2.611 
Adora2b -1.922 -1.813 
Akr1e1 -1.934 -2.267 
Aldh1l1 2.027 2.488 
Rrp36 1.344 -4.600 
Brf2 -1.966 -1.615 
Cyp4f14 2.296 5.039 
Cyp4f15 2.515 7.739 
Cyp4f16 1.664 2.582 
Dap3 1.956 2.276 
Fbxo6 -1.341 -1.427 
Hhatl -1.759 -1.807 
Hist1h2be -1.870 -2.845 
Kars 1.251 4.410 
Ldb3 -1.692 -2.500 
Rgl1 4.263 1.661 
Sap130 1.328 1.936 
Sh3gl2 1.447 1.644 
Slc25a34 1.806 3.002 
Slc35b2 1.375 7.649 
Spast 1.377 2.207 
Timp4 1.336 1.924 
Tmf1 -1.482 -1.450 
 
Rrp36 (Rrp36 ribosomal RNA processing 36 homolog) was detected by either gene 
expression profiling approach to differ significantly in its expression, but with 
contradictory fold changes. The gene was therefore not considered in further analyses, 
reducing the number of genes in the combined gene pool of differentially expressed 
genes to 981.  
4.1.4 Univariate vs. multivariate analysis of microarray data 
In addition to univariate analysis, two different multivariate algorithms were applied for 
microarray analysis. Using SVM-RFE, 368 hybridization probes were identified with 
frequencies between 30 and 40 after 40 iterations and were therefore rated to differ 
significantly in their expression. These 368 hybridization probes identified 337 genes. RF 
analysis resulted in the identification of 108 probes and 103 genes, respectively. A 
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comparison of genes identified to differ significantly in their expression in the 
hippocampus of HR vs. LR animals according to applied algorithms is assembled in 
Table S3. The SVM-RFE algorithm identified 74.07% (= 220 genes) of the genes already 
detected in the univariate analysis; the RF algorithm 30.3% (= 90 genes). The number of 
candidates exclusively detected as differentially expressed according to SVM-RF was 
109, using the RF algorithm five. The overlapping pool of genes detected as differentially 
expressed exclusively applying the multivariate algorithms yielded eight genes (Table 
S4). 
4.1.5 Cluster analyses of differentially expressed genes 
Annotational cluster analyses were performed to investigate functional relevance of 
candidates detected as differentially expressed in the microarray and in the SAGE 
experiments.  
4.1.5.1 Identification of significant gene clusters in microarray candidates using 
the DAVID Bioinformatics Database 
Submitting the list of genes detected as differentially expressed in the microarray study 
according to univariate analysis to the DAVID Bioinformatics Database for functional 
annotation clustering, five significantly enriched gene clusters were identified (Table 5). 
In order to assign a functional meaning to detected gene clusters, common 
denominators of assigned gene functions were defined and the clusters named 
accordingly.  
The first cluster contained 41 genes, all of them contributing to the various functions of 
the mitochondrion. Genes in the so-called ´mitochondrial cluster` are genomically 
encoded and cannot be ascribed to a specific mitochondrial function or pathway. The 
second enriched cluster comprised 25 genes which are specifically involved in functions 
along the mitochondrial membranes and the inter-membrane space. It is therefore called 
´mitochondrial envelope` cluster and depicts an envelope-associated fraction of genes 
already assigned to the mitochondrial cluster. The third significantly enriched cluster 
includes four genes, all of them annotated with esterase functions. The fourth functional 
group of genes, the ´cofactor cluster`, contains eight genes, all of them fulfilling 
metabolic and biosynthetic cofactor and coenzyme functions, respectively in various 
biochemical processes. The fifth enriched cluster counts five genes, all involved in the 
metabolism of xenobiotics. With exception of Ugt1a10, the genes contained in this 
cluster are also involved in the glutathione pathway.  
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Table 5: Summary of significantly enriched gene clusters detected using DAVID 
Bioinformatics tool. In total, five clusters were significantly enriched (enrichment score 
≥1.3). Genes contained in the particular clusters are listed in alphabetical order. The ´%` 
column indicates the proportion of genes contributing to the respective cluster among the 
297 genes differentially expressed according to univariate analysis. 
 
No. 
Functional 
assignment 
Enrichment 
score 
List of genes % 
1 Mitochondrion 2.2 
1810049H13Rik, Aars2, Abcb1b, 
Acaa2, Acot1, Acot13, Acss1, 
Aldh1l1, Brf2, Ccbl2, Cdc5l, Dap3, 
Dbt, Gcdh, Gm5512, Gstk1, Gstz1, 
Hey2, Hsp90ab1, Kars, Krr1, 
LOC100047937, Mff, Mobp, Mrpl10, 
Mrpl3, Mtus1, Nfya, Nipsnap1, 
Nt5dc3, Pdk2, Prodh, Prosc, 
Rmnd1, Rpain, Rpl10a, Sdhaf1, 
Slc25a17, Slc25a34, Top1mt, 
Ugt1a10 
13.8% 
2 
Mitochondrial 
envelope 
1.4 
Aars2, Abcb1b, Acaa2, Acss1, 
Alox5ap, Ankle2, Atp6v1g1, Chst5, 
Dap3, Dbt, Gcdh, Gstk1, Mff, 
Mrpl10, Mrpl3, Nipsnap1, Pdk2, 
Pex6, Prodh, Rep15, Sdhaf1, 
Slc25a17, Slc25a34, Tmf1, Ugt1a10 
8.4% 
3 Esterases 1.4 Acot1, Acot11, Acot13, Usp38 1.3% 
4 Cofactors 1.3 
Acot1, Acss1, Aldh1l1, Dbt, Dcxr, 
Gstk1, LOC100047937, Pank3 
2.7% 
5 
Xenobiotic  
metabolism 
1.3 
Gstk1, Gstm1, Gstz1, Oplah, 
Ugt1a10 
1.7% 
 
4.1.5.2 Identification of significant gene clusters in SAGE candidates using DAVID 
Bioinformatics Database 
Genes, detected as differentially expressed in the SAGE study, were in analogy to 
microarray candidates submitted for functional annotation analysis to the DAVID 
Bioinformatics Database, resulting in 14 significantly enriched gene clusters (Table 6). 
The gene cluster achieving the highest enrichment score was, in similarity to the 
functional annotation analysis of microarray candidates, a cluster containing genes which 
contribute in various ways to mitochondrial functions. 49 genes were assorted to this 
cluster, resulting in an explicitly significant enrichment score of 3.1. The second cluster 
counting 111 genes is the largest of all detected clusters and contained genes involved 
in the energy metabolism of the brain; for example, six genes encoding for different 
subunits of the ATP synthase, the proton transporting enzyme which is integrated into 
the mitochondrial F1 complex (Chinopoulos, 2011). Therefore, the cluster was entitled 
´energy metabolism`. The third enriched cluster based on the SAGE gene pool was 
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ascribed as ´iron metabolism` cluster. It included nine genes, all of them fulfilling 
metabolic functions around iron homeostasis. The fourth cluster contained, similarly to 
the second cluster detected based on the microarray candidates, genes encoding for 
protein products which are fulfilling functions in the mitochondrial bilayer and the inner-
membrane space. In total, 36 genes were attributed to this ´mitochondrial envelope` 
cluster. The fifth cluster, the so-called ´protein synthesis` cluster, comprised 49 genes 
involved in ribosomal protein synthesis. A further accumulation of functionally associated 
genes counted 21 candidates, all of them related to flavin adenine dinucleotide (FAD) 
and therewith linked with cellular redox reactions, was called ´FAD` cluster. The next 
cluster contained 32 genes with the functional similarity that all of them contribute to the 
respiratory chain. The eight genes counting to the eighth annotational cluster participate 
in a broad spectrum of metabolic processes, as they are involved in lipid, carbohydrate, 
and amino acid synthesis and degradation. The next cluster counting 56 genes was 
identified as a functional accumulation of genes involved in enzymatic processes along 
with cytochrome P450 activities. The common denominator of the next annotational 
cluster is the generation of energy. It contains 18 genes which all are involved in energy 
generation, for example via cellular or aerobic respiration, as well as via the tricarboxylic 
acid cycle. The eleventh cluster comprised 45 genes involved in immunological 
processes. The twelfth cluster, which contained four genes, was assembled based on 
shared sequence domains. According to UniProt sequence annotation features, integrins 
and sodium channels contained in this cluster have repeated sequence motifs in 
common. 20 genes were assorted to cluster thirteen, all of them fulfilling diverse 
functions in protein assembly. The last cluster contained 14 genes involved in the 
regulation of lipase activities.    
 
Table 6: Overview over annotational enrichment clusters resulting from genes detected 
in the SAGE study to be differentially expressed in the hippocampus of HR vs. LR mice. 
Genes assorted in respective functional clusters are listed in alphabetical order. The ´%` 
column is giving the percentage of genes assigned to the respective cluster based on the 
709 genes detected in the SAGE experiment.  
 
No. 
Functional 
assignment 
Enrichment 
score 
List of genes % 
1 Mitochondrion 3.1 
1110032A13Rik, 2310061I04Rik, 
Acadsb, Acot1, Acot3, Aldh18a1, 
Aldh1l1, Atp5e, Atp5g1, Atp5g3, 
Atp5h, Atp5j, Atp5o, Cac, Cat, 
Efhd1, Etfb, Ethe1, Fdx1, Fh1 Flnb, 
G6pd2, Glyat, Gm16517, Gm5436, 
Gm6419, Gm6419, Gm6419, Gng5, 
Gpd2, Hcrt, Mcee, Mip, Mosc2, 
Mrpl39, Mrpl42, Ndufb11, Ndufs1, 
Nt5dc3, Oxct1, Pgam5, Pgs1, Ppox, 
6.9% 
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Rbfa, Sdhaf1, Trpv6, Tusc3, Usp30, 
Uxs1 
2 
Energy 
metabolism 
2.4 
1110032A13Rik, 1500035H01Rik, 
3000002C10Rik, Aars2, Abca4, 
Abcb1b, Abcb4, Abcd1, Acadsb, 
Aco2, Aifm3, Aldh18a1, Ampd2, 
Aplp2, Aqp1, Atic, Atp5e, Atp5g1, 
Atp5g3, Atp5h, Atp5j, Atp5o, 
Atp6v0d1, Atp6v1a, Atp6v1d, 
Atp9a, Bcap31, Cacnb3, Casp12, 
Cat, Cbx3, Clcn4-2, Cyba, Dap3, 
Efhd1, Etfb, Ethe1, Fdx1, Fdx1l, 
Fdxr, Fh1, Ftl1, Gipc1, Gm6498, 
Gpd2, Grin2b, H47, Hmgcs2, Isca1, 
Kcne2, Kcnh3, Kcnh4, Kcnq2, 
Kctd8, LOC654426, Lpl, Mcee, 
Mfsd6, Mgat1, Mosc2, Mrpl39, 
Mrpl42, Msh2, Ndufa12, Ndufa4, 
Ndufa7, Ndufb11, Ndufs1, Ndufv3, 
Nfu1, Nmnat2, Nos1, Oat, Oxct1, 
Paics, Park2, Pdpn, Pgam1, 
Pgam5, Pgs1, Polr2d, Ppox, Prlr, 
Ptgds, Rpl38, Ryr2, Scn4a, Scn9a, 
Sdhaf1, Sdhc, Slc12a2, Slc25a34, 
Slc2a13, Slc35b1, Slc35b2, 
Slc37a2, Slc38a3, Slc40a1, Slc5a5, 
Slc6a3, Spast, St6galnac5, Suclg1, 
Syt1, Tes, Tgm2, Tmf1, Il5, Tusc3, 
Uchl1, Usp30 
15.7% 
3 
Iron 
metabolism 
2.4 
Aco2, Aifm3, Fdx1, Fdx1l, Isca1, 
Mrpl39, Ndufs1, Nfu1, Xdh 
1.3% 
4 
Mitochondrial 
envelope 
2.2 
Aars2, Acadsb, Aifm3, Aldh18a1, 
Atp5e, Atp5g1, Atp5h, Atp5j, Atp5o, 
Dap3, Efhd1, Etfb, Ethe1, Fdx1, 
Fdx1l, Fdxr, Gpd2, Hmgcs2, 
LOC654427, Mosc2, Mrpl39, 
Ndufa12, Ndufa4, Ndufa7, Ndufb11, 
Ndufs1, Ndufv3, Nos1, Oat, Oxct1, 
Ppox, Sdhaf1, Sdhc, Slc25a34, 
Suclg1, Usp30 
5.1% 
5 
Protein 
synthesis 
2.2 
Aars2, Aarsd1, Cldn11, Cldn2, 
Crnkl1, Cwc15, Dap3, Eef1b2, 
Eef1d, Eftud2, Eif2b1, Eif3h, Eif4b, 
Eif4g3, Eprs, Gm15427, Gm15772, 
Gm4987, Gm6402, Gm6548, Isca1, 
Kars, Krr1, Lsm14b, Lsm4, Mrpl39, 
Mrpl42, Nell2, Nol6, Plp1, Ppwd1, 
Prpf8, Rbm3, Rbm8a, Rpl11, Rpl26, 
Rpl38, Rpl5, Rps25, Rps29, Rps4x, 
Rps6, Rps6ka2, Sf3b1, Snora65, 
Snrpc, Srp9, Tuba3a, Tuba4a 
6.9% 
6 FAD 2.1 
3000002C10Rik, Acadsb, Aifm3, 
Bdh2, Etfb, Fdxr, Gad1, Gadl1, 
Gm6498, Gpd2, Kdm1a, Mosc2, 
Nos1, Oat, Pnpo, Ppox, Prlr, Sqle, 
3.0% 
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Txnrd1, Uxs1, Xdh 
7 
Respiratory 
chain 
2.0 
Aco2, Aifm3, Atp5e, Atp5g1, 
Atp5g3, Atp5h, Atp5j, Atp5o, 
Atp6v0d1, Atp6v1a, Atp6v1d, Cat, 
Cyba, Etfb, Fdx1, Fdx1l, Fdxr, Fh1, 
Gm6498, LOC654426, Msh2, 
Ndufa12, Ndufa4, Ndufa7, Ndufb11, 
Ndufs1, Ndufv3, Pgam1, Sdhc, 
Slc37a2, Suclg1, Txnrd1 
4.5% 
8 
Diverse 
metabolic 
processes 
1.6 
Acadsb, Akr1e1, Bdh2, Gad1, 
Hmgcs1, Hmgcs2, Mcee, Oxct1 
1.1% 
9 
Cyptochrome 
P450 
1.6 
Acadsb, Aco2, Aifm3, Akr1e1, 
Aldh18a1, Aldh1a2, Aldh1l1, 
Aldh3a1, Bdh2, Cat, Cyba, Cyp2e1, 
Cyp4f14, Cyp4f15, Cyp4f16, 
Cyp4f18, Cyp4f40, Etfb, Fdx1, 
Fdx1l, Fdxr, Fibp, Ftl1, Gm6498, 
Gpd2, Hbb-b2, Isca1, Kdm1a, 
Kdm4d, Mosc2, Ndufa12, Ndufa4, 
Ndufa7, Ndufb11, Ndufs1, Ndufv3, 
Nfu1, Nos1, Pdcd6, Plod3, Pnpo, 
Pon1, Ppox, Ppp4c, Ptgds, Ptgs2, 
Sdhc, Slc37a2, Slc40a1, Sord, 
Sqle, Trf, Txnrd1, Vkorc1, Xdh, 
Ywhab 
7.9% 
10 
Energy 
generation 
1.5 
Aco2, Acot1, Aldh1l1, Cat, Fh1, 
Folr1, Isca1, Mthfs, Ndufa7, Ndufs1, 
Nfu1, Nmnat2, Pdss2, Ppox, Sdhc, 
Slc37a2, Suclg1, Vkorc1 
2.5% 
11 
Immunological 
processes 
1.5 
Actb, Cd180, Cd74, Cldn11, Cldn2, 
Eif4g3, Gad1, Git1, Gm16379, H2-
Ab1, H2-D1, H2-Eb1, H2-K1, H2-
Q6, H2-Q8, H2-T9, Il1rl1, Islr, Itgb4, 
Lax1, LOC547349, Mafk, Masp2, 
Mfsd6, Mif, Mpzl2, Myh3, Myh4, 
Pcp4, Pira6, Psg23, Psg27, Psmb8, 
Robo1, Runx1, Sema3f, Serpina3g, 
Sh3gl2, Siglec1, Speg, Stbd1, 
Tgm2, Thy1, Tlr1, Tlr12 
6.3% 
12 
Repeated 
sequence 
motifs 
1.4 Itgb4, Itgb6, Scn4a, Scn9a 0.6% 
13 
Protein 
assembly 
1.4 
Anxa5, Brf2, C1qtnf7, Caly, Cd74, 
Crnkl1, Gsn, H2-D1, Hist1h2bc, 
Hp1bp3, Pdss2, Psmg2, Sdhaf1, 
Spast, Synj1, Taf10, Tes, Tgm2, 
Tuba3a, Tuba4a 
2.8% 
14 
Regulation of 
lipase activity 
1.4 
Adora2b, Aifm3, Bat2, Car8, Foxj1, 
Ghrh, Gnai2, Gng13, Hcrtr2, Pdcd6, 
S1pr1, Synj1, Tgm2, Thy1 
2.0% 
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4.1.6 GO analyses of differentially expressed genes detected in the microarray 
study  
In addition to annotational cluster analyses via the DAVID Bioinformatics Database, GO 
analyses were done based on candidates detected as differentially expressed in the 
microarray study. Genes were screened regarding overlapping entities in terms of 
cellular components, biological processes, and molecular functions. In total, 22 
overrepresented GO categories among cellular components were identified. Out of 
these, four significantly overrepresented categories were attributed to the mitochondrion 
(Table 7).  
 
Table 7: Summary of overrepresented GO categories which involved the mitochondrion 
and mitochondrial components, respectively.     
 
 
Cellular 
component 
List of genes p-value FDR 
Mitochondrion 
Mrpl3, Ttc19, Slc25a34, Abcb1b, Rpl10a, 
Hsp90ab1, Mthfd1, Elac2, Gstz1, Prodh, 
Dap3, Aldh1l1, Mff, Acaa2, Gstk1, Ccbl2, 
Gcdh, Nt5dc3, Mrpl10 
5.6 x 10-4 0.071 
Mitochondrial 
matrix 
Prodh, Dap3, Acaa2, Gstk1, Gcdh 2.7 x 10-3 0.172 
Mitochondrial 
large ribosomal 
subunit 
Mrpl3, Mrpl10 7.4 x 10-3 0.202 
Mitochondrial 
inner membrane 
Slc25a34, Prodh, Acaa2, Gstk1, Gcdh 4.6 x 10-2 0.266 
   
In the GO analyses of biological processes, 174 significantly enriched categories were 
identified. An overview of the category ´Central nervous system development`, which 
was further pursued in this study, is given in Table 8. In addition, 80 significantly 
enriched molecular functions were clustered. The complete lists of all significant clusters 
are provided in Tables S5 (cellular components), S6 (biological processes), and S7 
(molecular functions).    
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Table 8: Summary of the overrepresented GO category ´Central nervous system 
development`. 
 
 
Biological process List of genes p-value FDR 
Central nervous 
system 
development 
Timp4, Sh3gl2, Adam22 1.4 x 10-2 0.075 
 
4.1.7 Insufficient yield of mitochondrial protein lysate for 2D gel analysis 
2D gel analysis of mitochondrial protein fractions gained from hippocampi of HR and LR 
mice delivered no detectable protein spots. The amount of protein load extractable from 
the mitochondrial protein fraction of a whole hippocampus was too low for the reliable 
detection of analyzable protein signals on 2D gels. 
4.1.8 No differences in cytochrome c release from mitochondrial bilayer into 
cytoplasm in HR vs. LR mice 
In cytosolic protein fractions gained from hippocampal tissue of six HR and eight LR 
mice, no differences in the cytochrome c release from the mitochondrial bilayer into the 
cytoplasm were measured. The mean cytochrome c concentration in HR mice was 
4.41 ng/ml (SEM ±1.80), in LR mice 5.57 ng/ml (SEM ±1.97; MWU p-value = 0.156). 
Detected ODs were within the linear scope of the standard curve. The cytochrome c 
concentration of the positive control provided with the Quantikine kit was measured as 
1.44 ng/ml and, thus, within the range indicated in the kit.   
4.1.9 Cytochrome c oxidase activity in the hippocampus of HR vs. LR female 
mice 
Standardized values of densiometric quantification from CO stained hippocampal slices 
are summarized in Table 9. Comparison of CO activity in the whole hippocampus of 
twelve HR vs. eleven LR females marginally failed a statistical trend (MWU p-value = 
0.103). Densiometric quantification of both hemispheres as well as separate analyses of 
the right and the left hemisphere showed an increased CO activity in the dorsal 
hippocampus of HR female mice, resulting in statistical trends (MWU p-valueboth = 0.074, 
p-valueright = 0.074, p-valueleft = 0.097). No differences were detected in intermediate and 
ventral parts of the hippocampus. 
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Table 9: Summary of densiometric quantification values after CO staining from 
hippocampal slices of HR vs. LR female mice. While quantifying CO activity, it was 
distinguished between the dorsal, the intermediate, and the ventral hippocampus, and 
between hemispheres. Values given in the HR and LR column were calculated as 
standardized mean values of the respective lines in the hippocampal areas indicated in 
the Table.  
 
 
Hippocampal 
region 
Hemisphere 
HR means 
SEM 
LR means 
SEM 
p-value 
Dorsal 
Both 
1.488 
±0.43 
1.338 
±0.40 
0.074 
Right 
1.506 
±0.43 
1.352 
±0.40 
0.074 
Left 
1.471 
±0.44 
1.323 
±0.41 
0.097 
Intermediate 
Both 
1.438 
±0.42 
1.289 
±0.39 
0.110 
Right 
1.454 
±0.41 
1.299 
±0.39 
0.110 
Left 
1.423 
±0.42 
1.279 
±0.39 
0.140 
Ventral 
Both 
1.373 
±0.39 
1.249 
±0.38 
0.176 
Right 
1.382 
±0.39 
1.261 
±0.37 
0.196 
Left 
1.365 
±0.40 
1.236 
±0.38 
0.157 
Total  
1.444 
±0.42 
1.300 
±0.39 
0.103 
 
4.1.10 Confirmation of microarray candidates via qPCR analyses  
Selected candidates detected as differentially expressed in the microarray study were 
chosen for qPCR analysis in order to confirm the differential expression. In addition to 
microarray candidates, several genes, however interesting in the context of the stress 
reactivity mouse model, were tested for differential expression using qPCR as well. The 
results of qPCR analyses are summarized in Table 10. From 22 genes tested regarding 
their expression levels in the hippocampus of HR vs. LR mice, 18 genes were chosen 
based on their adjusted p-values in the microarray study. For these genes, the 
differential expression detected in the microarray was confirmed via qPCR in seven 
cases. In 11 cases, the microarray result could not be confirmed, whereas for Mthfd1 a 
significant, but contradictory expressional difference and for Tmem132d a contradictory 
trend was measured in the qPCR. Expressional analyses of the additional four genes of 
interest (Bdnf, Cfl-1, Hmgn3, and Rps6ka5) resulted in the detection of significant up-
regulations in HR vs. LR mice.  
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Table 10: Summary of qPCR analyses. Genes are listed in alphabetical order. ddCT 
values were standardized by setting LR ddCT group mean to 1.00; the HR ddCT group 
mean was calculated accordingly. Positive fold changes in the microarray indicate up-
regulation in HR vs. LR; negative fold changes show up-regulation in LR vs. HR. Fold 
changes of genes detected with more than one probe are shown as mean values. 
Respective genes were marked with ´*` (´#` n(HR) = 8, n(LR) = 10; ´+` n(HR) = 5, n(LR) = 6; ´°` 
n(HR/LR) = 6; n. s. = not significant, T = p-value <0.1, * = p-value <0.05, ** = p-value <0.01, 
*** = p-value <0.001; FC = fold change; MA = microarray; Sign. = significance).  
  
Gene 
HR mean 
SEM 
LR mean 
SEM 
p-value 
qPCR 
Sign. FC MA MA result 
Acot1# 
1.39 
± 0.32 
1.00 
± 0.16 
0.329 n. s. 1.28 
Not 
confirmed 
Acot11# 
2.19 
± 0.22 
1.00 
± 0.14 
0.002 ** 1.21 Confirmed 
Acot13# 
0.71 
± 0.15 
1.00 
± 0.19 
0.283 n. s. -1.38 
Not 
confirmed 
Aldh1l1# 
4.33 
± 0.97 
1.00 
± 0.17 
0.015 * 2.03 Confirmed 
Bdnf+ 
1.00 
± 0.20 
1.00 
± 0.11 
0.715 n. s. n. a. n. a. 
Cfl-1# 
1.70 
± 0.22 
1.00 
± 0.13 
0.021 * n. a. n. a. 
Cyp4f13# 
1.06 
± 0.25 
1.00 
± 0.15 
0.689 n. s. -1.33 
Not 
confirmed 
Cyp4f14# 
4.35 
± 0.65 
1.00 
± 0.11 
0.001 *** 2.3 Confirmed 
Cyp4f15# 
4.67 
± 1.04 
1.00 
± 0.16 
0.002 ** 2.5 Confirmed 
Cyp4f16# 
1.43 
± 0.35 
1.00 
± 0.23 
0.329 n. s. 1.66 
Not 
confirmed 
Dap3*° 
1.27 
± 0.15 
1.00 
± 0.11 
0.297 n. s. 1.96 
Not 
confirmed 
Gabrg2*+ 
1.72 
± 0.39 
1.00 
± 0.06 
0.028 * 2.58 Confirmed 
Hmgn3+ 
1.92 
± 0.43 
1.00 
± 0.13 
0.042 * n. a. n. a. 
Hsp90ab1° 
1.29 
± 0.12 
1.00 
± 0.15 
0.229 n. s. 3.13 
Not 
confirmed 
Mthfd1+ 
1.68 
± 0.34 
1.00 
± 0.10 
0.027 * -2.56 Conflicting 
Prodh*+ 
1.94 
± 0.47 
1.00 
± 0.13 
0.027 * 1.33 Confirmed 
Rgl1° 
1.13 
± 0.11 
1.00 
± 0.17 
0.631 n. s. 4.26 
Not 
confirmed 
Rps6ka5# 
0.89 
± 0.11 
1.00 
± 0.15 
0.810 n. s. n. a. n. a. 
Tesk1# 
1.83 
± 0.44 
1.00 
± 0.18 
0.159 n. s. 4.01 
Not 
confirmed 
Tmem132d# 
1.59 
± 0.22 
1.00 
± 0.14 
0.051 T -2.20 Conflicting 
Ttbk1# 
2.7 
± 0.49 
1.00 
± 0.16 
0.006 ** 6.17 Confirmed 
Usp38# 
1.61 
± 0.44 
1.00 
± 0.19 
0.283 n. s. -2.46 
Not 
confirmed 
Results 
66 
 
Furthermore, in order to test for the reliability of the microarray analysis, four genes 
(Accn2, Fam116b, Tmem106c, and Pvalb) that should show no expressional differences 
according to the microarray results were tested in the qPCR. For these four genes, non-
regulation in the hippocampus of HR vs. LR mice was confirmed in the qPCR. The 
results are listed in Table 11.  
 
Table 11: Summary of qPCR and microarray results from genes, which were detected as 
not regulated between the lines in the microarray. (n(HR) = 8, n(LR) = 10; FC = fold change; 
MA = microarray; Sign. = significance)  
 
Gene 
HR mean 
SEM 
LR mean 
SEM 
p-value 
qPCR 
Sign. FC MA 
Accn2 
1.16 
± 0.16 
1.00 
± 0.16 
0.374 1.00 Confirmed 
Fam116b 
1.28 
± 0.12 
1.00 
± 0.16 
0.178 1.00 Confirmed 
Tmem106c 
1.03 
± 0.16 
1.00 
± 0.09 
0.916 -1.02 Confirmed 
Pvalb 
0.87 
± 0.09 
1.00 
± 0.11 
0.596 1.00 Confirmed 
 
4.1.11  Neurodevelopmental study 
4.1.11.1 Expressional profiling of neurodevelopmentally expressed genes in 
hippocampal tissue of adult animals 
In addition to qPCR analyses of microarray candidates already described in Table 10, a 
further set of nine genes, all of them known to have diverse functions in neurogenesis 
and neurodevelopment, respectively, were chosen to be analyzed for expressional 
differences by qPCR. cDNA generated from hippocampal tissue of male embryos (ED 
18), pups (PND 7), and adolescent animals (PND 28) was used to test for differences in 
gene expression at earlier stages of the development. In addition to neurodevelopmental 
genes detected in the microarray, further genes interesting in the context of the SR 
mouse model and known to be expressed during neurodevelopment, were included in 
the analysis.  
In adult mice, a significantly different expression was detected for Adam11, Ash1l, 
Crtac1, Sh3gl2, and Ssh1 in the qPCR. For Fam123a, a statistical trend was detected. 
Adam22, Cntn6, and Timp4 were not differentially expressed in adult HR vs. LR 
according to qPCR and, hence, these genes were not pursued in cDNA gained from 
earlier stages of the development. Results are summarized up in Table 12. 
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Table 12: Summary of qPCR results conducted using cDNA of adult mice. Genes are 
assorted in alphabetical order. Group means of LR ddCTs are normalized to 1.00, group 
means of HR ddCTs were calculated accordingly. (n(HR) = 5, n(LR) = 6; n. s. = not 
significant, T = p-value <0.1, * = p-value <0.05, ** = p-value <0.01; Sign. = significance)  
 
Gene 
HR mean  
SEM 
LR mean 
SEM 
p-value 
qPCR 
Sign. 
Adam11 
2.24 
± 0.39 
1.00 
± 0.14 
0.018 * 
Adam22 
1.33 
± 0.17 
1.00 
± 0.09 
0.143 n. s. 
Ash1l 
2.29 
± 0.69 
1.00 
± 0.15 
0.028 * 
Cntn6 
0.74 
± 0.08 
1.00 
± 0.25 
0.711 n. s. 
Crtac1 
2.24 
± 0.35 
1.00 
± 0.13 
0.006 ** 
Fam123a 
1.44 
± 0.19 
1.00 
± 0.13 
0.085 T 
Sh3gl2 
2.11 
± 0.48 
1.00 
± 0.16 
0.045 * 
Ssh1 
1.46 
± 0.15 
1.00 
± 0.11 
0.033 * 
Timp4 
1.17 
± 0.17 
1.00 
± 0.09 
0.410 n. s. 
 
4.1.11.2 Expressional profiling of neurodevelopmental genes in hippocampal 
tissue of ED 18 mice 
Pursuing gene expression levels of neurodevelopmental genes in male ED 18 HR and 
LR mice, genes detected as differentially expressed in adults (Table 9) were tested in 
addition to further candidates confirmed to be differentially expressed earlier (Aldh1l1, 
Cfl-1, Hmgn3, Prodh; Table 7). Preceding qPCR analyses, the gender of the embryos 
was determined via SRY PCR. The only candidate detected to be significantly different 
expressed at ED 18 was Prodh. This gene was detected with a 1.49-fold up-regulation in 
HR vs. LR mice. Detailed results of qPCRs using cDNA of ED 18 mice are summarized 
in Table 13.   
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Table 13: Summary of qPCR results conducted using cDNA of ED 18 mice. Genes are 
assorted in alphabetical order. Group means of LR ddCTs are normalized to 1.00, group 
means of HR ddCTs were calculated accordingly. (n(HR/LR) = 6; n. s. = not significant, * = 
p-value <0.05; Sign. = significance )  
 
Gene 
HR mean 
SEM 
LR mean 
SEM 
p-value 
qPCR 
Sign. 
Adam11 
0.91 
± 0.22 
1.00 
± 0.25 
0.810 n. s. 
Aldh1l1 
0.83 
± 0.28 
1.00 
± 0.22 
0.522 n. s. 
Ash1l 
0.71 
± 0.37 
1.00 
± 0.42 
0.522 n. s. 
Cfl-1 
0.70 
± 0.25 
1.00 
± 0.26 
0.200 n. s. 
Crtac1 
1.01 
± 0.39 
1.00 
± 0.19 
0.575 n. s. 
Hmgn3 
0.85 
± 0.26 
1.00 
± 0.41 
0.873 n. s. 
Prodh 
1.49 
± 0.15 
1.00 
± 0.12 
0.040 * 
Sh3gl2 
0.89 
± 0.14 
1.00 
± 0.29 
0.715 n. s. 
Ssh1 
0.78 
± 0.28 
1.00 
± 0.18 
0.337 n. s. 
 
 
4.1.11.3 Expressional profiling of neurodevelopmental genes in hippocampal 
tissue of PND 7 mice 
Independent of the results gained in hippocampal tissue from ED 18 mice, the same nine 
gene candidates were tested in hippocampal tissue from PND 7 animals which were 
identified as male mice using SRY PCR. The only gene detected to differ in the 
expression between the lines was Prodh with an up-regulation close to 2-fold in LR vs. 
HR mice, resulting in a statistical trend. The other candidates were not differentially 
expressed between the lines. Data gained from PND 7 mice are summarized in Table 
14. 
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Table 14: Summary of qPCR results conducted using cDNA of PND 7 mice. Genes are 
listed in alphabetical order. Group means of LR ddCTs are normalized to 1.00, group 
means of HR ddCTs are calculated accordingly. (n(HR/LR) = 6; n. s. = not significant, T = p-
value <0.1; Sign. = significance)  
 
Gene 
HR mean 
SEM 
LR mean 
SEM 
p-value 
qPCR 
Sign. 
Adam11 0.79 
± 0.25 
1.00 
± 0.18 
0.150 n. s. 
Aldh1l1 1.23 
± 0.48 
1.00 
± 0.17 
1.00 n. s. 
Ash1l 1.15 
± 0.39 
1.00 
± 0.18 
1.00 n. s. 
Cfl-1 0.89 
± 0.26 
1.00 
± 0.12 
0.297 n. s. 
Crtac1 0.83 
± 0.22 
1.00 
± 0.15 
0.200 n. s. 
Hmgn3 1.10 
± 0.19 
1.00 
± 0.11 
0.715 n. s. 
Prodh 0.47 
± 0.10 
1.00 
± 0.16 
0.055 T 
Sh3gl2 0.87 
± 0.19 
1.00 
± 0.15 
0.465 n. s. 
Ssh1 0.74 
± 0.22 
1.00 
± 0.10 
0.201 n. s. 
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4.1.11.4 Expressional profiling of neurodevelopmental genes in hippocampal 
tissue of PND 28 mice 
The same genes were tested in tissue of adolescent HR and LR mice (PND 28), 
resulting in the detection of a significant up-regulation of Hmgn3 in LR vs. HR mice. The 
other candidates were quantified as not differentially expressed between the lines. qPCR 
results are summarized in Table 15. 
 
Table 15: Summary of qPCR results conducted using cDNA of PND 28 mice. Genes are 
listed in alphabetical order. Group means of LR ddCTs are normalized to 1.00, group 
means of HR ddCTs were calculated accordingly (n(HR/LR) = 6; n. s. = not significant, * = 
p-value <0.05; Sign. = significance).  
 
Gene 
HR mean 
±SEM 
LR mean 
±SEM 
p-value 
qPCR 
Sign. 
Adam11 0.67 
± 0.12 
1.00 
± 0.23 
0.337 n. s. 
Aldh1l1 0.92 
± 0.17 
1.00 
± 0.22 
0.936 n. s. 
Ash1l 1.13 
±0.24 
1.00 
± 0.15 
0.855 n. s. 
Cfl-1 0.96 
±0.18 
1.00 
± 0.15 
0.670 n. s. 
Crtac1 0.80 
± 0.15 
1.00 
± 0.19 
0.337 n. s. 
Hmgn3 0.47 
± 0.08 
1.00 
± 0.17 
0.037 * 
Prodh 0.82 
± 0.12 
1.00 
± 0.18 
0.378 n. s. 
Sh3gl2 0.81 
± 0.15 
1.00 
± 0.13 
0.465 n. s. 
Ssh1 0.87 
± 0.22 
1.00 
± 0.17 
0.522 n. s. 
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4.2 From gene expressional profiling to behavior – tracking one candidate gene 
to a behavioral phenotype  
4.2.1 Non-detection of differential expression of Cfl-1 in hippocampal tissue of 
HR vs. LR mice in microarray study 
The differential expression of the Cfl-1 gene in HR vs. LR mice was shown using qPCR 
analysis (Table 10), but the up-regulation of the gene was not detected in the microarray 
experiment. This non-detection was due to the obsolete design of the microarray probe 
for this gene. According to the current annotation of Cfl-1 (genome build version 37.2; 
chr. 19: 5,489,915 - 5,494,563) the microarray probe (chr. 19: 5,494,951 - 5,495,000) 
would have bound to genomic coordinates at least 388 bp after the 3´-terminal end of the 
target gene. The microarray probe, therefore, presents the complementary sequence of 
a genomic fragment in the intergenic region between Cfl-1 and Snx32, the gene located 
down-stream of Cfl-1. This excludes the correct detection of Cfl-1 expression levels in 
the mRNA-based expressional assay used for this study. 
4.2.2 Behavioral phenotype in heterozygous Cfl-1+/- mice 
Cfl-1+/- and WT controls were subjected to the behavioral test battery described on under 
point 3.2.4.1. 
4.2.2.1 No distinct behavior of Cfl-1+/- vs. WT mice in the OF 
None of the parameters tested in the OF differed between Cfl-1+/- and WT controls, 
neither in male, nor in female mice. This applied to the key parameters indicating 
anxiety-like and locomotive behavior, like the total distance travelled and the time spent 
in the inner zone, as well as to additional parameters tested, like free and wall rearings 
which were taken as indicators for explorative behavior. In male mice, the mean distance 
travelled in the OF for Cfl-1+/- mice was 12.46 m (SEM ±1.06), for WT littermates 11.66 m 
(SEM ±0.82; IST p-value = 0.549). On average, Cfl-1+/- mice spent 89.63 s (SEM ±15.94) 
in the inner zone of the OF apparatus, WT mice 91.49 s (SEM ±13.51; IST p-value = 
0.93). In female mice, the mean total distance travelled of Cfl-1+/- mice was 13.08 m 
(SEM ±1.31) and 15.53 m in WT littermates (SEM ±0.89; IST p-value = 0.155). The time 
spent in the inner zone of Cfl-1+/- females was measured with 93.94 s (SEM ±18.26), for 
female WT littermates 101.34 s (SEM ±12.08; IST p-value = 0.749). These two 
parameters were depicted in Figure 12, exemplarily for all the other features tested in the 
OF but not differing between groups.   
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Figure 12: Results of the OF parameters ´total distance travelled` (A) and ´time spent in 
the inner zone` (B) in Cfl-1+/- vs. WT male and female mice (Males: n(Cfl-1+/-) = 16, n(WT) = 
22; females: n(Cfl-1+/-) = 8, n(WT) = 22; n. s. = not significant). 
 
 
4.2.2.2 Anxiety-related behavior in Cfl-1+/- vs. WT mice on the EPM 
The behavior of animals on the EPM indicated an anxiety-related phenotype in Cfl-1+/- 
mice compared to WT controls. This applied to both genders, although the anxiety-
related features were more pronounced in female mice. In males, the total distance 
travelled on the EPM did not differ between the test groups, again implying equal 
locomotor activity between Cfl-1+/- and WT males. On average, male Cfl-1+/- mice 
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travelled 4.91 m (SEM ±0.83) on the EPM, WT males 4.63 m (SEM ±0.54; IST p-value = 
0.769). Also, for the time spent immobile on the EPM no differences were detected 
between the groups (mean value Cfl-1+/- mice 80.71 s, SEM ±13.21; WT 82.11 s, SEM 
±11.24; IST p-value = 0.936). Differences between the groups though were measured in 
the time spent on the open arm. Cfl-1+/- males spent 28.20 s (SEM ±9.86) on the open 
arm, WT controls spent more than twice as much time on the open arm (67.24 s, SEM 
±20.39; IST p-value = 0.095). The distances Cfl-1+/- males travelled on the open arm did 
not differ significantly in comparison to WT males, neither did the number of entries into 
the open arm (mean distance travelled on the open arm: Cfl-1+/- 0.58 m, SEM ±0.17 vs. 
WT 1.17 m, SEM ±0.34; IST p-value = 0.135; mean open arm entries: Cfl-1+/- 6.94, SEM 
±1.61 vs. WT controls 6.64, SEM ±1.26; IST p-value = 0.882). In females, the total 
distance travelled on the maze differed significantly (Cfl-1+/- 0.39 m, SEM ±0.17 vs. WT 
controls 6.91 m, SEM ±0.66; IST p-value <0.001). The time animals spent immobile on 
the EPM also varied (Cfl-1+/- 68.1 s, SEM ±11.14 vs. WT controls 43.12 s, SEM ±7.11), 
resulting in a statistical trend (IST p-value = 0.077). The time Cfl-1+/- females spent on 
the open arm was measured with 22.76 s (SEM ±10.19), WT controls spent more than 
three times more time on the open arm (75.11 s, SEM ±20.47; IST p-value = 0.03). 
Correspondingly, the distance travelled on the open arm differed as well (Cfl-1+/- 0.39 m, 
SEM ±0.17 vs. 1.57 m, SEM ±0.38; IST p-value = 0.008). The number of open arm 
entries of Cfl-1+/- females was counted with 8.13 (SEM ±2.09), for WT controls 10.55 
(SEM ±1.91; IST p-value = 0.486). Exemplary EPM data of male and female mice were 
depicted in Figures 13 and 14. 
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Figure 13: Comparison of the EPM parameters ´total distance travelled` (A) and 
´percentage time spent on the open arm` (B) between male and female Cfl-1+/- and WT 
controls (Males: n(Cfl-1+/-) = 16, n(WT) = 22; females: n(Cfl-1+/-) = 8; n(WT) = 22; n. s. = not 
significant, T = p-value <0.1, * = p-value <0.05, *** = p-value <0.001). 
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Figure 14: Comparison of EPM parameters ´distance travelled on the open arm` (A) and 
´open arm entries` (B) between male and female Cfl-1+/- and WT mice (Males: n(Cfl-1+/-) = 
16, n(WT) = 22; females: n(Cfl-1+/-) = 8; n(WT) = 22; n. s. = not significant, ** = p-value <0.01). 
 
4.2.2.3 Detection of increased anxiety-related behavior in female Cfl-1+/- vs. WT 
mice in the DL box  
In male Cfl-1+/- vs. WT mice, none of the parameters tested in the DL box differed 
between the groups. In females, the total distance travelled showed a significantly 
shorter distance for Cfl-1+/- compared to WT mice (8.10 m, SEM ±0.76 vs. 13.1 m, SEM 
±1.24; IST p-value = 0.002). In the time animals spent in the light compartment no 
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difference was detected (Cfl-1+/- 44.54 s, SEM ±16.92 vs. 64.52 s, SEM ±14.31; IST 
p-value = 0.427), but the distance females travelled in the light compartment was 
measured as significantly shorter compared to WT controls (1.79 m, SEM ±0.61 vs. 
4.25 m, SEM ±0.62; IST p-value = 0.026). Furthermore, the number of entries into the 
light compartment was clearly reduced in Cfl-1+/- females (Cfl-1+/- 1.88, SEM ±0.69 vs. 
4.79, SEM ±0.68; IST p-value = 0.018; Figures 15 and 16).  
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Figure 15: Comparison of DL box parameters ´total distance travelled` (A) and ´time 
spent in the light compartment` (B) (Males: n(Cfl-1+/-) = 13, n(WT) = 17; females: n(Cfl-1+/-) = 8; 
n(WT) = 19; n. s. = not significant, ** = p-value <0.01). 
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Figure 16: Comparison of DL box parameters ´distance travelled in the light 
compartment` (A) and ´number of entries into light compartment` (B) (Males: n(Cfl-1+/-) = 
13, n(WT) = 17; females: n(Cfl-1+/-) = 8; n(WT) = 19; n. s. = not significant, * = p-value <0.05). 
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4.2.2.4 FST data indicate more active stress-coping style of female Cfl-1+/- vs. WT 
mice  
None of the parameters tested in the FST differed in male Cfl-1+/- vs. WT mice. In 
females, struggling time as well as the struggling frequency were significantly different in 
Cfl-1+/- compared to WT mice (struggling time Cfl-1+/- 59.61 s, SEM ±5.90 vs. in WT 
39.3 s, SEM ±3.32; IST p-value = 0.004; struggling frequency Cfl-1+/- 6.88 s, SEM ±0.97 
vs. in WT 10.05, SEM ±0.81; IST p-value = 0.039). The average swimming frequency 
counted in Cfl-1+/- females was significantly decreased in comparison to WT controls 
(27.63, SEM ±3.68 vs. 35.27, SEM ±1.62; IST p-value = 0.036). FST data are depicted in 
Figures 17 and 18. 
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Figure 17: Results of FST scoring. Significant differences in the time struggling were 
detected in females only (Males: n(Cfl-1+/-) = 16, n(WT) = 22; females: n(Cfl-1+/-) = 8; n(WT) = 22; 
n. s. = not significant, ** = p-value <0.01). 
 
 
 
Results 
 
79 
 
WT Cfl-1+/- WT Cfl-1+/-
S
w
im
m
in
g
 f
re
q
u
e
n
c
y
 [
n
o
.]
10
20
30
40
50
60
Male mice Female mice
n. s. *
Male mice Female mice
WT Cfl-1+/- WT Cfl-1+/-
S
tr
u
g
g
lin
g
 f
re
q
u
e
n
c
y
 [
n
o
.]
0
5
10
15
20
n. s. *
A
B
 
Figure 18: Results of FST scoring. Significant differences in struggling (A) and swimming 
(B) frequencies were detected in females only (Males: n(Cfl-1+/-) = 16, n(WT) = 22; females: 
n(Cfl-1+/-) = 8; n(WT) = 22; n. s. = not significant, * = p-value <0.05). 
 
4.2.2.5 Increased stress reactivity in Cfl-1+/- vs. WT mice 
As detected in the SRT, the initial corticosterone concentrations in the plasma of male 
and female Cfl-1+/- vs. WT mice did not differ (males: Cfl-1+/- 7.49 ng/ml, SEM ±2.57 vs. 
in WT 5.08 ng/ml, SEM ±0.87; MWU p-value = 0.885; females: Cfl-1+/- 14.67 ng/ml, SEM 
±4.61 vs. in WT 13.62 ng/ml, SEM ±3.93; MWU p-value = 0.453). The corticosterone 
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concentrations in the plasma of reaction samples differed significantly independent of 
gender (males: 268.42 ng/ml, SEM ±18.02 vs. in WT 224.57 ng/ml, SEM ±14.06; MWU 
p-value = 0.043; females: 453.45 ng/ml, SEM ±26.25 vs. in WT 387.15 ng/ml, SEM 
±14.15; MWU p-value = 0.028), suggesting that the stress reactivity of tested animals is 
influenced by the genotype at the Cfl-1+/- locus. The same applied to the corticosterone 
increase. The increase calculated between the initial and the reaction plasma 
corticosterone concentration showed as a statistical trend in male mice (Cfl-1+/- 
260.92 ng/ml, SEM ±17.66 vs. in WT 219.50 ng/ml, SEM ±14.11; MWU p-value = 0.055) 
and differed significantly in female mice (Cfl-1+/- 438.78 ng/ml, SEM ±26.08 vs. in WT 
373.53 ng/ml, SEM ±11.84; MWU p-value = 0.039). In addition, the recovery value as 
well as the corticosterone decrease between the reaction and the recovery sample did 
not show any statistically relevant differences in male mice (mean recovery value Cfl-1+/- 
33.28 ng/ml, SEM ±7.29 vs. in WT 31.11 ng/ml, SEM ±4.87; MWU p-value = 0.773; 
mean decrease value Cfl-1+/- 244.15 ng/ml, SEM ±23.47 vs. in WT 226.69 ng/ml, SEM 
±22.76; MWU p-value = 0.564). In females, the corticosterone concentration in the 
recovery plasma sample was still increased in Cfl-1+/- compared to WT mice (Cfl-1+/- 
40.05 ng/ml, SEM ±8.90 vs. in WT 18.12 ng/ml, SEM ±2.80; MWU p-value = 0.064). This 
statistical effect did not show in the corticosterone decrease, as the reaction and the 
recovery sample were increased at equal measures (Cfl-1+/- 405.29 ng/ml, SEM ±45.70 
vs. in WT 354.50 ng/ml, SEM ±30.72; MWU p-value = 0.28). In general, the 
corticosterone concentrations measured in female mice were considerably increased 
compared to male mice, independent of the genotype at the Cfl-1 locus. The results of 
SRT data are summarized in Figures 19, 20, and 21.   
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Figure 19: Results of the SRT. Independent of gender, initial corticosterone 
concentrations (A) did not differ between the lines, reaction corticosterone 
concentrations (B) differed significantly between Cfl-1+/- and WT mice (Males: n(Cfl-1+/-) = 
15, n(WT) = 18; females: n(Cfl-1+/-) = 8; n(WT) = 22; n. s. = not significant, * = p-value <0.05). 
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Figure 20: Results of the SRT. Corticosterone increase values (A) and recovery 
corticosterone concentrations (B) gender-dependently differed between Cfl-1+/- and WT 
mice (Corticosterone increase males: n(Cfl-1+/-) = 15, n(WT) = 18; females: n(Cfl-1+/-) = 8; n(WT) 
= 22; recovery corticosterone concentrations males; n(Cfl-1+/-) = 8, n(WT) = 9; females: 
n(Cfl-1+/-) = 4; n(WT) = 9; n. s. = not significant, T = p-value <0.1, * = p-value <0.05). 
 
 
 
Results 
 
83 
 
WT Cfl-1+/- WT Cfl-1+/-
C
o
rt
ic
o
s
te
ro
n
e
 d
e
c
re
a
s
e
 [
n
g
/m
l]
100
200
300
400
500
600
n. s. n. s.
Male mice Female mice
 
Figure 21: Results of the SRT. Corticosterone decrease values did not differ between 
Cfl-1+/- and WT mice (Males: n(Cfl-1+/-) = 8, n(WT) = 9; females: n(Cfl-1+/-) = 4; n(WT) = 9; n. s. = 
not significant). 
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4.3 Segmental copy number variation and SNP profiling of HAB vs. LAB and HR 
vs. LR mice 
4.3.1 Regions of segmental copy number variation in DNA copy numbers 
differing in HAB vs. LAB and in HR vs. LR mice  
The Jax Mouse Diversity Genotyping array disclosed 180 regions harboring segmental 
copy number variations between HAB and LAB mice, fragment sizes ranging from 2 to 
7,383,756 bp. Among these 180 regions, 137 CNVs (>1 kbp) and 43 segmental changes 
(<1 kbp) were identified covering in total 14,731,644 bp of the HAB/LAB genome. Having 
taken the LAB sequence as reference sequence, 62 losses and 118 gains were 
identified in the HAB sequence in relation to the reference sequence. The comparison of 
HR and LR sequences resulted in the detection of 154 segmental copy number 
variations, the shortest segmental variation counted 9 bp, the longest 1,115,056 bp. 
Among these, 115 CNVs and 39 segmental changes were revealed, which covered in 
total 5,445,908 bp of the HR/LR genome. In this comparison, the LR sequence served as 
reference sequence. Thus, 108 gains and 46 losses were detected in the HR sequence 
in respect to the LR sequence. A rather general observation applying to both mouse 
models was the accumulation of segmental variations in proximate vicinity. A detailed 
summary of the detected segmental variation in DNA copy numbers is provided in 
Tables S8 (HAB/LAB) and S9 (HR/LR). Figures 22 (HAB vs. LAB) and 23 (HR vs. LR) 
depict the genomic location of segmental variations in both mouse models. 
Independent of the fragment size, segmental changes are further on referred to as 
CNVs.  
 
 
Results 
 
85 
 
 
 
Figure 22: Locations of segmental copy number variations in the genome of HAB vs. 
LAB mice. Relative gains are indicated with green, relative losses with red arrows.   
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Figure 23: Locations of segmental copy number variations in the genome of HR vs. LR 
mice. Relative gains were indicated with green, relative losses with red arrows.   
 
 
4.3.2 Influence of segmental variation in DNA copy numbers on gene expression 
in the hippocampus of HR and LR mice 
A regulatory effect of segmental copy number variation on gene expression in the 
hippocampus of HR and LR mice was found based on CNV data derived from the Jax 
Mouse Diversity Genotyping array and the pool of genes detected to be differentially 
regulated in the microarray experiment (p-value = 0.042). For this analysis, a two-
proportion Z-test was performed comparing the proportion of probes covering regions of 
segmental variation in all probes not showing expressional differences with the 
proportion of probes covering regions of segmental variations in all probes that were 
shown to be differentially expressed. Numbers underlying this calculation are 
summarized in Table 16. 
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Table 16: Numbers underlying the calculation of the two-proportion Z-test based on the 
microarray study.  
 
No. of HR vs. LR 
Regulated genes 300 
Segmental variation in DNA 154 
Total microarray probes 45,281 
Detectable probes 20,154 
Differentially expressed probes 248 
Probes in CNVs 735 
Differentially expressed probes in segmental variation 15 
p-value 0.042 
 
 
To overcome the limitation coming along with non-detectable probes in the microarray 
study, the identical calculation was repeated with genes detected to be differentially 
expressed in the hippocampus of HR vs. LR mice according to the SAGE study. This 
NGS-based transcriptome analysis was chosen as a probe-independent approach which 
did not entail the identification of a delimited pool of regulated genes only. Thus, the two-
proportion Z-test compared the proportion of genes encoded for in regions of segmental 
variation in the total of non-differentially expressed genes genome-wide with the 
proportion of those genes in segmental variations in the total of differentially expressed 
genes.   
In either case, protein coding genes only were taken into account. The number of protein 
coding genes in the mouse was according to the UCSC genome browser assessed with 
25,071 (http://genome.ucsc.edu/). The two-proportion Z-test resulted in a p-value of 
0.043 and, thus, very much resembled the p-value calculated based on the microarray 
gene pool. The data underlying the two-proportion Z-test are shown in Table 17.  
 
Table 17: Numbers underlying the calculation of the two-proportion Z-test based on the 
SAGE study.  
 
No. of HR vs. LR 
Differentially expressed protein coding genes 662 
Protein coding genes in regions harboring segmental variation 795 
Differentially expressed protein coding genes in segmental variation 30 
p-value  0.043 
 
4.3.3 SNP profiling of HAB vs. LAB and HR vs. LR animals using the JAX Mouse 
Diversity Genotyping array 
The SNP profiling of one representative animal (´master animal`) per line resulted in the 
identification of 60,077 heterozygous SNPs to differ between HAB and LAB which equals 
9.64% of SNPs tested in the Jax Mouse Diversity Genotyping array. A total of 47,470 
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SNPs was detected to diverge between the HR and LR sequences, which equals 7.62% 
of all SNPs tested in the array. According to their location, SNPs were classified in 
intragenic (coding non-synonymous, coding, UTR, intronic) and intergenic SNPs. The 
exact numbers are summarized in Table 18. In addition, complete lists of all 
heterozygous SNPs between HAB and LAB and between HR and LR assorted according 
to their chromosomal location (genome build version 37) including information regarding 
the locus symbols of intragenic SNPs and type of SNP are provided in Table S8 (HAB 
vs. LAB) and S9 (HR vs. LR; excel-files).  
 
Table 18: Summary of heterozygous SNPs differing between the lines of the inbred 
mouse models detected in the Jax Mouse Diversity Genotyping array.  
 
No. of SNPs HAB vs. LAB HR vs. LR 
Intragenic 23,248 18,758 
 Coding non-synonymous 299 213 
 Coding 603 526 
 UTR 533 471 
 Intronic 21,813 17,548 
Intergenic 36,829 28,712 
Total 60,077 47,470 
 
Based on the SNP profiling of the two mouse models, an overlapping pool of SNPs was 
created containing heterozygous SNPs differing between HAB and LAB and at the same 
time between HR and LR mice. This overlapping SNP pool contained 17,722 SNPs, 
7,374 intragenic (96 coding non-synonymous, 189 coding, 171 UTR, 6,918 intronic) and 
10,348 intergenic SNPs. A complete list of SNPs of the overlapping pool was prepared in 
Table S10 (excel-file). This file contains information regarding SNP genotypes, 
chromosomal coordinates (genome build version 37), locus symbols of intragenic SNPs 
and the type of SNPs. This overlapping SNP pool served as basis for the design of two 
customized Illumina SNP genotyping chips.  
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4.4 Phenotypic characterization of an outbred population of CD-1 male mice     
4.4.1 Results of behavioral testing of 384 CD-1 male mice 
384 CD-1 male mice were batch-wise subjected to the ´CD-1 panel` behavioral test 
battery described under point 3.2.4.2. 
4.4.1.1 Results of EPM testing 
First, it was excluded that there were relevant differences in the behavior of animals on 
the EPM between the eight test batches assuring the comparability of separate batches. 
The means values did not differ significantly between the batches. The majority of 
animals displayed an intermediate level of anxiety-related behavior, though extreme 
traits towards both directions were collected as well. The mean values per batch 
including SEMs of the total distance travelled on the EPM, the percentage time spent on 
the open arm, and the numbers of open arm entries are provided in Table 19. In addition, 
the distribution of the three EPM parameters named above over the eight test batches is 
provided in Figures 24 and 25 A. Furthermore, the distribution of the percentage time 
animals spent on the open arm of the EPM among the 384 animals tested is shown in 
Figure 25 B. The percentage time animals spent on the open arm was therefore plotted 
against the number of animals displaying the respective time. This graph reflects the 
continuum of the anxiety-related behavior present in the outbred population. The majority 
of animals displayed an intermediate anxiety-related phenotype by spending roughly 20 - 
60% of their time on the open arm of the EPM. Animals displaying around 10% of their 
time on the maze on the open arm represent the fraction of the CD-1 population 
displaying extremes in the anxiety-related behavior and, therefore, resemble to HAB 
mice in that aspect. Also, extremely non-anxious mice spending approximately 90% of 
their time on the EPM on the open arm were observed in the CD-1 population, 
resembling to the behavior of LAB mice.   
 
Results 
90 
 
Table 19: Summary of data collected from EPM core parameters including mean values 
and the respective SEMs for the eight different test batches and the total of animals 
tested.  
   
Batch 
Total distance         
travelled 
[m] 
 
Batch means 
±SEM 
Percentage time 
spent on open arm 
[%] 
 
Batch means 
±SEM 
Open arm 
entries 
[no.] 
 
Batch means 
±SEM 
1 
9.52 
±0.35 
34.16 
±1.76 
32.02 
±1.22 
2 
9.52 
±0.32 
35.43 
±1.85 
30.65 
±1.15 
3 
9.58 
±0.31 
37.71 
±2.03 
28.81 
±1.16 
4 
10.15 
±0.34 
35.02 
±1.44 
31.13 
±1.13 
5 
9.67 
±0.32 
35.98 
±1.84 
30.19 
±1.52 
6 
10.02 
±0.32 
35.34 
±1.57 
28.65 
±1.12 
7 
8.84 
±0.30 
31.13 
±1.71 
29.81 
±1.13 
8 
9.97 
±0.25 
37.30 
±1.52 
28.73 
±1.23 
Total 
9.66 
±0.11 
35.26 
±0.61 
29.00 
±0.43 
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Figure 24: Graphic comparison of EPM data. The total distance travelled on the EPM (A) 
and the percentage time animals spent on the open arm of the EPM (B) did not 
significantly differ between the eight test batches.  
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Figure 25: Graphic comparison of EPM data. The number of open arm entries on the 
EPM did not significantly differ between the eight test batches (A) and furthermore, the 
distribution of the EPM parameter ´percentage time spent on the open arm` in the 384 
animals (B) is provided.  
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4.4.1.2 Results of OF testing 
In similarity to data collected from EPM testing, considerable differences in the behavior 
of mice in the OF from different batches were excluded. A summary of the results of the 
OF key parameters ´total distance travelled in the OF`, ´time spent in the inner zone`, 
and ´the distance travelled in the inner zone` is compiled in Table 20. In Figures 26 and 
27 A graphic illustrations of these OF key parameters are provided. According to this, the 
majority of CD-1 mice tested displayed an intermediate trait anxiety in the OF, though, 
extremes towards both directions were observed as well. In addition, in Figure 27 B the 
distribution of the parameter ´total distance travelled in the OF` is plotted against the 
respective number of animals displaying the trait. This graph reflects the continuum of 
anxiety-related behaviors presented in the CD-1 population. The majority of mice 
travelled between 16 and 40 m in the OF apparatus. Individuals displaying extremes of 
trait anxiety were observed as well. Data of EPM and OF testing were also analyzed 
regarding a potential influence of the test order – EPM testing first vs. OF testing first. An 
influence of the test order on the behavior of the animals was excluded. This is 
exemplarily shown for the total distance animals travelled on the EPM in Figure 28.  
 
Table 20: Summary of OF key parameters from different test batches and from the total 
number of animals tested. Batch mean values and SEMs are provided for the three key 
parameters. 
 
Batch 
Total distance         
travelled 
[m] 
 
Batch means 
±SEM 
Time spent in  
inner zone 
[s] 
 
Batch means 
±SEM 
Distance travelled 
inner zone 
[m] 
 
Batch means 
±SEM 
1 
23.98 
±1.03 
22.84 
±2.59 
2.26 
±0.22 
2 
25.97 
±0.98 
25.71 
±2.25 
2.86 
±0.23 
3 
25.58 
±0.85 
23.85 
±2.31 
2.53 
±0.24 
4 
27.55 
±1.07 
24.21 
±2.15 
2.96 
±0.28 
5 
27.94 
±0.80 
24.89 
±2.02 
2.98 
±0.22 
6 
25.88 
±0.88 
15.89 
±1.58 
1.99 
±0.19 
7 
25.36 
±0.79 
25.09 
±1.95 
2.60 
±0.27 
8 
27.35 
±0.87 
22.47 
±1.53 
2.73 
±0.21 
Total 
26.20 
±0.33 
23.12 
±0.74 
2.62 
±0.08 
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Figure 26: Graphic comparison of OF data. The mean distances travelled (A) and the 
time animals spent in the inner zone of the OF (B) did not differ substantially between the 
eight separate test batches.  
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Figure 27: Graphic comparison of OF data. The distance travelled in the inner zone of 
the OF (A) did not significantly differ between the eight test batches and furthermore, the 
distribution of the OF parameter ´total distance travelled in OF` among the 384 animals 
tested is shown (B). 
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Figure 28: Graphic illustration of the total distances animals travelled on the EPM. The 
alternating order of EPM and OF testing did not influence the behavior of animals in the 
tests for anxiety-related behavior.   
 
 
4.4.1.3 Results of FST 
An overview over data from FST key parameters ´time swimming`, ´time floating`, and 
´floating latency` is provided in Table 21 and in Figures 29 and 30 A. In similarity to the 
behavioral tests reflecting anxiety-related behavior, also in the FST no significant 
differences between the batches were observed. Furthermore, the majority on CD-1 
mice displayed an intermediate depression-like behavior but also extreme traits towards 
both directions were observed. The continuum of depression-like behaviors in the CD-1 
outbred population is shown in Figure 30 B. The total immobility time which comprises 
the time animals spent floating and freezing during FS testing, was therefore plotted 
against the number of animals showing the respective immobility time. According to this, 
the majority on CD-1 mice spent 151 to 299 s immobile during the FST period.  
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Table 21: Summary of FST key parameters from different test batches and from the total 
of animals tested. Mean values and SEMs are provided for the three key parameters. 
 
 
Batch 
Time swimming  
[s] 
 
Batch means 
±SEM 
Time floating 
[s] 
 
Batch means 
±SEM 
Floating latency 
[s] 
 
Batch means 
±SEM 
1 
102.5 
±8.58 
200.34 
±8.95 
85.06 
±5.11 
2 
83.69 
±6.18 
216.2 
±6.80 
70.81 
±3.25 
3 
78.79 
±5.84 
234.86 
±7.10 
67.29 
±3.41 
4 
80.28 
±4.82 
235.52 
±4.96 
62.97 
±2.91 
5 
89.54 
±5.62 
230.74 
±5.94 
56.26 
±3.22 
6 
94.74 
±5.88 
230.57 
±5.45 
66.15 
±2.58 
7 
85.41 
±5.17 
225.56 
±5.88 
64.75 
±3.10 
8 
73.60 
±4.54 
235.96 
±5.58 
63.61 
±3.57 
Total 
86.07 
±2.13 
226.22 
±2.33 
68.24 
±1.26 
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Figure 29: Graphic comparison of FST data. The times animals spent swimming (A) and 
floating (B) did not differ significantly between the eight test batches.   
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Figure 30: Graphic comparison of FST data. The floating latency (A) did not differ 
significantly between the eight test batches and furthermore, the distribution of the total 
immobility time is shown (B). 
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4.4.1.4 Results of SRT 
The plasma corticosterone concentrations measured in initial and reaction probes, as 
well as the corticosterone increase which was calculated based on these measures, are 
shown as mean values of the test batches including the respective SEMs in Table 22. In 
Figures 31 and 32 A graphical illustrations of the data shown in Table 22 are provided. 
Also in the SRT, major differences between the separate test batches were excluded. 
Furthermore, a broad range of corticosterone increased was detected in the CD-1 
outbred population (Figure 32 B). The majority of animals displayed an intermediate 
corticosterone increase, ranging from 121 to 240 ng/ml. Though, animals showing 
extremes in stress reactivity were observed. CD-1 mice showing a sub-standard 
corticosterone increase (about 100 ng/ml) resemble to LR mice in this aspect, whereas 
animals displaying a corticosterone increase by about 250 ng/ml and higher resemble 
the stress reactivity observed in HR mice.  
 
Table 22: Summary of corticosterone measures detected after the SRT. Mean 
corticosterone concentrations per batch including SEMs are provided as well as for the 
total number of animals tested.   
 
Batch 
Initial 
corticosterone 
conc.  
[ng/ml] 
 
Batch means 
±SEM 
Reaction 
corticosterone 
conc. 
[ng/ml] 
 
Batch means 
±SEM 
Corticosterone 
increase 
[ng/ml] 
 
 
Batch means 
±SEM 
1 
8.0 
±2.31 
199.6 
±9.02 
191.6 
±8.33 
2 
6.8 
±1.23 
182.3 
±6.04 
175.4 
±5.45 
3 
7.0 
±1.57 
193.4 
±7.0 
186.5 
±6.53 
4 
11.2 
±2.63 
223.7 
±8.17 
212.5 
±7.08 
5 
5.4 
±1.28 
191.3 
±7.27 
185.9 
±6.86 
6 
10.1 
±3.54 
208.5 
±10.03 
198.4 
±9.89 
7 
16.0 
±5.18 
226.6 
±10.07 
210.5 
±8.25 
8 
4.8 
±1.19 
180.6 
±7.57 
175.8 
±6.89 
Total 
8.8 
±1.00 
201.3 
±3.04 
192.5 
±2.74 
 
Results 
 
101 
 
Batch no.
1 2 3 4 5 6 7 8
In
it
ia
l 
c
o
rt
ic
o
s
te
ro
n
e
 c
o
n
c
. 
[n
g
/m
l]
0
50
100
150
200
250
Batch no.
1 2 3 4 5 6 7 8
R
e
a
c
ti
o
n
 c
o
rt
ic
o
s
te
ro
n
e
 c
o
n
c
. 
[n
g
/m
l]
0
100
200
300
400
500
A
B
 
 
Figure 31: Graphic illustration of SRT data. Initial (A) and reaction (B) corticosterone 
concentrations are shown. No major differences were observed between the different 
test batches.  
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Figure 32: Graphic illustration of SRT data. The corticosterone increase (A) did not 
significantly differ between the test batches and furthermore, the distribution of the 
corticosterone increases (B) among the 384 CD-1 mice is shown.   
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4.4.1.5 Results of TST 
The results of the TST are summarized in Table 23 and Figure 33 A. Major differences in 
the depression-like behavior between the test batches were excluded. The majority of 
mice displayed an intermediate time immobile in the TST reflecting intermediate 
depression-like behavior. Figure 33 B depicts the distribution of the time immobile 
observed among the 384 CD-1 mice tested and reflects the continuum of depression-like 
features presented by the CD-1 outbred population. The majority of mice showed 
immobile phases between 0 and 150 s.  
 
Table 23: Summary of data collected in the TST. The mean values including the 
respective SEMs of the total immobility time, the immobility frequency, and the latency to 
the first immobile phase are shown for the eight different batches and the total of all 
animals tested.  
 
Batch 
Immobility        
time              
[s]       
 
Batch means 
±SEM 
Immobility 
frequency 
[no.] 
 
Batch means 
±SEM 
Immobility 
latency          
[s] 
 
Batch means 
±SEM 
1 
77.61 
±7.28 
5.55 
±0.51 
114.04 
±11.51 
2 
59.56 
±6.64 
4.77 
±0.45 
145.01 
±12.48 
3 
66.91 
±6.74 
5.81 
±0.52 
143.64 
±11.93 
4 
73.99 
±6.77 
4.87 
±0.41 
131.25 
±10.47 
5 
88.10 
±6.74 
5.96 
±0.39 
126.40 
±8.93 
6 
72.18 
±7.83 
5.17 
±0.52 
130.98 
±11.80 
7 
60.77 
±6.46 
4.70 
±0.42 
139.85 
±13.07 
8 
61.37 
±7.88 
4.50 
±0.43 
122.94 
±12.71 
Total 
70.21 
±2.51 
5.18 
±0.16 
131.96 
±4.12 
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Figure 33: Graphic illustration of TST results. The immobility time did not differ 
significantly between the eight batches (A) and furthermore, the immobility time was 
plotted against the number of animals displaying the respective time immobile (B).  
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4.4.1.6 No correlation between phenotypes collected in behavioral experiments of 
the ´CD-1 panel`  
The PCA revealed no significant correlation of phenotypes collected in the behavioral 
test battery of the ´CD-1 panel`. As shown in Figure 34, the only correlated features were 
the ones implicated by the experimental set-up as, for example, mice can spend their 
time either in the inner or in the outer zone of the OF. The resulting inverse correlation is, 
thus, reflecting the experimental design and no biological correlation. A correlation of 
biological relevance, like for example the time spent floating in the FST and the 
immobility time in the TST, was not detected. Co-segregating phenotypes were, thus, not 
identified.     
 
Figure 34: Graphical illustration of PCA results for phenotypes collected in the ´CD-1 
panel`. Red bars show negative correlations, blue bars indicate positive correlations. The 
only correlations detected in the PCA are those implied by the experimental set-up (lat. = 
latency, prox. = proximal, OA = open arm, CA = closed arm, perc. = percentage, cort. = 
corticosterone, IZ = inner zone, OZ = outer zone, frequ. = frequency). 
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4.5 Association study – attribution of functional relevance to SNPs  
4.5.1 Selection of 32 phenotypically characterized CD-1 mice based on behavioral 
data 
The Jax Mouse Diversity Genotyping array was used to SNP- and CNV genotype 32 
male CD-1 mice which were prior to that behaviorally characterized regarding anxiety-
related and depression-like behavior, as well as regarding stress reactivity in the context 
of the ´CD-1 panel`. The selection of the 32 CD-1 mice was done by choosing the twelve 
most ´HAB-like` mice, the twelve most ´LAB-like` mice and eight animals displaying 
intermediate behaviors in the respective behavioral traits. As selection criterion for the 
determination of the anxiety-related behavior the time animals spent on the open arm of 
the EPM was taken. As key indicator for depression-like behavior served the time 
floating in the FST and the corticosterone increase after the SRT was chosen as the 
parameter reflecting the animal´s stress reactivity. In order to simulate the behavioral 
patterns of the inbred mouse models in the 32 selected CD-1 mice, the most anxious 
mice showing the strongest depression-like feature and at the same time the lowest 
stress reactivity were considered as ´HAB-like`. Mice selected as ´LAB-like` fulfilled 
opposite criteria. Animals were ranked regarding each of the above named behavioral 
feature. Individuals reaching the highest, the lowest and the most intermediate mean 
ranking values among the population of 384 CD-1 mice were selected for array analysis. 
A complete list containing all behavioral features detected in the behavioral test battery 
of these 32 selected mice is provided in Table S13. 
4.5.1.1 PCA of quantitative behavioral traits confirmed correlation of phenotypes 
which served as selection criterion 
In addition to the PCA conducted with phenotypic data from the entire ´CD-1 panel` 
population, a separate PCA was calculated based on 31 phenotypic parameters 
collected from the 32 selected CD-1 mice. The PCA resulted in the formation of nine 
components which describe the phenotypic entity of these 32 mice to 84% (summation 
of proportion of variances, Table S14). For example, the first phenotypic component 
comprising six phenotypic parameters described the phenotypic variances to 19%. This 
component contained the three key parameters which served as ranking criteria for the 
selection of the 32 mice. The parameters were correlated as expected as the time 
animals spent on the open arm of the EPM and the corticosterone increase were 
negatively correlated within this cluster (-0.84 and -0.94) and the time animals spent 
floating in the FST was positively correlated (0.81). In addition to that, there were further 
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components comprising loadings of biological relevance. For example, component six 
which showed the positive correlation of the struggling frequency in the FST and an 
inverse correlation for the time spent immobile in the TST. A high struggling frequency 
which is reflecting an active stress coping style would most likely go along with a shorter 
period spent immobile in the TST, as immobility during TS testing indicates a passive 
stress coping style. Therefore, the grouping of those two loadings with inverse algebraic 
signs within the identical component reflected the conflicting stress coping styles 
detected by the respective behavioral phenotypes.  
4.5.1.2 Polymorphic SNPs detected in 32 selected CD-1 mice 
In the Jax Mouse Diversity Genotyping array, samples were screened regarding 623,124 
SNPs positions. Out of theses 623,124 SNPs, a recall of 549,665 SNPs per sample was 
achieved which made a total of 17,589,280 recalls in the 32 selected CD-1 mice. 
Deleting SNP positions non-polymorphic among the animals, a SNP-pool of 176,291 
heterozygous or opposite homozygous SNPs remained and was employed for first, the 
generation of a CD-1 specific haplotype map and second, for the calculation of primary 
associations between SNP genotypes and phenotypic traits of selected animals. 
Polymorphic SNPs recalls are provided in Table S15 (text-file).  
4.5.1.3 Generation of the first CD-1 specific haplotype map 
The calculation of a CD-1 strain-specific haplotype map revealed a genome-wide 
coverage of 78.6% with 138,652 of the original 176,291 positions polymorphic among the 
32 selected CD-1 mice with R2 ≥0.8. The remaining 21.4% of polymorphic marker 
positions could not be tagged. Based on the LD clustering of the tag-SNP-pool, a 
selection of 6,000 SNPs could cover these 138,652 polymorphic positions. Hence, 
78.6% of the CD-1 genome could be tagged choosing 6,000 SNPs in respect to the CD-
1 strain-specific LD clustering. In Table S16, the list of 138,652 SNPs which could be 
reliably tagged with 6,000 tag-SNPs is provided (text-file).  
4.5.1.4 Primary associations identified between genotypes and phenotypes of 
selected CD-1 mice 
Before the analyses of associated loci seven phenotypes were excluded from the 
analyses to ensure a certain data distribution in the down-sized population of 32 mice. 
Phenotypic traits were therefore clustered against the respective frequency of animals 
displaying the trait to the respective extend. If histograms did not reveal a minimum 
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distribution over three clusters with a minimum animal number of five animals in at least 
two of these clusters, the respective phenotype was excluded from further analysis. 
Phenotypic parameters, therefore, disqualified from the association study were the 
latency to the first closed arm entry on the EPM, the freezing and struggling latency in 
the FST, the free rearing frequency, latency, and time in the OF, as well as the latency to 
the first outer zone entry in the OF.  
Detection of the internal calibrator Tmem132d to be significantly associated  
The detection of the Tmem132d locus as associated locus was expected and served as 
internal quality standard for the entire approach. This gene was chosen as internal 
calibrator as it was shown in humans and in mice to be associated with anxiety severity 
and a 3.5-fold expressional up-regulation in the cingulate cortex of HAB vs. LAB mice 
was reported (Erhardt et al.). In the mouse, Tmem132d is encoded on the negative 
strand of chromosome 5 (-129,039,800 : -128,162,202). In this study, the Tmem132d 
locus was identified with 17 SNPs (most up-stream coordinate at bp 128,210,585 and 
most down-stream coordinate at bp 128,324,243). The locus was identified to be 
associated with the time spent freezing in the FST (mean nominal p-value = 1.48 x 10-6 
and mean empiric p-value = 0.018) and the latency to wall rearings in the OF (mean 
nominal p-value = 3.0 x 10-5, mean empiric p-value = 0.029).  
Detection of second calibrator locus PPARGC1A 
The detection of a second calibrator locus which was recently published as a result of an 
association study in humans and mice after diverse levels of locus filtering and 
prioritizing (Hettema et al., 2011) was also taken as quality measure in testing the validity 
of the association study presented in this study. Hettema and colleagues detected the 
locus to be associated with anxiety-spectrum disorders. The Ppargc1a locus identified in 
this study comprised in total 16 markers (nominal and empiric p-values ≤0.05), all of 
them associated with at least two different phenotypes. Among the associated 
phenotypes were the corticosterone concentration detected in reaction samples as well 
as the corticosterone increase, the time immobile in the EPM, which was considered a 
parameter reflecting locomotor activity, three OF phenotypes indicating anxiety-related 
behavior (inner zone distance and time, as well as outer zone time) and the wall rearing 
time in the OF as a parameter for explorative behavior.  
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4.5.1.5 Identified associations between genotypes and phenotypes of selected 
CD-1 mice 
Significantly associated loci were identified using WG-Permer software. Associated loci 
were analyzed focusing on phenotypes most interesting in the context of the two inbred 
mouse models. Therefore, to evaluate loci associated with the locomotor activity of 
animals, the anxiety-related and the depression-like behavior as well as with the stress 
reactivity, key parameters reflecting respective traits were analyzed by identifying in each 
case the ten best associated loci.  
As key parameters for locomotor activity the number of entries into the closed arm of the 
EPM and total distance travelled in the OF were considered; for anxiety-related behavior 
the percentage of time spent on the open arm of the EPM and the time spent in the inner 
zone of the OF; for depression-like behavior the time spent floating in the FST and the 
time spent immobile in the TST; for stress reactivity the corticosterone increase after the 
SRT. In Table 24 - 30, the ten top associated loci for these phenotypes are summarized 
in the same order named above. All loci detected were identified with a multitude of 
markers. The SNPs listed in the Tables were the markers of the respective locus 
associated with the lowest nominal p-value. If this marker was located in a protein coding 
sequence, the encoded gene is provided under locus information.  
For graphical illustrations, the chromosomal coordinates of every single marker were 
plotted against the logarithmized value of the nominal p-value. Resulting peaks were 
used for the identification of the ten best associated loci per key phenotype. This is 
exemplarily shown in Figure 35 for the associations of the total distance travelled in the 
OF on chromosome 4. In a separate folder of the supplementary data, graphic 
illustrations of associations between nominal p-values of all SNPs which were plotted 
against the chromosomal coordinates of the particular marker for every key phenotype 
named above are provided.  
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Figure 35: Markers on chromosome 4 are plotted against the -log10 value of the nominal 
p-values. The marked peak (roughly at 140 Mb) identifies a significantly associated 
marker for the total distance travelled in the OF.    
 
 
Table 24: Top ten loci associated with the total distance travelled in the OF, the first key 
parameter reflecting locomotor activity of tested mice. Loci are assorted according to 
ascending nominal p-values (Chr. = chromosome). 
 
SNP 
identifier 
Chr. 
Mapping 
position 
[bp] 
p-value 
nominal 
p-value 
empiric 
Locus 
information 
JAX00626778 6 133,988,869 3,50 x 10-5 3,00 x 10-4 Etv6 
JAX00617278 6 90,542,520 8,80 x 10-5 1,60 x 10-3 Aldh1l1 
JAX00140826 6 50,294,630 1,53 x 10-4 9,90 x 10-3 Osbpl3 
JAX00568919 4 140,500,033 1,24 x 10-4 2,20 x 10-3 Padi2 
JAX00450828 18 4,655,562 2,81 x 10-3 1,25 x 10-2 9430020K01Rik 
JAX00087163 19 15,019,345 1,23 x 10-4 6,00 x 10-4 - 
JAX00149816 7 31,508,107 3,81 x 10-4 1,10 x 10-3 Atp4a 
JAX00701915 9 92,808,477 2,34 x 10-4 2,40 x 10-3 - 
JAX00031647 11 108,977,709 2,06 x 10-4 1,20 x 10-3 - 
JAX00038958 12 92,061,749 3,81 x 10-4 1,30 x 10-3 - 
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Table 25: Top ten loci associated with the number of entries to the closed arm of the 
EPM, the second key parameter reflecting locomotor activity of tested mice. Loci are 
assorted according to ascending nominal p-values (Chr. = chromosome). 
 
SNP identifier Chr. 
Mapping 
position 
[bp] 
p-value 
nominal 
p-value 
empiric 
Locus 
information 
JAX00075625 17 39,714,123 7.30 x 10-5 3.10 x 10-3 - 
JAX00245014 1 26,142,536 7.40 x 10-5 3.50 x 10-3 - 
JAX00067751 16 28,499,048 1.35 x 10-4 4.50 x 10-3 Fgf12 
JAX00126081 4 150,644,666 1.44 x 10-4 1.20 x 10-3 Camta1 
JAX00036804 12 62,664,359 1.64 x 10-4 1.00 x 10-4 Lrfn5 
JAX00123455 4 113,903,896 2.28 x 10-4 4.00 x 10-4 Skint11 
JAX00587308 5 82,279,118 4.57 x 10-4 5.00 x 10-4 - 
JAX00309959 11 46,350,318 4.63 x 10-4 9.80 x 10-3 Gm12169 
JAX00478394 19 44,531,281 6.33 x 10-4 6.70 x 10-3 - 
JAX00595431 5 124,825,486 6.92 x 10-4 5.00 x 10-4 Sbno1 
 
 
 
 
Table 26: Top ten loci associated with the percentage time spent on the open arm of the 
EPM, the first key parameter reflecting the anxiety-related behavior of tested mice. Loci 
are assorted according to ascending nominal p-values (Chr. = chromosome). 
 
SNP 
identifier 
Chr. 
Mapping 
position 
[bp] 
p-value 
nominal 
p-value 
empiric 
Locus 
information 
JAX00050949 14 24,116,606 4.60 x 10-5 1.20 x 10-3 Kcnma1 
JAX00103389 2 174,543,382 6.30 x 10-5 5.50 x 10-3 - 
JAX00135316 5 125,382,793 1.15 x 10-4 9.00 x 10-4 Zfp664 
JAX00440034 17 46,872,086 1.69 x 10-4 6.00 x 10-4 - 
JAX00446740 17 75,872,005 1.88 x 10-4 1.50 x 10-3 Rasgrp3 
JAX00430427 17 6,591,073 2.17 x 10-4 5.20 x 10-3 Tmem181a 
JAX00236854 9 49,974,017 2.35 x 10-4 8.50 x 10-3 - 
JAX00134644 5 116,337,492 3.14 x 10-4 5.00 x 10-4 Cit 
JAX00481320 19 57,937,240 3.71 x 10-4 2.00 x 10-4 Atrnl1 
JAX00113859 3 139,103,916 6.74 x 10-4 2.30 x 10-3 B930007M17Rik 
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Table 27: Top ten loci associated with the time spent in the inner zone of the OF, the 
second key parameter reflecting the anxiety-related behavior of tested mice. Loci are 
assorted according to ascending nominal p-values (Chr. = chromosome). 
 
SNP 
identifier 
Chr. 
Mapping 
position 
[bp] 
p-value 
nominal 
p-value 
empiric 
Locus 
information 
JAX00031163 11 102,506,664 1.05 x 10-4 9.00 x 10-4 - 
JAX00042197 13 17,761,023 1.07 x 10-4 2.70 x 10-3 5033411D12Rik 
JAX00354790 13 36,009,260 1.28 x 10-4 2.60 x 10-3 - 
JAX00089284 19 43,417,525 1.78 x 10-4 1.10 x 10-3 Hpse2 
JAX00251722 1 56,465,746 1.80 x 10-4 3.00 x 10-4 - 
JAX00565563 4 127,344,997 1.88 x 10-4 3.40 x 10-3 - 
JAX00284281 10 19,179,675 1.91 x 10-4 1.70 x 10-3 - 
JAX00132992 5 92,212,356 1.95 x 10-4 4.90 x 10-3 - 
JAX00663942 8 28,245,239 1.97 x 10-4 6.00 x 10-4 - 
JAX00129961 5 51,784,223 2.01 x 10-4 1.00 x 10-4 - 
 
 
 
 
Table 28: Top ten loci associated with the time spent floating during the FST, the first key 
parameter reflecting the depression-like behavior of tested mice. Loci are assorted 
according to ascending nominal p-values (Chr. = chromosome). 
 
SNP 
identifier 
Chr. 
Mapping 
position 
[bp] 
p-value 
nominal 
p-value 
empiric 
Locus 
information 
JAX00683491 8 127,957,369 5.90 x 10-5 2.60 x 10-3 Sipa1l2 
JAX00270773 1 150,967,884 7.70 x 10-5 2.80 x 10-3 - 
JAX00175893 9 114,330,617 8.40 x 10-5 3.00 x 10-4 Glb1 
JAX00134648 5 116,381,992 1.63 x 10-4 2.00 x 10-4 Cit 
JAX00092931 2 33,831,599 1.69 x 10-4 4.00 x 10-4 - 
JAX00427027 16 87,263,808 2.31 x 10-4 5.00 x 10-4 - 
JAX00113852 3 138,998,360 2.39 x 10-4 6.00 x 10-4 B930007M17Rik 
JAX00130206 5 55,054,215 2.46 x 10-4 1.00 x 10-4 - 
JAX00017391 10 44,133,271 2.60 x 10-4 3.10 x 10-3 - 
JAX00075193 17 33,830,219 2.83 x 10-4 6.00 x 10-4 March2 
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Table 29: Top ten loci associated with the time spent immobile during the TST, the 
second key parameter reflecting the depression-like behavior of tested mice. Loci are 
assorted according to ascending nominal p-values (Chr. = chromosome). 
 
SNP 
identifier 
Chr. 
Mapping 
position 
[bp] 
p-value 
nominal 
p-value 
empiric 
Locus 
information 
JAX00148181 6 149,122,293 1.50 x 10-5 2.00 x 10-4 Amn1 
JAX00100376 2 134,184,125 2.00 x 10-5 1.00 x 10-4 - 
JAX00041837 13 12,499,053 2.50 x 10-5 4.00 x 10-4 Heatr1 
JAX00386775 14 92,554,883 3.10 x 10-5 2.00 x 10-3 - 
JAX00032515 11 120,587,173 5.40 x 10-5 5.00 x 10-4 Dcxr 
JAX00056672 14 102,650,784 6.10 x 10-5 5.00 x 10-4 - 
JAX00418320 16 38,026,034 8.60 x 10-5 2.30 x 10-3 - 
JAX00103199 2 171,879,487 9.40 x 10-5 3.00 x 10-4 - 
JAX00487114 2 35,321,279 1.04 x 10-4 2.00 x 10-4 - 
JAX00163546 8 77,683,474 1.24 x 10-4 2.00 x 10-4 - 
 
 
 
 
Table 30: Top 10 loci associated with the corticosterone increase in the SRT, the key 
parameter reflecting the animal´s stress reactivity. Loci are assorted according to 
ascending nominal p-values (Chr. = chromosome). 
 
SNP 
identifier 
Chr. 
Mapping 
position 
[bp] 
p-value 
nominal 
p-value 
empiric 
Locus 
information 
JAX00439485 17 44,940,393 1.8 x 10-5 8 x 10-4 Runx2, Supt3h 
JAX00581955 5 51,223,710 2.2 x 10-5 5 x 10-4 - 
JAX00491991 2 67,591,108 3.2 x 10-5 2.2 x 10-4 - 
JAX00113859 3 139,103,916 3.4 x 10-5 1 x 10-3 B930007M17Rik 
JAX00385356 14 81,815,070 3.5 x 10-5 4 x 10-4 - 
JAX00650341 7 115,395,389 5.5 x 10-5 1.9 x 10-3 - 
JAX00056641 14 102,243,612 1.4 x 10-4 7 x 10-4 Lmo7 
JAX00375069 14 24,269,502 1.5 x 10-4 6 x 10-4 Kcnma1 
JAX00586108 5 75,115,900 1.7 x 10-4 9 x 10-4 - 
JAX00166521 8 117,358,480 2.4 x 10-4 1 x 10-3 Wwox 
 
4.5.1.6 Confirmation of the predictive validity of an association study in 32 animals 
In order to test the predictive validity of the associations calculated based on phenotypic 
and genotypic data of 32 CD-1 mice only, it was aimed to simulate this approach of 
testing ´surrogate individuals` which are representing a considerably larger population in 
a data set which was analyzed previously and, therefore, the result was already known. 
The association study revealing TMEM132D to be significantly associated with anxiety 
severity in humans and in HAB vs. LAB mice was chosen as control study (Erhardt et 
al.). Simulating the situation in the association study presented in this work, data of the 
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16 patients displaying the most severe symptoms of anxiety according to DSM-IV (SKID 
I and II) and of the 16 most intermediate individuals of the control group were chosen. 
Apart from the n number, the association was calculated with identical settings as 
described in the publication.  
The TMEM132D locus was detected to be significantly associated also in the down-sized 
cohort with a nominal p-value of 1.83 x 10-4. The SNP representing the locus was a 
different one (rs1918409; chr. 12: 129,989,303) compared to the SNP detected in the 
cohort as a whole (rs7309727; 12: 129,955,359). In Figure 36, markers along the human 
chromosome 12 were plotted against the -log value of the respective nominal p-values, 
also graphically identifying the association.  
 
 
 
Figure 36: Markers on human chromosome 12 were plotted against the -log10 value of 
the respective nominal p-values. The marked SNP rs1918409 at bp 129,989,303 was 
identified as significantly associated with the severity of anxiety. The SNP identifying the 
TMEM132D locus in the original publication was located 33,944 bp upstream of the SNP 
detecting the Tmem132d locus in the down-sized cohort.   
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4.5.1.7 Potential expansions of the association study in 32 CD-1 mice to the total 
population of the ´CD-1 panel` 
For the expansion of the association study conducted so far in 32 selected animals to the 
entire population of behaviorally characterized CD-1 mice, two potential procedural 
methods were prepared. 
First, a chromosome-centered approach testing 384 selected SNPs on selected 
chromosomes was discussed and an Illumina Golden Gate Assay for 384 mice was 
developed accordingly. Based on former findings and on the literature of the field, six 
chromosomes (1, 2, 3, 5, 11, and 17) which were considered of special interest in the 
context of the two inbred mouse lines were defined. The selection of 384 polymorphic 
positions on these six chromosomes was done in a gene-centered manner. Therefore, 
intragenic SNPs from the overlapping SNP pool between HAB and LAB and HR and LR 
mice (Table S12) were selected only. In addition, genomic ´hotspots` were defined 
harboring genes which were known, however, to contribute to the phenotypes of the two 
mouse models. For example, genes detected in the microarray study to be significantly 
differential expressed between the lines were considered as hotspots, or loci identified 
as significantly associated with the anxiety-phenotype in an F2 study of the HAB/LAB 
model were included into the selection. As a satisfying marker density throughout the six 
selected chromosomes could not be achieved with 384 SNPs only, it was aimed to reach 
a sufficiently high marker density in the genomic hotspots, whereas genomic regions on 
selected chromosomes less interesting to the HAB/LAB and the HR/LR mouse models 
were excluded from the analysis by not covering them with SNPs. Five hotspots were 
allowed on chromosomes other than the ones named above as these SNPs were 
particularly interesting and the functional contribution of the respective gene products to 
the phenotype of the HAB/LAB mouse model was already shown in earlier studies (Nps 
locus on chromosome 7, Npsr and Hmgn3 loci on chromosome 9, Scl25a17 locus on 
chromosome 15 and Syt4 locus on chromosome 15). In Table S17, selected 384 SNPs 
including chromosomal coordinates, flanking sequences and Illumina scoring results 
were listed. The technical feasibility for the Golden Gate assay was calculated with 
0.869, the designability for the assay was 1.00, and in addition, no failure codes were 
detected.  
Alternatively, a genome-wide SNP screening approach was considered. The Illumina 
iSelect assay provides the platform to genotype 6,000 SNP positions in 1,152 animals 
and the resulting marker density was approximately one marker per 450 kbp. The 
selection of the 6,000 SNPs was again done based on the overlapping SNP pool 
between HAB and LAB and HR and LR mice. In this case, the focus of the SNP selection 
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was given to a consistent distribution throughout the genome. As the overlapping SNP 
pool contained 17,722 SNPs, roughly every third SNP was selected, irrespective of inter- 
or intragenic position of the marker. In Table S18, the selection of the 6,000 SNPs is 
summarized including the scoring results of the Illumina assay design tool. A mean final 
score of 0.964 was achieved and none of the selected SNPs produced failure codes. 
According to these scoring results, the technical feasibility of the developed iSelect 
assay was considered very promising (Ingrid Du Plooy, Illumina technical support, 
personal communication). 
4.6 Overview supplementary data  
 
The external data source attached to this thesis contains the following data files:  
 
Table S1: Differentially expressed genes microarray study 
Table S2: Differentially expressed genes SAGE experiment 
Table S3: Multivariate vs. univariate analyses 
Table S4: Multivariate candidates only 
Table S5: GO analysis cellular components 
Table S6: GO analysis biological processes 
Table S7: GO analysis molecular functions 
Table S8: Segmental copy number variation HAB vs. LAB 
Table S9: Segmental copy number variation HR vs. LR 
Table S10: Heterozygous SNPs HAB vs. LAB 
Table S11: Heterozygous SNPs HR vs. LR 
Table S12: Overlapping SNP pool 
Table S13: Phenotypic data 32 selected CD-1 
Table S14: PCA 32 selected CD-1 
Table S15: Polymorphic SNP recalls 32 CD-1 
Table S16: Tag SNPs plus associated SNPs 
Table S17: Golden Gate assay 
Table S18: iSelect assay 
 
A separate folder called ´Graphs association study` contains seven pdf-files showing 
plots which served for the analysis of associated loci. For the seven key phenotypes of 
the association study, every marker was plotted against the nominal p-value which it 
achieved for the respective phenotype.   
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5 Discussion 
 
In this study, a broad spectrum of methods was used to generate genomic data and to 
subsequently test the functional impact of collected genomic information on the behavior 
of HAB vs. LAB and HR vs. LR mice, thereby making use of molecular biological, 
bioinformatical, and behavioral biological approaches.   
Mitochondrial impact on endophenotypes of HR and LR mice 
First, for genetic characterization of the SR mouse model, expressional profiling 
experiments were conducted aiming to elucidate the functional relevance of differentially 
expressed genes on the endophenotypes of HR and LR mice. All attempts to genetically 
characterize the SR mouse model were focused on hippocampal tissue as the 
hippocampus is a known target region of glucocorticoids and is subjected to structural 
and physiological alterations upon stress exposure. It is further involved in the 
termination of HPA axis stress response (McEwen, 2007).  
The expressional profiling of HR vs. LR mice resulted in the detection of a total of 981 
genes to be differentially expressed between the lines. The initial pool of differentially 
expressed genes gained from the microarray study (Table S1) was extended conducting 
a SAGE analysis (Table S2). This probe-independent approach allowed the detection of 
a considerably larger fraction of genes, in particular the detection of low abundance 
genes known to be difficult to detect in microarray-based expression approaches 
(Coppee, 2008; Draghici et al., 2006; Karssen et al., 2006; Livesey, 2003). This fraction 
of low abundance genes is of special interest in an expressional profiling attempt, as 
respective gene products often implement crucial functions (Draghici et al., 2006). The 
enlarged pool of differentially expressed genes resulting from the combination of two 
independent profiling methods increased the informative content of subsequently 
performed annotational cluster analyses.  
In order to test the pool of differentially expressed genes for functional enrichment, 
annotational cluster analyses were performed using different bioinformatic tools. 
Analyses of the microarray-based gene pool via the DAVID Bioinformatics Database 
clearly pointed towards a distinct contribution of mitochondrially active genes likely to 
influence the endophenotypes of the SR mouse model (Table 5). Mitochondrially active 
genes per se were detected as significantly enriched in addition to a separate 
mitochondrial cluster containing genes assorted specifically to the mitochondrial 
envelope. This finding was confirmed by GO analyses using the identical gene pool. In 
similarity to the results gained from annotational cluster analysis using the DAVID 
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Bioinformatics Database, also in GO analyses mitochondrially active genes were 
detected as significantly enriched. This applied as well to a separate mitochondrial matrix 
cluster, and further clusters comprising genes of the mitochondrial large ribosomal 
subunit and the inner mitochondrial membrane. The gene pool resulting from the SAGE 
experiment strengthened the idea of a mitochondrial contribution to the endophenotypes 
of the mouse lines (Table 6). Eight out of 14 significantly enriched clusters (no. 1, 2, 3, 4, 
6, 7, 9, and 10) suggested mitochondrially active genes as the major player in 
differentiating between HR and LR mice on an expressional level. Importantly, the 
mitochondrial envelope, which harbors the respiratory chain and therefore is crucially 
involved in the cells energy metabolism, was indicated in seven out of these eight 
clusters. A particular pathway or distinct component belonging to the mitochondrial 
membranes or the inner-membrane space was not detected in the annotational cluster 
analyses. Nevertheless, these findings strongly suggest that, on a gene expressional 
level, the differences in stress reactivity between HR and LR mice are primarily 
determined by differences in mitochondrial function and, more precisely, in energy-
generating processes originating in the mitochondrial envelope.  
The so-called ´respiratory chain` or electron transfer chain (Figure 37), which is located 
in the inner mitochondrial membrane, comprises the three classical electron transport 
complexes (I, III, and IV) which transfer electrons to molecular oxygen. This electron 
transfer is coupled to proton extrusion from the inner mitochondrial matrix and goes 
along with a reduction in the redox potential of electrons resulting in an electrochemical 
proton gradient. This gradient is used for the oxidative phosphorylation of ADP to ATP, 
the universal cellular energy supplier (Brand and Nicholls, 2011; Mourier and Larsson, 
2011).  
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Figure 37: Schematic illustration of the electron transport chain which is integrated into 
the inner mitochondrial membrane. In total, five protein complexes are involved in the 
generation of ATP. Complexes I, III, and IV direct electrons from electron donor to 
electron acceptor molecules and are thereby generating a proton efflux across the inner 
mitochondrial membrane. The coenzyme flavin adenine dinucleotide (FAD) is involved in 
the electron delivery of complex II, which, in addition to complex I, delivers electrons to 
the acceptor molecule ubiquinone. The fifth complex is the ATP synthase, which 
generates ATP via oxidative phosphorylation. (Figure adopted from www.wikipedia.org.)   
 
For most clusters, the connection to the mitochondrion and the respiratory chain, 
respectively, is quite obvious, whereas in some cases the attribution as a mitochondrial 
cluster might require explanation. The ´iron metabolism` cluster 3 was attributed to the 
mitochondrion as all genes accounted into this cluster are functionally associated to the 
mitochondria (Kulic et al., 2011; Pagliarini et al., 2008; Wirtz and Schuelke, 2011) and 
redox processes along the respiratory chain are an iron-dependent system (Gille and 
Reichmann, 2011). Furthermore, six genes were annotation-based clustered to the ´FAD 
cluster`. FAD is the abbreviation for the coenzyme flavin adenine dinucleotide. It 
transfers additional electrons originating from succinate and other electron donors to the 
ubiquinone pool in complex II of the electron transfer chain (Hanukoglu, 2006). In cluster 
no. 9, genes however associated to the cytochrome P450 system were collected and 
also indexed as mitochondrial cluster as these hemoproteins comprise a large and rather 
divergent group of proteins, either membrane-associated to microsomes or to the 
mitochondria (Omura, 2010).    
Mitochondria fulfill diverse functions, ranging from energy generation to calcium 
homeostasis, from the control of cellular differentiation, fission, and fusion processes to 
the induction of apoptosis (McBride et al., 2006). They were implicated in a whole variety 
of neurodegenerative diseases, such as Huntington´s, Parkinson´s, and Alzheimer´s 
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disease, and are known to play a pivotal role in several psychopathologies such as 
MDD, bipolar disorder, schizophrenia, and autism (Jou et al., 2009; Rezin et al., 2009). 
In either case, mitochondrial impairment ultimately resulting in insufficient energy supply 
was shown, but precise insights on a molecular level into the role of the mitochondria to 
psychopathologies is largely missing (de Castro et al., 2010; Han et al., 2011). For 
example, by a large-scale DNA microarray analysis, altered expression of mitochondria-
related genes in post-mortem brains of bipolar disorder and schizophrenia patients was 
discovered. In this study, a global down-regulation of mitochondria-related genes in 
these patients was shown, independent of the patient´s medication status and sample 
pH-values. Genes detected to significantly differ in their expression ranged from 
respiratory chain components to various mitochondrial enzymes (Clay et al., 2011; 
Iwamoto et al., 2005). A distinct pathway was, in similarity to results of annotational 
cluster analyses presented in this study, not distinguishable among differentially 
expressed genes.  
In the context of pathological stress reactivity and HPA axis dysregulation, so far a 
mitochondrial contribution has hardly been shown (Zhang et al., 2011). Considering the 
energy need of the brain – it accounts for roughly 2% of the total body weight, is 
consuming approximately 20% of total oxygen, and the mitochondria supply more than 
95% of the required energy – the importance of mitochondrial homeostasis does not 
seem surprising (de Castro et al., 2010; Rezin et al., 2009). The question, if the 
behavioral phenotypes of HR and LR mice have their origin in mitochondrial dysfunction 
finally determining the differential regulation of the HPA axis, or if mitochondrial 
peculiarities are a result of neurophysiological conditions in these animals, could not be 
answered based on gene expressional profiling and subsequent annotational cluster 
analyses. The result of the gene expressional profiling in the mouse model for SR allows 
to hypothesize that the increased levels of corticosterone in the brain of HR vs. LR mice 
(Heinzmann et al., 2010) either determine an elevated energy need in the brain of HR 
mice, or however destructive conditions in the brain of HR mice upon exposure to high 
levels of corticosterone sustainably harm mitochondrial homeostasis resulting in 
insufficient energy generation.  
Du and colleagues proposed a dynamic influence of corticosterone on mitochondrial 
functions in a dose-dependent manner. According to this model, low and acute 
corticosterone exposure increases mitochondrial functions allowing the cell to cope with 
the stress impact, whereas high and chronic corticosterone concentrations disrupt 
mitochondrial homeostasis (Du et al., 2009a; Du et al., 2009b). Applying this theory to 
the SR mouse model would mean that LR mice profit from the substandard 
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corticosterone answer, whereas mitochondria in HR mice would be affected by the 
remarkably high corticosterone increase upon stress exposure.   
Increased neuronal activity in dorsal hippocampus of HR vs. LR mice 
A slightly increased overall metabolic activity in the dorsal, but not intermediate or 
ventral, hippocampus of HR vs. LR female mice was shown in the CO staining of 
hippocampal brain slices (Table 9). This increased metabolic turnover indicates elevated 
long-term neuronal activity in the respective brain region. A certain unspecificity of the 
technique needs to be taken into account though as the detected signal is a cumulative 
signal which allows no differentiated analysis (Gonzalez-Lima and Garrosa, 1991; Harro 
et al., 2011; Hevner and Wong-Riley, 1990). The dorsal hippocampus was functionally 
attributed to cognition, the ventral part to stress, emotion, and affectivity (Fanselow and 
Dong, 2010). Cognitive impairments regarding deficits in hippocampus-dependent 
memory functions in HR compared to LR mice were reported (Knapman et al., 2010a) 
which could entail dissimilar levels of neuronal activity in the respective brain area.  
Increased neuronal activity consequently entails increased energy demands. 
Consolidating the hypothesis of insufficient mitochondrial energy supply in HR mice 
(which was generated based on the annotational analyses of expressional profiling data) 
and the detection of increased energy demands in the dorsal hippocampus of HR mice, 
the latter suggests insufficient levels of energy generation. The very moderate 
differences detected in the CO staining, however, cannot sufficiently serve as 
explanation for dissimilar mitochondrial function which was indicated in the annotational-
based enrichment analyses of transcriptomic data.     
Increased energy demands – increased reactive oxygen species?  
Presuming that the respiratory chain of HR mice complies with an elevated energy 
demand, an increased production of reactive oxygen species (ROS), the known side 
product of oxidative phosphorylation, would occur in HR vs. LR mice (Mammucari and 
Rizzuto, 2010). In rats it was already shown, that high corticosterone plasma levels 
trigger ROS which caused oxidative damage and subsequent neurodegeneration in the 
hippocampus of test animals. These rats also showed cognitive deficits (Sato et al., 
2010). One consequence of increased ROS levels is the induction of apoptosis via the 
intrinsic mitochondrial pathway (Mehmeti et al., 2011). In order to test for differences in 
the cytochrome c release-based apoptosis rate between the lines, a cytochrome c 
specific ELISA was conducted using cytosolic protein lysates of HR and LR mice. 
According to this assay, the apoptosis rate between the lines does not differ. This is in 
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line with findings that HR vs. LR mice do not exhibit major structural alterations in the 
brain (Knapman et al., in press; Pillai et al., in preparation). The animals used for the 
generation of the cytosolic protein lysates were about eight weeks old. Nevertheless, 
testing for differences in apoptosis to a later point in life would be suggested as at the 
age of eight weeks potential differences might not be pronounced enough to be 
detectable. Another known consequence of increased ROS levels is the oxidation of 
macromolecules, in particular the mitochondrial DNA (mtDNA) resulting in oxidative 
modification of purine and pyrimidine bases, the desoxyribose backbone, and DNA 
strand breaks. As the protein products of mtDNA are all involved in electron transfer 
chain and subsequent oxidative phosphorylation, damages in the respective DNA 
sequences are likely to interfere with mitochondrial ATP synthesis (Ott et al., 2007).  
 
A proteomic screening approach which was performed to more precisely define the 
character of mitochondrial dysfunction failed as only insufficient amounts of 
mitochondrial protein lysate were gained from hippocampal tissue.     
qPCR confirmation of selected candidates 
Selected candidate genes, which were detected as significantly differently expressed 
between the lines in the microarray study, were tested for differential expression using 
qPCR analyses (Table 10). An algorithm or, however, unbiased strategy for the selection 
of candidates is not available, and the abundance of cancidates did not allow to test 
every single candidate in the qPCR. Genes fulfilling certain criteria were therefore tested, 
but still, the selection of candidates was doubtlessly a biased procedure. The criteria, 
which were looked at, were the prior identification of the gene product and a 
characterization of the gene product in the literature. Furthermore, the function of the 
gene product needed to integrate into the neurobiological context of stress reactivity and 
HPA axis dysfunction. Some of the candidates, therefore, were chosen for qPCR 
analyses as they were shown in earlier studies to be involved in stress reactivity and/or 
contribute to further characteristics of HR and LR endophenotypes. Others were selected 
as they were detected to be differentially regulated between HAB and LAB mice. qPCR 
confirmation of mitochondrial candidates was largely disclaimed, as there were too many 
genes with known mitochondrial functions detected in the microarray-based expressional 
profiling to deflect further perception from confirmation or disproof of separate 
candidates. Mitochondrial genes as potential causative factors in the determination of 
extremes in stress reactivity between HR and LR mice were considered to require 
examination en bloc as a functional entity.  
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In general, gene expressional regulation detected in the microarray study could be 
confirmed in about 52% of genes selected for qPCR analyses (qPCR confirmation and 
neurodevelopmental study) which is a moderate level and underlines the necessity of 
complementary approaches to microarray-based expressional profiling attempts. The 
assignment of functional impact was in the focus of this study, rather than the detection 
of differential gene regulation between the lines. Separate genes will therefore not be 
discussed, with exception of two candidates, which seem particularly interesting in the 
context of the SR mouse model, namely Ttbk1 and Gabrg2.   
The Ttbk1 locus 
Ttbk1 was detected in the microarray study with the lowest adjusted p-value to be up-
regulated in HR vs. LR, and this up-regulation was confirmed via qPCR. It is a 
serine/threonine/tyrosine kinase of the casein superfamily 1 and phosphorylates the 
microtubule-associated tau proteins. It is conserved among species and its expression 
was mapped to the cytoplasma of cortical and hippocampal neurons (Sato et al., 2006; 
Xu et al., 2010). Interestingly, TTBK1 expression was detected to be up-regulated in the 
brains of Alzheimer´s disease patients (Sato et al., 2008). A transgenic mouse encoding 
for the human form of TTBK1 was therefore generated. These mice showed age-
dependently a significant spatial memory impairment in the radial arm water maze test 
which was accompanied by increased phosphorylation rates of tau and neurofilament 
and subsequent aggregation of these proteins (Sato et al., 2008; Xu et al., 2010). In 
addition, modification of expressional levels of several components known to be involved 
in memory dysfunction, such as NMDA receptor types 2B and calpain I, was found and 
might shed light on mechanism which are involved in the dramatic loss of memory 
capacity during the course of Alzheimer´s disease (Sato et al., 2008). Making use of a 
further transgenic mouse model, Xu and colleagues showed that up-regulation of Ttbk1 
expression was accompanied by locomotor dysfunction, neuroinflammation, and 
degeneration of motor neurons in the spinal cord (Xu et al., 2010). Differences in 
locomotor activity were not observed in the SR mouse model, but spatial memory was 
shown to be impaired in HR compared to LR mice. Spatial as well as object memory 
impairment in HR mice so far were associated with decreased hippocampal levels of 
brain derived neurotrophic factor (BDNF) (Knapman et al., 2010a), but detected 
differences in Ttbk1 expression should likewise be considered as a determinant 
contributing to cognitive deficits in HR mice.  
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The Gabrg2 locus 
Gabrg2 was as well detected to be up-regulated in HR vs. LR mice in the microarray-
study and the result was confirmed by qPCR analysis. A potential influence of Gabrg2, 
which stands for gamma 2 subunit of the gamma-aminobutyric acid (GABA) A receptor, 
on affective disorders was studied making use of a heterozygous Gabrg2 knockout 
mouse line (Gabrg2+/-) which at first resulted in the detection of increased levels of harm 
avoidance behavior and sensitivity to negative associations in Gabrg2+/- vs. control mice, 
representing trait anxiety (Crestani et al., 1999). Based on these findings, the authors 
discussed GABAA receptor dysfunctions to represent a potentially causative 
predisposition to anxiety disorders. Taking the story further, effects of cell type-specific 
and developmental stage-dependent inactivation of the gamma 2 subunit were studied 
by a heterozygous deletion of the Gabrg2 locus in embryonic compared to adult 
forebrain neurons. Independent of the inactivation time-point, adult neurogenesis was 
impaired and features indicating trait anxiety and depression-like behavior were 
observed (Earnheart et al., 2007). Finally, Gabrg2 deficits in Gabrg2+/- mice were 
associated with hyperactivity of the HPA axis and, furthermore, with sensitivity to 
antidepressant agents resembling melancholic forms of depression (Shen et al., 2010). 
HPA axis reactivity in Gabrg2+/- mice is hence contradictory to the reactivity observed in 
HR mice. Anxiety-related and depression-like features were observed in both lines of the 
SR mouse model with HR mice phenotypically resembling to features associated with 
melancholic forms of depression and LR mice displaying symptoms indicative for atypical 
forms of depression (Touma et al., 2008). The features of melancholic depression in 
Gabrg2+/- mice, which were indicated by antidepressant drug sensitivity, are also in 
disagreement with depression-like symptoms observed in HRs. To summarize what was 
described so far, two different mouse models show hyper-activation of the HPA axis 
going along with typically associated symptoms, but with opposing levels of Gabrg2 
expression. Besides differences in experimental set-ups and strain backgrounds, the 
differences between the mouse models are quite obvious. In SR mice, Gabrg2 gene 
expressional differences are embedded in a variety of genetic factors which determine in 
cooperation the endophenotypes of HR and LR mice. In Gabrg2+/- mice, stress 
responsiveness and behavioral features were induced by a single targeted genetic 
lesion. These predominantly conflicting findings underline the importance of the 
respective neurotransmitter system in the context of HPA axis dysregulation, and it 
stresses out the genetic complexity of these disorders (Cryan and Holmes, 2005).  
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Does Cfl-1 dose-dependently influence SR? 
In order to test the functional relevance of a gene known to be differentially expressed on 
animal´s stress reactivity, one candidate gene was chosen to be tracked from 
expressional profiling data to a behavioral phenotype.  
Here, Cfl-1 was prioritized as it was shown to be significantly differently expressed in 
hippocampal tissue of HR vs. LR mice on mRNA and on protein level, even though with 
conflicting tendencies (Knapman et al., in press). Furthermore, Cfl-1 is a well 
characterized protein, and many of the features described in the literature supported the 
idea of the gene´s dose-dependent functional impact on the behavior of HR and LR 
mice. Cfl-1 which is ubiquitously expressed was described to be involved in the 
regulation of actin dynamics and actin filament branching. It features a nuclear-
localization sequence, might induce the release of cytochrome c and can activate 
phospholipase D1 (Bernstein and Bamburg, 2010). Data gained from cell culture studies 
proved an inhibitory effect of Cfl-1 on the glucocorticoid receptor, thereby causing 
glucocorticoid resistance. A co-precipitation of Cfl-1 and the glucocorticoid receptor was 
thereby excluded; hence, one can conclude that Cfl-1 does not bind to the glucocorticoid 
receptor directly. It was further shown though, that an over-expression of Cfl-1 influences 
the subcellular localization of the glucocorticoid receptor (Ruegg et al., 2004). 
Independently, it is known that Cfl-1 in combination with the actin depolymerizing factor 
(ADF) is involved in the regulation of actin dynamics in a way that ADF/CFL-1 protein 
complexes dissociate actin filaments and hence increase the filament turnover in the 
neuronal cytoskeleton (Sarmiere and Bamburg, 2004). This function is particularly 
interesting in the context of neuronal growth cone motility and morphology (Endo et al., 
2003; Kuhn et al., 2000; Minamide et al., 2000). The activity state of Cfl-1 is thereby 
depending on the phosphorylation state of the protein. Phosphorylation of Cfl-1 via LIM 
or TES kinases converts it into its inactive state and dephosphorylation via slingshot 
phosphatases, for example, transforms Cfl-1 to its active form (Endo et al., 2003). In 
addition, Cfl-1 was shown to be particularly susceptible to protein oxidation upon ROS. In 
its oxidized form, Cfl-1 tends to dissociate from the actin cytoskeleton, migrates into the 
mitochondria and induces apoptosis via opening of the mitochondrial permeability 
transition pore and subsequent cytochrome c release into the cytoplasma (Chua et al., 
2003; Endo et al., 2003; Klamt et al., 2009; Zdanov et al., 2010). A schematic overview 
over the current idea of how Cfl-1 is being activated and deactivated and how it might be 
involved in mitochondria-induced apoptosis is given in Figure 38. 
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Figure 38: Schematic overview of how Cfl-1 dissociates from the actin cytoskeleton and 
translocates into the mitochondria upon influence of oxidants. There, opening the 
permeability transition pore (PTP) finally results in the induction of cytochrome c release 
into the cytoplasma and cell death via apoptosis. LIM and TES kinases confer Cfl-1 into 
the inactive state, whereas dephosphorylation via slingshot proteins activates Cfl-1 and 
hence induces the association of phosphorylated Cfl-1 to the actin cytoskeleton. (Figure 
adopted from Zdanov et al., 2010.) 
 
Another important point in describing the functionality of Cfl-1 is its dose-dependent 
mode of action. The cellular function and localization of Cfl-1 strongly depends on the 
ratio actin/CFL-1 and, regardless of that, on the expression level of Cfl-1 itself. In case of 
excessively high concentrations of the active form of Cfl-1, rod-shaped Cfl-1-saturated 
actin filament bundles, the so-called ´rods`, will be formed (Bamburg et al., 2010; 
Bernstein and Bamburg, 2010; Minamide et al., 2000). This autoregulatory process of 
bundle formation could be considered a ´capturing` mechanism in order to neutralize 
non-physiologically high levels of active Cfl-1.  
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For the behavioral experiments in this study, Cfl-1+/- mice were used. The examination of 
Cfl-1+/- mice in an embryonic stage showed the contribution of Cfl-1 to the migration of 
neural crest cells resulting in a strongly impaired development of neural crest derived 
tissues. Furthermore, it is an inevitable factor for proliferation and scattering of neuronal 
precursor cells showing as a total lack in neural tube closure (Gurniak et al., 2005). 
Moreover, based on its regulatory impact on the actin cytoskeleton, it was associated 
with neuronal migration disorders and an impaired cell cycle progression in the cerebral 
cortex (Bellenchi et al., 2007). Based on the Cfl-1+/- mice, additional functions in the 
course of the actin dynamics regulating feature of Cfl-1 were proposed, such as shaping 
the characteristics of synaptic plasticity and the diffusion of extrasynaptic excitatory 
AMPA receptors. These findings suggest an impact of Cfl-1 on all kinds of associative 
learning (Rust et al., 2010). In addition, Cfl-1 contribution to the maintenance of the 
mature podocyte architecture (Garg et al., 2010), to platelet formation and sizing (Bender 
et al., 2010) and, in combination with destrin, to the branching morphogenesis of the 
ureteric bud (Kuure et al., 2010) was observed. The homozygous knockout of the Cfl-1 
gene is lethal in an early embryonic stage (Gurniak et al., 2005).   
The behavioral phenotyping of Cfl-1+/- vs. WT mice presented in this study revealed an 
increased anxiety-related behavior in Cfl-1+/- mice on the EPM (males and females; 
Figures 13 and 14) and in the DL box (female mice only; Figures 15 and 16). In the FST, 
a more active coping style of female Cfl-1+/- mice was detected (Figures 17 and 18), and 
increased stress reactivity was observed regardless of gender (Figures 19, 20, and 21). 
In either case, phenotypic indication was more pronounced in female compared to male 
mice. This could be due to the fact that also in humans women are in general more 
susceptible towards the respective traits than man (Cahill, 2006) and in the SR mouse 
model, the average corticosterone increase in HR female mice (about 400 ng/ml) is 
considerably higher than in males (250 ng/ml) (Touma et al., 2008). However, these 
results show a dose-dependent effect of Cfl-1 on the anxiety-related and depression-like 
behavior, as well as on the stress reactivity.  
Comparing these endophenotypes observed in Cfl-1+/- mice to the endophenotypes of 
the stress reactivity mouse model, in terms of anxiety-related and depression-like 
behavior, Cfl-1+/- mice more resemble to LR mice, as this line was observed to spend 
less time on the open arm of the EPM and to travel a shorter distance in the OF, as well 
as to spent more time immobile and floating in TST and FST, respectively, in comparison 
to HR mice (Touma et al., 2008). Regarding stress reactivity, Cfl-1+/- mice resemble to 
HR mice. Comparing the expression levels of Cfl-1, this gene is significantly stronger 
expressed in HR vs. LR mice and less expressed in the Cfl-1+/- mice compared to WT 
mice (Gurniak et al., 2005). In Table 31, the comparison of behavioral traits and Cfl-1 
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expression levels are summarized. A direct comparison of, for example Cfl-1 expression 
levels between Cfl-1+/- and LR mice was considered pointless as both mouse models 
were generated on dissimilar strains (C57BL/6 vs. CD-1).  
 
Table 31: Summary of features detected in behavioral and gene expressional studies of 
Cfl-1+/- vs. WT and HR vs. LR mice. In respect to anxiety-related and depression-like 
traits as well as in the Cfl-1 expression level, Cfl-1+/- mice resemble LRs, in respect to 
stress-reactivity to HRs. 
  
Feature Cfl-1
+/-
 vs. WT HR vs. LR 
Anxiety-related 
behavior ↑ ↓ 
Depression-like 
behavior ↑ ↓ 
Stress         
reactivity ↑ ↑ 
Level of Cfl-1    
expression ↓ ↑ 
 
 
Stress reactivity and comorbid features are, similar to depression, complex traits and 
determined by complex interactions of genetic, epigenetic and environmental factors. 
The expression level of Cfl-1 seems to be associated with certain aspects of this 
complex trait, though not only Cfl-1 expression determines behavioral effects described 
above. As the gene is crucially involved in neurodevelopmental processes, Cfl-1 
deficiency during this critical period presumably contributes to the phenotype displayed 
by Cfl-1+/- mice.  
As mentioned above, the regulation of Cfl-1 is clearly dose-dependent. The status quo of 
active Cfl-1 after the formation of bundles could possibly be compared to the situation of 
insufficient levels of Cfl-1 expression. In either case – too high or too low expression 
levels of Cfl-1 – the cell is rendered with a limited and eventually deficient amount of 
active Cfl-1 (Figure 39). 
Discussion 
 
129 
 
 
 
 
 
Figure 39: Unscaled illustration depicting the proposed influence of Cfl-1 on stress 
reactivity in a dose-dependently, U-shaped manner. According to this model, presumable 
overexpression of Cfl-1 like in HR mice in the end renders the cell with a comparable 
insufficient amount of Cfl-1 which was detected in Cfl-1+/- mice, as after a certain Cfl-1 
concentration level the protein is bound to actin filaments and therefore no longer 
available for cellular processes.  
  
As Cfl-1+/- mice resemble the stress reactivity to HR mice, although HRs show elevated 
expression levels of Cfl-1, a U-shaped regulation of Cfl-1 expression in the context of 
stress reactivity might be proposed. In case of HR mice, the over-expression might have 
induced the formation of bundles, whereas in Cfl-1+/- mice the expressional capacity 
based on one allele is insufficient. The insufficiency of Cfl-1 expression can clearly be 
stated based on the phenotypes observed earlier in Cfl-1+/- mice (Gurniak et al., 2005). 
Furthermore, Ssh1, which positively regulates the actin binding capacity of Cfl-1, was as 
well significantly up-regulated in HR vs. LR mice. HR mice, therefore, do not only 
express more Cfl-1, the fraction of dephosphorylated and hence active Cfl-1 might be 
increased, too.  
Finally, the physiological relevance of differentially expressed Cfl-1 was also shown in a 
mouse model selectively bred for extremes in aggressive behavior. An up-regulation of 
Cfl-1 was detected in mice selectively bred for long attack latency (LAL) in comparison to 
mice displaying a short attack latency (SAL) (Feldker et al., 2003). Interestingly, 
differences in aggressiveness were also reported from HR and LR mice, in which LR 
animals displayed a shorter latency to attack (Touma et al., 2008). In case of both inbred 
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mouse models, the lines expressing Cfl-1 at higher levels showed a longer attack latency 
and hence, a reduced level of aggressive behavior.  
The neurodevelopmental study – further proof for influence of ROS on 
endophenotype of HR mice?  
A further approach aimed to add functional relevance to expressional profiling data was 
performed in the so-called ´neurodevelopmental study`. This project was based on the 
assumption, that a certain fraction of genes which was detected to be differentially 
expressed in the hippocampus of adult HR and LR mice, is causally and dose-
dependently involved in mechanisms determining the extremes in SR. A further fraction, 
though, does not contribute to endophenotypes in a causative manner; these genes 
were differentially regulated during adulthood as they were brought about either by 
negative feedback mechanisms, or were involved in additive, cumulative or 
compensatory effects. All mechanisms the organism might dispose to overcome this 
situation of extremes in stress reactivity need to be considered as explanation for 
differential regulation detected in adulthood. Furthermore, regarding differential 
expression as a genetic marker, it also needs to be taken into account that a certain 
fraction of differentially expressed genes is not related to stress reactivity at all. These 
´random` genetic markers were collected and conserved based on the selective breeding 
approach. The difficulty coming along with this is to differentiate between the fraction of 
genetic markers clearly contributing to the endophenotypes and the fraction of 
´randomly` collected genetic markers.  
The expressional levels of 13 genes in total detected to be differentially expressed in 
transcriptome profiling approaches using adult mice were, therefore, tested for 
differential expression in hippocampal tissue of ED 18, PND 7, and PND 28 mice (Tables 
12 - 15). Nine out of these 13 genes were chosen as they were known from the literature 
to be expressed already during embryogenesis or were detected in the ´central nervous 
system development` cluster of GO analysis (Comai et al., 2010; Diez-Roux et al., 2011; 
Gregory et al., 2007; Hard et al., 2005; Kousaka et al., 2008; Lamprianou et al., 2011; 
Rybnikova et al., 2002; Zhu et al., 2005). The other four genes, such as for example Cfl-
1, were selected as they seemed to be of special interest in the context of the SR mouse 
model.  
Also the points in time were chosen for a good reason. Extremes in stress reactivity and 
HPA axis dysfunction are partially genetically determined (Bale, 2006; de Kloet et al., 
2005; Touma et al., 2008). It was therefore aimed to test for expressional differences 
which might be detectable already at the stage of ED 18. In the mouse, the time period 
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ranging from postnatal day one to twelve is hallmarked by the so-called stress 
hyporesponsiveness (Schmidt et al., 2003). PND 7 was chosen to test for gene 
expressional levels roughly in the middle of the HPA axis hyposensitive phase. Finally, 
as the trait of differential HPA axis reactivity was shown to be apparent already at 
postnatal day 30 (Touma et al., 2008), the point in time PND 28 was selected to reflect 
an intermediate stage of the development between neonatal and adult animals.  
The only gene confirmed to be differentially expressed in adult mice and also detected to 
be differentially expressed in an embryonic stage was proline dehydrogenase (Prodh). At 
both points in time Prodh was significantly up-regulated in HR vs. LR mice. Interestingly, 
during the phase of stress hyporesponsiveness (PND 7) an opposing differential 
expression was measured (up-regulation in LR vs. HR) and no differences were found in 
PND 28 mice.  
Based on these findings one could argue that expressional levels of Prodh might be 
causally involved in the endophenotypes of HR and LR mice as the differential regulation 
is apparent already before birth and, furthermore, during the developmental phase of 
HPA axis hyposensitivity it is directed to the opposite (Figure 40). This allows the 
hypothesis that HR mice down-regulate the expression of Prodh when not being 
susceptible to stress, resulting in a lower expression in HR than in LR mice. This 
expressional ratio apparently disappears after the onset of stress susceptibility. During 
the time-period between PND 7 and PND 28, the expressional activity of Prodh was up-
regulated HR vs. LR mice. This tendency for up-regulation seems to be continued over 
the time of stress exposure, as in adult HR vs. LR mice a significantly increased Prodh 
expression was measured. 
 
 
Figure 40: Graphic illustration of Prodh expression levels in different stages of maturation 
in HR and LR mice. Letter size is reflecting expression levels between the lines in a non-
scale manner, whereas large letters indicate stronger and small letters weaker 
expression in the respective line compared to the other.  
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In different species, for example in humans and Escherichia coli, Prodh catalyzes the 
enzymatic conversion of proline into 1-pyrroline-5-carboxylate (P5C), which is the initial 
reaction of glutamic acid synthesis. Depending on metabolic conditions, Prodh activation 
might lead to the generation of toxic concentrations of P5C. It further might affect the 
cellular redox homeostasis or generate ROS. In humans it is known that an over-
expression of the human form of the Prodh gene (Proline oxidase, POX) induces an 
accumulation of ROS, finally deploying mitochondria-mediated apoptosis (Cecchini et al., 
2011; Hu et al., 2007; Maxwell and Rivera, 2003). According to this, the up-regulated 
expression of Prodh in HR mice might create elevated levels of ROS and, hence, induce 
apoptosis as a response to the animal´s stress physiology. This finding goes along with 
the result of the annotational cluster analyses which might also indicate the contribution 
of differing levels of ROS to the endophenotypes of HR and LR mice.  
Noteworthy, there is accumulating evidence in schizophrenia research that Prodh is 
among the susceptibility genes for this disease (Kempf et al., 2008; O'Tuathaigh et al., 
2007; Roussos et al., 2009).  
CNV- and SNP-genotyping 
Analyzing genetic polymorphisms, the CNV- and SNP-genotyping of in each case one 
HAB and LAB as well as HR and LR ´master` animal resulted in the identification of 180 
regions harboring CNVs between HAB and LAB (Table S8), and 154 such regions 
between HR and LR mice (Table S9). Furthermore, 60,077 polymorphic positions were 
detected between HAB and LAB, and 47,470 between HR and LR (Tables S10 and 
S11). The increased genetic heterogeneity between HAB and LAB compared to HR and 
LR mice is probably a result of the inbreeding strategy employed at the very beginning of 
the generation of the inbred mouse models. For the generation of the HAB/LAB mouse 
model, a selective approach combining out- and in-breeding was used, thereby 
incorporating a larger pool of trait relevant genetic markers than in the HR/LR mouse 
model, as in this case a stricter inbreeding protocol was followed right from the 
beginning. 
CNVs were proven to impact gene expression in both mouse models (in HR/LR as 
presented in this study, Tables 16 and 17; also in HAB/LAB, Julia Brenndoerfer, personal 
communication). The influence of CNVs on the expression was controversially discussed 
so far. In accordance to the data presented here, some studies reported a correlation 
between transcripts mapping to CNV regions and differential expression. Gen-dosage 
effects towards both directions were detected. Positive correlations in the way of ´more 
copies, more transcripts`, as well as inverse correlations shown by a significant down-
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regulation of transcripts mapping to CNVs were found. For other genes mapping to 
CNVs, the copy number did not at all influence their expressional level (Dopman and 
Hartl, 2007; Guryev et al., 2008; Henrichsen et al., 2009b). The expressional effect of 
CNVs is apparently liable to several factors. Tissue-specific gene-dosage effects need to 
be considered, the regulatory and compensatory network of the gene located in a CNV 
(Henrichsen et al., 2009b), and the epigenetic modification of the respective DNA stretch 
(Hogart et al., 2009), to only name a few.  
The clustering of CNV regions detected in both inbred mouse models was reported for 
the mouse before. The accumulation of rather small CNVs in proximate vicinity of both 
inbred mouse models could hence be regarded as a phenomenon typically observed in 
the species (Cutler et al., 2007; Henrichsen et al., 2009a), but nevertheless, a more 
detailed definition of CNV borders or a confirmation of CNV coordinates detected using 
the Jax Mouse Diversity Genotyping array, respectively, might be necessary for taking 
the study further, as the assessment of CNVs strongly depends on the platform applied 
(Henrichsen et al., 2009a; Pinto et al., 2011; She et al., 2008).  
Furthermore, the consideration of how CNVs might influence the endophenotypes of 
HAB/LAB and HR/LR mice needs to be taken further. To simply regard the CNVs impact 
on the animal’s transcriptome might not be the appropriate approach in understanding 
CNVs functional relevance. Structural rearrangements are known to influence genomic 
integrity and stability over long distances, as well as chromatin architecture (Henrichsen 
et al., 2009a; Petrov et al., 2006; Sharp, 2009; Shaw and Lupski, 2004). A more 
integrative examination of CNV´s influence on the endophenotypes should be continued.  
One example how to pursue testing the influence of CNVs on expression profiles and 
finally behavioral endophenotypes was shown in a study concerning the glyoxalase 1 
(Glo1) locus (Hambsch et al., 2010; Williams et al., 2009b). Multiple genomic copies 
(two- to three-fold) of the Glo1 gene were detected in LAB mice presumably determining 
increased gene expressional levels. HAB mice encode for a single copy of the Glo1 gene 
and supposably therefore show a lower gene expressional activity of Glo1. These 
differences in copy numbers at the Glo1 locus were also shown in the data provided in 
this study. Phenotypic correlation of anxiety with Glo1 expression levels have already 
been described earlier in multiple studies (Ditzen et al., 2006; Kromer et al., 2005; 
Landgraf et al., 2007; Williams et al., 2009b) 
Characterization of an outbred population of CD-1 mice 
Selective breeding approaches are aimed to solidify certain genomic traits by directed 
mating of parental animals displaying the endophenotypic trait of interest. In parallel to 
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the manifestation of the endophenotypic trait, respective genetic underpinnings 
determining the behavioral feature can be accumulated and conserved over the 
generations if an inbreeding protocol is applied (Phillips et al., 2002). Thereby, a certain 
extent of genetic characteristics found in an inbred population, such as the HAB/LAB 
mouse model, is closely related to the respective endophenotypes, whereas other 
genetic features were randomly collected as they appeared in the founder population 
without any contribution to the trait anxiety (El Yacoubi et al., 2003). In the generation of 
both mouse models the risk of genetic drift was considered and efforts were made in 
order to reduce the risk of genetic drift (outbreeding in first eight generations for 
HAB/LAB vs. interfamilial mating for HR/LR), but nevertheless, a certain degree of allelic 
frequency shifting cannot be excluded. As it is impossible to distinguish between causal 
and non-causal genetic differences by exclusively analyzing the selectively bred 
HAB/LAB or HR/LR mice, an association study was set up in analogy to human GWAS. 
The classical strategy used in human GWAS is based on the incidence of a genetic 
variant in a group of patients suffering from the respective disease in comparison to a 
healthy control group. The statistical analysis of genotype frequencies being detected 
significantly more often in one of the groups depicts the probability of a contribution of 
the genetic variant to the disease pattern (Lohoff, 2010). 
     
A population of 384 male outbred CD-1 mice, the so-called ´CD-1 panel`, was therefore 
phenotypically characterized regarding the respective traits. The ´CD-1 panel` presented 
a typical outbred population in a way that a broad variety of quantitative traits was 
detected. As expected, the majority of mice displayed intermediate phenotypes of the 
behaviors tested, though extremes in both directions were observed as well (Figures 
27 B, 30 B, 32 B, and 33 B). Correlated phenotypes among the 384 CD-1 mice, like for 
example increased levels of parameters indicating depression-like and anxiety-related 
behaviors, were not detected (Figure 34). The co-occurrence of these two quantitative 
traits is on the one hand frequently reported from animal studies (Finn et al., 2003; 
Lifschytz et al., 2011), and also the clinically relevant comorbidity of, for example GAD 
and MDD, is well known (Simon, 2009). On the other hand, behavioral features reflecting 
anxiety-related and depression-like behavior were shown to display remarkable variation 
in an outbred population (Jacobson and Cryan, 2007). Outbred strains, therefore, are 
sometimes used for scientific purposes with the presumption that they model human 
populations (Yalcin et al., 2010).  
It is therefore not surprising that in a large population of 384 mice comorbid features for 
depression and anxiety are not pronounced enough to show significant correlations. In 
the PCA, which was calculated based on phenotypic data of 32 CD-1 mice selected for 
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high-throughput SNP-genotyping, correlations between depression-like and anxiety-
related behaviors, and the corticosterone increase were detected (Table S14). This 
confirmed the selection strategy for the 32 CD-1 mice as it was aimed to chose mice 
which resemble the endophenotypes of the inbred mouse models (so-called ´HAB-like` 
and ´LAB-like` features).  
 
As commercially available chips for the genome-wide SNP-genotyping of the mouse are 
available from one source exclusively, the amount of resources to genotype 384 
individuals is considerably limited. The development of a customized SNP chip was 
therefore considered. In this context, different strategies for the genotyping were 
discussed and two customized SNP chips, both on Illumina platforms, were designed. In 
either case, the overlapping pool of SNPs differing between HAB and LAB and at the 
same time between HR and LR mice served as SNP pool (Table S12), as the 
occurrence of the polymorphic position in either one of the mouse models was 
considered reflecting the overlapping phenotypes of the two inbred mouse models on the 
one hand. On the other hand, it was expected to exclude the selection of alleles with 
minor frequencies in the CD-1 strain, since allelic frequencies, which are too low, do not 
serve for the calculation of associations.  
As a potential initial approach, a chromosome-centered SNP genotyping assay (Illumina 
Golden Gate assay, Table S17) was developed. Here, six chromosomes were chosen 
and genes located on these chromosomes which were considered to be of special 
interest the inbred mouse lines, were covered with in total 384 markers, thereby focusing 
on a discrete marker density in selected areas. This initial approach could be expanded 
to other chromosomes, finally covering the entire genome. The clear disadvantage of this 
approach is that it involves diverse biased selection procedures. First, the biased 
selection of chromosomes and genes considered as particularly promising and second, 
the biased selection of SNPs based on the overlapping SNP pool. Furthermore, the 
identification of novel loci contributing to the behavior of the inbred mouse models was 
hardly possible, as all loci covered with markers were, however, already noted as 
potentially relevant in the context of the inbred mouse lines.  
The second customized SNP genotyping assay (Illumina iSelect assay, Table S18) was 
developed for the genome-wide screening of 6,000 SNPs. The SNP selection was again 
conducted based on the overlapping SNP pool, focusing on a close to equal marker 
distribution throughout the genome. The identification of novel loci would be possible 
based on the equal marker distribution. The average marker density of about one marker 
per 450 kbp seemed still unsatisfying though.  
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The classical approach to determine the marker distribution for GWAS is usually based 
on haplotype blocks (Simon-Sanchez and Singleton, 2008). Marker distribution in regard 
of haplotype blocks allows the genotyping of a limited number of tag-SNPs as the 
genotypes of these tag-SNPs are representative for a varying number of other SNPs 
located within the same haplotype block (Cuppen, 2005). Neither in the development of 
the Golden Gate assay, nor in the design of the iSelect chip haplotype blocks were 
considered, as to date no haplotype map was available for outbred mouse lines and 
particularly not for the CD-1 outbred line (Yalcin et al., 2010).  
Along these lines, Yalcin and colleagues published a survey regarding the suitability of 
commercially available outbred mice for GWAS concluding that outbred CD-1 mice are a 
rather defective mouse strain for this purpose. This was stated based on a 
heterozygosity of 0.22 and an inbreeding coefficiency of -1.82. Although the SNP 
genotyping by Yalcin and colleagues was performed on the identical platform like the 
one presented in this study, the heterozygosity calculated for the 32 selected CD-1 mice 
was 0.32 and hence reached a moderate level. This deviation could be caused by the 
fact that they used mice from a different source. Furthermore, the calculation of an 
inbreeding coefficiency for CD-1 mice based on a SNP screening via a commercially 
available platform is per se considered inapplicable as the fraction of CD-1 specific SNPs 
and polymorphisms on commercial SNP arrays is under-represented (for details see 
Table S2 of supplementary data in Yalcin et al.) and this strain harbors a variety of 
polymorphic positions so far not annotated in established SNP databases (Czibere et al., 
2011).  
The calculation of a CD-1 specific haplotype map was therefore set up to facilitate the 
SNP selection of a third customized SNP assay based on the haplotype map. As 
mentioned above, the calculation of the haplotype map required a high-density SNP 
genotyping of CD-1 mice. For this purpose, 32 CD-1 mice out of the population of 384 
phenotypically characterized mice were genotyped using the Jax Mouse Diversity 
Genotyping array. Heterozygous and opposite homozygous SNPs in these mice were on 
the one hand used for the calculation of the CD-1 specific haplotype map, and on the 
other hand for the calculation of preliminary associations between phenotypic and 
genotypic data collected from these mice. 
Genetic loci associated with phenotypes 
The analysis of significantly associated loci was done focusing on key phenotypes. In 
addition, the replication of loci detected to be significantly associated in earlier studies 
served as internal quality standard. For each key phenotype, the statistically considered 
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top ten associated loci (regarding nominal p-values) were analyzed and subsequently 
examined regarding a protein coding nature of the locus (Tables 24  - 30). Based on the 
biological function of the gene products, the most interesting loci are discussed below.  
The Aldh1l1 locus 
The locus encoding for Aldh1l1 was detected to be significantly associated with the total 
distance animals travelled in the OF. The Aldh1l1 gene is encoding for 
10-formyltetrahydrofolate dehydrogenase, a major enzyme of the folate metabolism 
(Anthony and Heintz, 2007). This gene is of particular interest, as it was detected in both, 
the microarray and the SAGE experiment to be up-regulated in HR vs. LR mice. This 
regulation was confirmed via qPCR. It was described to be down-regulated in blood 
samples of patients suffering from high hallucination and delusion states and discussed 
as a potential blood biomarker for these psychotic conditions (Kurian et al., 2011). 
Furthermore, it was reported to be up-regulated in subcortical regions of schizophrenia, 
MDD, and bipolar disorder patients compared to controls with no psychiatric history 
(Barley et al., 2009). This goes along with the notion that HR mice resemble to 
symptoms known from melancholic depression (Touma et al., 2008). In addition, in cell 
culture it was shown that Aldh1l1 is able to dephosphorylate Cfl-1, thereby activating it 
and hence influencing cell motility (Oleinik et al., 2010). However, the fact, that this gene 
was detected at the level of gene expression and on polymorphic positions associated 
with a disease relevant parameter, suggests its functional impact on the endophenotypes 
of HR and LR mice. 
The Kcnma1 locus 
The percentage of time animals spent on the open arm of the EPM was considered a 
key parameter reflecting anxiety-related behavior. Here, the Kcnma1 locus was 
significantly associated. The identical locus was further identified to be associated with 
the corticosterone increase after the SRT. The gene product is a well characterized 
calcium activated potassium channel (large conductance, subfamily M, alpha member) 
with a regulatory effect on membrane potential (Clark et al., 2011). Most importantly, it 
was detected in human GWAS to be associated with obesity (Jiao et al., 2011), with 
symptoms of alcohol dependence (Kendler et al., 2011) and late onset and duration of 
Alzheimer´s disease (Burns et al., 2011). Each disease pattern found in the GWAS 
presents a complex disorder and all of them are related to symptoms of anxiety and 
stress reactivity suggesting a general influence of Kcnma1 on mental state and health. In 
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particular, the relationship between HPA axis dysfunction and obesity seems to be an 
emerging connection (Bose et al., 2009; Hillman et al., 2011; Stevens et al., 2011). 
The Cit locus 
The next locus detected as significantly associated with two behavioral parameters was 
the transcriptional unit encoding for Citron-N and Citron-K (Cit-k), the two isoforms of the 
Cit gene (Di Cunto et al., 1998). For this locus, a significant association was calculated 
for the percentage of time animals spent on the open arm of the EPM and the time spent 
floating in the FST. Cit-k is a serine/threonine kinase and a down-stream target of 
activated Rho (Figure 41). In Cit-k-/- mice it was shown that it is involved in cytokinesis 
and Cit-k absence seems to be accompanied by apoptosis (Anastas et al., 2010; Di 
Cunto et al., 2000). Furthermore, there are reports about its contribution to dendritic 
morphogenesis of cortical neurons (Di Cunto et al., 2003), the morphological influence 
on interneurons in the barrelfield cortex (Muzzi et al., 2009), and a regulatory effect on 
axonal growth via a signaling cascade downstream of RhoGTP that converges on Cfl-1 
(Ahmed et al., 2011).  
In this in vitro study, Cit-k mRNA was knocked down rendering the cell with equal 
amounts of RhoGTP but significantly increased levels of Cfl-1. A structural affinity 
between Cit-k and Rock-1 might explain the functional conjunction between Cit-k and 
Cfl-1 (Sandvig et al., 2004). However, further studies need to be conducted to enlighten 
this signaling cascade between Cit-k and Cfl-1, as there is evidence from the 
expressional profiling of HR vs. LR mice, and the phenotypic characterization of Cfl-1+/- 
mice which showed that Cfl-1 is clearly involved in the anxiety-related and depression-
like phenotypes as well as in stress reactivity.  
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Figure 41: Schematic illustration of the model Ahmed and colleagues proposed 
regarding the pathway via Cit might be impacting axonal growth in the CNS. As 
mentioned above, Cit is activated by RhoGTP. A so far unknown signaling cascade 
consolidates on Cfl-1 which in the phosphorylated (inactive) state depolymerizes actin 
resulting in growth cone collapse and in the dephosphorylated (active) state boosts 
growth cone development, respectively. (Figure adopted from Ahmed et al., 2011.) 
 
 
The Atrnl1 locus 
Another interesting locus assessed to be significantly associated with the percentage of 
time animals spent on the open arm of the EPM is the locus encoding for attractin like 1 
(Atrnl1). This gene is a known ligand of the melanocortin-4 receptor and hence involved 
in the regulation of energy homeostasis (Haqq et al., 2003). It can furthermore 
compensate for loss of attractin (Walker et al., 2007). Independent of that, a 
chromosomal microdeletion comprising the ATRNL1 locus is associated with cognitive 
impairments, autistic symptoms, and dysmorphic features in affected patients. 
Analogously, the phenotype of mice displaying homozygous mutations at the Atrn locus 
largely resembled the patient´s symptoms (Bronson et al., 2001; Stark et al., 2010). In 
addition, cognitive impairments were also reported in HAB and LAB mice (Yen et al., 
2011).  
 
Discussion 
140 
 
The Runx2/Wox1 loci 
For the corticosterone increase, two separate loci encoding for known interaction 
partners at protein level were identified in the association study. The gene product of the 
first locus is Runx2, the runt related transcription factor 2; the other is Wox1, the WW 
domain-containing oxidoreductase (also known as Wwox). Both gene products were 
intensively studied and are, hence, well characterized. For example, Runx2 is known to 
be a crucial factor in bone development, in particular for osteoblast differentiation and 
chondrocyte maturation (Baek and Kim, 2011; Komori, 2011). Mutations in the Runx2 
gene were investigated to cause cleidocranial dysplasia (Cohen, 2009). Also noteworthy, 
an oncogenic potential was attributed to Runx2 (Cohen, 2009). Furthermore, an 
essential function of Runx2 in the regulation of the sterol/steroid metabolism was 
proposed as it affects the regulation of enzymes critically involved in the respective 
pathways (Teplyuk et al., 2009). Wox1 was also implied in a variety of cellular functions, 
like cellular growth and differentiation processes, apoptosis, and tumor suppression (Del 
Mare et al., 2009). The observation that Wox1 is frequently de-regulated in cancer 
patients led to its classification as tumor suppressor (Aqeilan and Croce, 2007; O'Keefe 
and Richards, 2006). Wox1-/- mice suffered from metabolic bone disease (Aqeilan et al., 
2008). Furthermore, along the lines of the regulatory function of Runx2 in the 
sterol/steroid metabolism, Wox1 has also been shown to be involved in steroidogenesis 
(Del Mare et al., 2009). A study, which involved the pharmacological manipulation of 
mice with a dopaminergic neurotoxin, revealed an up-regulation of Wox1 in neurons of 
the striatum and the cortex ipsilaterally to the intoxication. Wox1 was found in its 
phosphorylated/activated form to cluster in nuclei and mitochondria of neurodegenerative 
neurons inducing apoptosis and rendering animals with Parkinson´s disease like 
symptoms. Interestingly, upon inhibition of the Wox1 phosphorylation the 
neurodegenerative events were stopped (Lo et al., 2008).  
Its pro-apoptotic potential is mostly transmitted via its p53-binding domain, but could also 
be exerted via binding to other cellular components characterized to initiate cell death 
pathways. Wox1/p53 complexes were shown to translocate to the mitochondria inducing 
apoptosis. As reaction to apoptotic events and/or stress responses, the cytosolic levels 
of Wox1 were shown to rise, subsequently to its translocation into the mitochondria 
(Chang, 2002; Chang et al., 2003).    
The key point in describing the diverse functions of Runx2 and Wox1 is the inhibitory 
potential of Wox1 on Runx2. Upon binding to Runx2, Wox1 was shown to be able to 
inhibit the transactivator function of Runx2 in certain cell types and even more, 
expressional profiling of Runx2 in Wox1-deficient bone material disclosed its explicit up-
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regulation implying a regulatory function of Wox1 on Runx2 (Aqeilan et al., 2008). In 
summary, the fact, that among the top ten loci associated with the phenotypic parameter 
corticosterone increase two known binding partners were detected, and even more as 
the functional impact of these loci point towards neurodegenerative events, strongly 
suggests the consideration of Runx2 and Wox1 in further studies aimed to elucidate 
molecular underpinnings of extremes in stress reactivity.  
The B930007M17Rik locus 
One further locus remains to be discussed. The locus which is described by the Riken 
clone B930007M17Rik was the only locus among the top ten loci of key phenotypes 
which was identified to be significantly associated with all three phenotypic categories; 
namely one parameter for anxiety-related behavior (total time spent on the open arm of 
the EPM), one parameter reflecting depression-like behavior (time floating in the FST), 
and the parameter displaying the animal´s stress reactivity (corticosterone increase). 
This combination of phenotypes reflects the comorbidity of depression and associated 
diseases and the substantial traits describing the two inbred mouse lines. The locus has 
not been further characterized yet, but it clearly presents an interesting target in the 
context of comorbidity of affective disorders and pleiotropic gene functions. 
Testing of reliability of associated loci 
Being aware, that the associations presented here were calculated based on behavioral 
data and SNP genotypes of 32 selected CD-1 mice only, the question of the reliability of 
detected loci arises. The successful identification of Tmem132d as a locus being 
associated with parameters reflecting anxiety-related behavior was considered to be an 
internal hallmark of the study, as this locus was shown to associated with anxiety 
severity in humans as well as in mice (Erhardt et al., 2010). Furthermore, the recently 
detected locus PPARGC1A as marker associated with anxiety disorders after the 
integration of diverse and complementary data sources based on human and murine 
screening approaches (Hettema et al., 2011) was as well among significantly associated 
markers in this study, though not under the top ten associated loci with the key 
phenotypes. 
In addition, the approach presented here, which simplified was the calculation of primary 
associations based on n = 32 and the establishment of the prerequisites to subsequently 
extend the study to the entire ´CD-1 panel`, was simulated using data of a GWAS with 
known outcome. The data sets underlying the identification of TMEM132D as marker for 
anxiety disorders by Erhardt and colleagues were used to simulate the approach 
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presented in this study. Therefore, 32 patients also reflecting the extremes of the cohort 
were selected and analysis of significantly associated loci resulted again in the 
identification of the TMEM132D locus among the 20 most significant markers.   
 
It can therefore be assumed that the most promising candidate loci are among the loci 
identified in the smaller population, but certainly a number of false positive markers were 
detected as significantly associated as well. In order to confirm the associations 
calculated so far, it is aimed to test for associations in the entire population of 384 CD-1 
mice. The basis therefore was established by the generation of the CD-1 specific 
haplotype map, as lege artis, the genome-wide distribution of SNPs is assessed based 
on the LD clustering of the respective species. The selection strategy for a customized 
haplotype map-based tag-SNP genotyping assay is currently a matter of debate. 
Equipping the customized assay with the 6,000 tag-SNPs would in the end cover 80% of 
the polymorphic positions detected genome-wide in the 32 CD-1 mice with an 80% 
probability. This constitutes an estimated reliability of 60% for the tag-SNPs approach. 
The genetic heterogeneity in the remaining genome would still render unconsidered and 
the question of the bias coming along with disregarding roughly one third of the 
heterozygous loci needs to be raised. The only alternative to the design of a tag-SNP-
based customized SNP assay is a high-throughput SNP screening of the entire ´CD-1 
panel` via the Jax Mouse Diversity Genotyping array. 
  
In general, GWAS did, on the one hand, contribute to the identification of a variety of 
common genetic variants enhancing the susceptibility for complex diseases, such as 
depression and anxiety disorders. On the other hand, detected associations were often 
identifying loci which were difficult to interpret regarding their biological relevance in the 
context of the respective disease (Lohoff, 2010), and the identification of susceptibility 
loci seemed to strongly depend on the cohort (Patel et al., 2010). In addition, the large 
number of SNPs usually tested in GWAS result in innumerous tests; hence, multiple 
comparison adjustments might frequently mask biologically relevant markers (Gershon et 
al., 2011; Jia et al., ; Jia et al., 2010; Wang et al., 2011). For these reasons, it seems 
necessary to consider data gained from GWAS as first indications for susceptibility loci 
which require additional confirmation. Different strategies how to potentially increase the 
output of GWAS were discussed recently. Gene set analysis of GWAS, which involves 
the testing of functionally related genes in a GWAS (Wang et al., 2011), or pathway-
based GWAS were also applied in psychiatric research (Jia et al., 2010). Another 
promising idea, how to condense and filter the enormous amount of data gained from 
GWAS, was demonstrated in the aforementioned publication by Hettema and 
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colleagues, which involved the integration of murine and human GWAS plus a multitude 
of in silico analyses to finally prioritize one locus. The extension of the association study 
to the entire ´CD-1 panel` will likely confirm certain loci detected to be associated so far. 
The investigation of these loci´s functional impact on the endophenotypes of the 
HAB/LAB and the HR/LR mouse models offers a promising approach to verify the 
contribution of the respective loci to the mosaic of factors which in a complex interplay 
determine the quantitative traits.   
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6 Perspectives 
The findings presented in this study provide the basis for various consecutive projects 
which, in part, were already initiated. 
First, the results of the transcriptome analysis from HR and LR mice, and the projects 
which resulted from these gene expressional profiling attempts so far, clearly suggest the 
characterization of the mitochondria in a comparative approach in HR vs. LR mice. To 
precise the kind of potential mitochondrial dysfunction, the repetition of the proteomic 
screening with mitochondrial protein lysates, which failed in individuals upon insufficient 
protein yield, should be conducted using pooled mitochondrial protein lysates from at 
least three animals to reach sufficient protein loads. In general, the more defined the kind 
of dysfunction is, the more precise techniques can be applied in order to investigate the 
modes of mitochondrial functions in HR and LR mice. In any case, as the primary 
mitochondrial task is the generation of ATP adapted to energy demands, potential 
differences in the ATP turnover between the lines should be determined.    
Along these lines, the assessment of ROS levels in HR and LR seems an obvious future 
step. The mutation rate in mtDNA could therefore be determined, as dissimilar mutation 
frequencies between HR and LR might serve as a primary indicator for differing levels of 
ROS. Furthermore, the activity state of antioxidant enzymes catalyzing the detoxification 
of ROS, such as superoxide dismutase (SOD) and glutathion peroxidase (GPx), would 
shed light on potential differences in oxidative stress between the lines.  
In addition, a time-dependent accumulation of pro-apoptotic signals might enable the 
detection of differing apoptosis rates in animals older than the ones used for the 
cytochrome c ELISA. 
Ultimately, the gene expressional profiling attempts should be extended to further tissues 
relevant in the context of stress reactivity and HPA axis dysfunction. Gene regulatory 
differences in, for example the pituitary or the adrenal glands, would supply a more 
comprehensive idea about endophenotype relevant transcriptional activity.  
 
Second, to further characterize the role of Cfl-1 in the context of stress reactivity, 
quantitative real-time analyses in order to determine the gene expressional levels of 
known Cfl-1 interaction partners will be conducted in Cfl-1 vs. WT mice. In addition, 
using perfused brains of these animals, the subcellular localization of the glucocorticoid 
receptor will be investigated considering temporal aspects. As Cfl-1 was shown to dose-
dependent influence the nuclear translocation of the glucocorticoid receptor, potential 
differences in glucocorticoid receptor migration will be looked at via 
immunohistochemical staining.   
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Third, the extension of the preliminary association study based on 32 mice only to the 
entire population of the ´CD-1 panel` should be further pursued. Whether a tag-SNP 
genotyping approach in a third customized assay, which is detecting 6,000 markers 
genome-wide, or a high-throughput SNP assay, which allows the simultaneous 
genotyping for more than 623,000 SNPs and even more invariant probe sequences, 
should be used, is currently a matter of debate. Regarding the results of the haplotype 
map and tag-SNP approach calculations, the Jax Mouse Diversity Genotyping array is 
the most promising and, therefore, favorable approach to accomplish this project.   
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7 Abbreviations 
2D 2-dimensional 
5-HT 5-hydroxytryptamin 
ADF actin depolymerizing factor  
ADP adenosin diphosphat 
APS ammonium persulfate 
ATP adenosin triphosphat 
bp basepairs 
BSA bovine serum albumine 
WT C57BL/6 mice 
chr. chromosome 
CNV copy number variant 
CO cytochrome c oxidase 
conc. concentration 
CP crossing points 
cRNA copy RNA 
DAB 3,3-diaminobenzadine 
DL box dark-light box 
DTT Dithiothreitol 
ED embryonic day 
EDTA ethylenediaminetetraacetic acid 
EGTA ethyleneglycoltetraacetic acid 
ELISA enzyme-linked immunosorbent assay 
EPM  elevated plus-maze 
F2 filial generation 2 
FAD  flavin adenine dinucleotide 
FC fold change 
FST  forced swim test 
g  rcf; relative centrifugal force 
GO  gene ontology 
GWAS genome-wide association study 
HAB high anxiety-related behavior 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
HR high stress reactivity 
IAA iodoacetamide 
IST Independent student´s t-test 
K2HPO4 Dipotassium phosphate 
Kbp kilobasepair 
KCl kalium chloride 
LAB low anxiety-related behavior 
LD linkage disequilibrium 
LR low stress reactivity  
lx lux 
mbp megabasepairs 
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MgCl2 magnesium chloride 
mRNA messenger ribonucleic acid 
MWU Mann -Whitney U test 
n. a. not applicable 
n. s. not significant 
Na2HPO4 Disodium phosphate 
NGS next generation sequencing 
Ni(NH4)2(SO4)2      Nickel ammonium sulfate 
OD  optical density 
OF open field test 
PBS phosphate buffered saline 
PCA principle component analysis 
PCR  polymerase chain reaction 
PFA paraformaldehyde 
PMSF phenylmethylsulfonylfluoride 
PND post-natal day 
PVC polyvinyl chloride 
qPCR quantitative real-time PCR 
R2  correlation coefficient 
RF  Random Forest 
ROS reactive oxygen species 
RT room temperature 
SAGE serial analysis of gene expression 
SDS sodium dodecyl sulfate 
SEM  standard error of the mean 
SNP single nucleotide polymorphism 
SR  stress reactivity  
SRT  stress reactivity test 
SVM-RFE  support vector machines with recursive feature elimination 
TGS Tris/glycine/SDS 
Tm melting temperature 
Tris trisaminomethane 
TST  tail suspension test 
u unit 
V Volt 
 
 
Bibliography 
 
149 
 
8 Bibliography 
Ahmed, Z., Douglas, M. R., Read, M. L., Berry, M. and Logan, A. (2011): Citron kinase 
regulates axon growth through a pathway that converges on cofilin downstream of RhoA. 
Neurobiol Dis 41(2): 421-429. 
 
Akiskal, H. S. (1998): Toward a definition of generalized anxiety disorder as an anxious 
temperament type. Acta Psychiatr Scand Suppl 393: 66-73. 
 
Anastas, S. B., Mueller, D., Semple-Rowland, S. L., Breunig, J. J. and Sarkisian, M. R. 
(2010): Failed cytokinesis of neural progenitors in citron kinase-deficient rats leads to 
multiciliated neurons. Cereb Cortex 21(2): 338-344. 
 
Anisman, H., Merali, Z. and Hayley, S. (2008): Neurotransmitter, peptide and cytokine 
processes in relation to depressive disorder: comorbidity between depression and 
neurodegenerative disorders. Prog Neurobiol 85(1): 1-74. 
 
Anthony, T. E. and Heintz, N. (2007): The folate metabolic enzyme ALDH1L1 is 
restricted to the midline of the early CNS, suggesting a role in human neural tube 
defects. J Comp Neurol 500(2): 368-383. 
 
Aqeilan, R. I. and Croce, C. M. (2007): WWOX in biological control and tumorigenesis. J 
Cell Physiol 212(2): 307-310. 
 
Aqeilan, R. I., Hassan, M. Q., de Bruin, A., Hagan, J. P., Volinia, S., Palumbo, T., 
Hussain, S., Lee, S. H., Gaur, T., Stein, G. S., Lian, J. B. and Croce, C. M. (2008): The 
WWOX tumor suppressor is essential for postnatal survival and normal bone 
metabolism. J Biol Chem 283(31): 21629-21639. 
 
Augustin, R., Lichtenthaler, S. F., Greeff, M., Hansen, J., Wurst, W. and Trumbach, D. 
(2011): Bioinformatics identification of modules of transcription factor binding sites in 
Alzheimer's disease-related genes by in silico promoter analysis and microarrays. Int J 
Alzheimers Dis 2011: 154325. 
 
Baek, W. Y. and Kim, J. E. (2011): Transcriptional regulation of bone formation. Front 
Biosci (Schol Ed) 3: 126-135. 
 
Bailey, K. R. and Crawley, J. N. (2009). Methods of Behavior Analysis in Neuroscience. 
Boca Raton, Taylor & Francis Group, LLC. 
 
Bale, T. L. (2006): Stress sensitivity and the development of affective disorders. Horm 
Behav 50(4): 529-533. 
 
Bamburg, J. R., Bernstein, B. W., Davis, R. C., Flynn, K. C., Goldsbury, C., Jensen, J. 
R., Maloney, M. T., Marsden, I. T., Minamide, L. S., Pak, C. W., Shaw, A. E., Whiteman, 
I. and Wiggan, O. (2010): ADF/Cofilin-actin rods in neurodegenerative diseases. Curr 
Alzheimer Res 7(3): 241-250. 
 
Barley, K., Dracheva, S. and Byne, W. (2009): Subcortical oligodendrocyte- and 
astrocyte-associated gene expression in subjects with schizophrenia, major depression 
and bipolar disorder. Schizophr Res 112(1-3): 54-64. 
 
Bibliography 
150 
 
Becker, J., Schmidt, P., Musshoff, F., Fitzenreiter, M. and Madea, B. (2004): MOR1 
receptor mRNA expression in human brains of drug-related fatalities-a real-time PCR 
quantification. Forensic Sci Int 140(1): 13-20. 
 
Bellenchi, G. C., Gurniak, C. B., Perlas, E., Middei, S., Ammassari-Teule, M. and Witke, 
W. (2007): N-cofilin is associated with neuronal migration disorders and cell cycle control 
in the cerebral cortex. Genes Dev 21(18): 2347-2357. 
 
Bender, M., Eckly, A., Hartwig, J. H., Elvers, M., Pleines, I., Gupta, S., Krohne, G., 
Jeanclos, E., Gohla, A., Gurniak, C., Gachet, C., Witke, W. and Nieswandt, B. (2010): 
ADF/n-cofilin-dependent actin turnover determines platelet formation and sizing. Blood 
116(10): 1767-1775. 
 
Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N. and Golani, I. (2001): Controlling the false 
discovery rate in behavior genetics research. Behav Brain Res 125(1-2): 279-284. 
 
Bernstein, B. W. and Bamburg, J. R. (2010): ADF/cofilin: a functional node in cell 
biology. Trends Cell Biol 20(4): 187-195. 
 
Binder, E. B., Owens, M. J., Liu, W., Deveau, T. C., Rush, A. J., Trivedi, M. H., Fava, M., 
Bradley, B., Ressler, K. J. and Nemeroff, C. B. (2010): Association of polymorphisms in 
genes regulating the corticotropin-releasing factor system with antidepressant treatment 
response. Arch Gen Psychiatry 67(4): 369-379. 
 
Bondy, B. (2011): Genetics in psychiatry: are the promises met? World J Biol Psychiatry 
12(2): 81-88. 
 
Bose, M., Olivan, B. and Laferrere, B. (2009): Stress and obesity: the role of the 
hypothalamic-pituitary-adrenal axis in metabolic disease. Curr Opin Endocrinol Diabetes 
Obes 16(5): 340-346. 
 
Bourin, M. and Hascoet, M. (2003): The mouse light/dark box test. Eur J Pharmacol 
463(1-3): 55-65. 
 
Brand, M. D. and Nicholls, D. G. (2011): Assessing mitochondrial dysfunction in cells. 
Biochem J 435(2): 297-312. 
 
Bronson, R. T., Donahue, L. R., Samples, R., Kim, J. H. and Naggert, J. K. (2001): Mice 
with mutations in the mahogany gene Atrn have cerebral spongiform changes. J 
Neuropathol Exp Neurol 60(7): 724-730. 
 
Burns, L. C., Minster, R. L., Demirci, F. Y., Barmada, M. M., Ganguli, M., Lopez, O. L., 
DeKosky, S. T. and Kamboh, M. I. (2011): Replication study of genome-wide associated 
SNPs with late-onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 
156B(4): 507-512. 
 
Cahill, L. (2006): Why sex matters for neuroscience. Nat Rev Neurosci 7(6): 477-484. 
 
Carboni, S., Antonsson, B., Gaillard, P., Gotteland, J. P., Gillon, J. Y. and Vitte, P. A. 
(2005): Control of death receptor and mitochondrial-dependent apoptosis by c-Jun N-
terminal kinase in hippocampal CA1 neurones following global transient ischaemia. J 
Neurochem 92(5): 1054-1060. 
 
Cassano, P. and Fava, M. (2002): Depression and public health: an overview. J 
Psychosom Res 53(4): 849-857. 
Bibliography 
 
151 
 
Cecchini, N. M., Monteoliva, M. I. and Alvarez, M. E. (2011): Proline dehydrogenase is a 
positive regulator of cell death in different kingdoms. Plant Signal Behav 6(8): 1195-
1197. 
 
Cerda, M., Sagdeo, A., Johnson, J. and Galea, S. (2010): Genetic and environmental 
influences on psychiatric comorbidity: a systematic review. J Affect Disord 126(1-2): 14-
38. 
 
Chang, N. S. (2002): A potential role of p53 and WOX1 in mitochondrial apoptosis 
(review). Int J Mol Med 9(1): 19-24. 
 
Chang, N. S., Doherty, J., Ensign, A., Lewis, J., Heath, J., Schultz, L., Chen, S. T. and 
Oppermann, U. (2003): Molecular mechanisms underlying WOX1 activation during 
apoptotic and stress responses. Biochem Pharmacol 66(8): 1347-1354. 
 
Charmandari, E., Tsigos, C. and Chrousos, G. (2005): Endocrinology of the stress 
response. Annu Rev Physiol 67: 259-284. 
 
Chinopoulos, C. (2011): Mitochondrial consumption of cytosolic ATP: not so fast. FEBS 
Lett 585(9): 1255-1259. 
 
Chomczynski, P. and Sacchi, N. (1987): Single-step method of RNA isolation by acid 
guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162(1): 156-159. 
 
Chua, B. T., Volbracht, C., Tan, K. O., Li, R., Yu, V. C. and Li, P. (2003): Mitochondrial 
translocation of cofilin is an early step in apoptosis induction. Nat Cell Biol 5(12): 1083-
1089. 
 
Cichon, S., Craddock, N., Daly, M., Faraone, S. V., Gejman, P. V., Kelsoe, J., Lehner, T., 
Levinson, D. F., Moran, A., Sklar, P. and Sullivan, P. F. (2009): Genomewide association 
studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry 
166(5): 540-556. 
 
Clark, R. B., Kondo, C., Belke, D. D. and Giles, W. R. (2011): Two-pore domain K+ 
channels regulate membrane potential of isolated human articular chondrocytes. J 
Physiol 589(Pt 21): 5071-5089. 
 
Clay, H. B., Sillivan, S. and Konradi, C. (2011): Mitochondrial dysfunction and pathology 
in bipolar disorder and schizophrenia. Int J Dev Neurosci 29(3): 311-324. 
 
Cohen, M. M., Jr. (2009): Perspectives on RUNX genes: an update. Am J Med Genet A 
149A(12): 2629-2646. 
 
Colman, I. and Ataullahjan, A. (2010): Life course perspectives on the epidemiology of 
depression. Can J Psychiatry 55(10): 622-632. 
 
Comai, G., Boutet, A., Neirijnck, Y. and Schedl, A. (2010): Expression patterns of the 
Wtx/Amer gene family during mouse embryonic development. Dev Dyn 239(6): 1867-
1878. 
 
Connolly, K. R. and Thase, M. E. (2011): If at first you don't succeed: a review of the 
evidence for antidepressant augmentation, combination and switching strategies. Drugs 
71(1): 43-64. 
 
Bibliography 
152 
 
Coppee, J. Y. (2008): Do DNA microarrays have their future behind them? Microbes 
Infect 10(9): 1067-1071. 
 
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., 
Small, G. W., Roses, A. D., Haines, J. L. and Pericak-Vance, M. A. (1993): Gene dose of 
apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. 
Science 261(5123): 921-923. 
 
Costall, B., Jones, B. J., Kelly, M. E., Naylor, R. J. and Tomkins, D. M. (1989): 
Exploration of mice in a black and white test box: validation as a model of anxiety. 
Pharmacol Biochem Behav 32(3): 777-785. 
 
Cox, B. and Emili, A. (2006): Tissue subcellular fractionation and protein extraction for 
use in mass-spectrometry-based proteomics. Nat Protoc 1(4): 1872-1878. 
 
Craddock, N., O'Donovan, M. C. and Owen, M. J. (2008): Genome-wide association 
studies in psychiatry: lessons from early studies of non-psychiatric and psychiatric 
phenotypes. Mol Psychiatry 13(7): 649-653. 
 
Crawford, M. and Masterson, F. A. (1982): Species-specific defense reactions and 
avoidance learning. An evaluative review. Pavlov J Biol Sci 17(4): 204-214. 
 
Crawley, J. and Goodwin, F. K. (1980): Preliminary report of a simple animal behavior 
model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13(2): 
167-170. 
 
Crawley, J. N. (1999): Behavioral phenotyping of transgenic and knockout mice: 
experimental design and evaluation of general health, sensory functions, motor abilities, 
and specific behavioral tests. Brain Res 835(1): 18-26. 
 
Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J. P., Belzung, C., 
Fritschy, J. M., Luscher, B. and Mohler, H. (1999): Decreased GABAA-receptor 
clustering results in enhanced anxiety and a bias for threat cues. Nat Neurosci 2(9): 833-
839. 
 
Cryan, J. F. and Holmes, A. (2005): The ascent of mouse: advances in modelling human 
depression and anxiety. Nat Rev Drug Discov 4(9): 775-790. 
 
Cryan, J. F., Mombereau, C. and Vassout, A. (2005): The tail suspension test as a model 
for assessing antidepressant activity: review of pharmacological and genetic studies in 
mice. Neurosci Biobehav Rev 29(4-5): 571-625. 
 
Cuppen, E. (2005): Haplotype-based genetics in mice and rats. Trends Genet 21(6): 
318-322. 
 
Cutler, G., Marshall, L. A., Chin, N., Baribault, H. and Kassner, P. D. (2007): Significant 
gene content variation characterizes the genomes of inbred mouse strains. Genome Res 
17(12): 1743-1754. 
 
 
 
 
 
 
Bibliography 
 
153 
 
Czibere, L., Baur, L. A., Wittmann, A., Gemmeke, K., Steiner, A., Weber, P., Putz, B., 
Ahmad, N., Bunck, M., Graf, C., Widner, R., Kuhne, C., Panhuysen, M., Hambsch, B., 
Rieder, G., Reinheckel, T., Peters, C., Holsboer, F., Landgraf, R. and Deussing, J. M. 
(2011): Profiling trait anxiety: transcriptome analysis reveals cathepsin B (Ctsb) as a 
novel candidate gene for emotionality in mice. PLoS One 6(8): e23604. 
 
de Castro, I. P., Martins, L. M. and Tufi, R. (2010): Mitochondrial quality control and 
neurological disease: an emerging connection. Expert Rev Mol Med 12: e12. 
 
de Kloet, E. R., Joels, M. and Holsboer, F. (2005): Stress and the brain: from adaptation 
to disease. Nat Rev Neurosci 6(6): 463-475. 
 
Del Mare, S., Salah, Z. and Aqeilan, R. I. (2009): WWOX: its genomics, partners, and 
functions. J Cell Biochem 108(4): 737-745. 
 
Di Cunto, F., Calautti, E., Hsiao, J., Ong, L., Topley, G., Turco, E. and Dotto, G. P. 
(1998): Citron rho-interacting kinase, a novel tissue-specific ser/thr kinase encompassing 
the Rho-Rac-binding protein Citron. J Biol Chem 273(45): 29706-29711. 
 
Di Cunto, F., Ferrara, L., Curtetti, R., Imarisio, S., Guazzone, S., Broccoli, V., Bulfone, A., 
Altruda, F., Vercelli, A. and Silengo, L. (2003): Role of citron kinase in dendritic 
morphogenesis of cortical neurons. Brain Res Bull 60(4): 319-327. 
 
Di Cunto, F., Imarisio, S., Hirsch, E., Broccoli, V., Bulfone, A., Migheli, A., Atzori, C., 
Turco, E., Triolo, R., Dotto, G. P., Silengo, L. and Altruda, F. (2000): Defective 
neurogenesis in citron kinase knockout mice by altered cytokinesis and massive 
apoptosis. Neuron 28(1): 115-127. 
 
Diez-Roux, G., Banfi, S., Sultan, M., Geffers, L., Anand, S., Rozado, D., Magen, A., 
Canidio, E., Pagani, M., Peluso, I., Lin-Marq, N., Koch, M., Bilio, M., Cantiello, I., Verde, 
R., De Masi, C., Bianchi, S. A., Cicchini, J., Perroud, E., Mehmeti, S., Dagand, E., 
Schrinner, S., Nurnberger, A., Schmidt, K., Metz, K., Zwingmann, C., Brieske, N., 
Springer, C., Hernandez, A. M., Herzog, S., Grabbe, F., Sieverding, C., Fischer, B., 
Schrader, K., Brockmeyer, M., Dettmer, S., Helbig, C., Alunni, V., Battaini, M. A., Mura, 
C., Henrichsen, C. N., Garcia-Lopez, R., Echevarria, D., Puelles, E., Garcia-Calero, E., 
Kruse, S., Uhr, M., Kauck, C., Feng, G., Milyaev, N., Ong, C. K., Kumar, L., Lam, M., 
Semple, C. A., Gyenesei, A., Mundlos, S., Radelof, U., Lehrach, H., Sarmientos, P., 
Reymond, A., Davidson, D. R., Dolle, P., Antonarakis, S. E., Yaspo, M. L., Martinez, S., 
Baldock, R. A., Eichele, G. and Ballabio, A. (2011): A high-resolution anatomical atlas of 
the transcriptome in the mouse embryo. PLoS Biol 9(1): e1000582. 
 
Ditzen, C., Jastorff, A. M., Kessler, M. S., Bunck, M., Teplytska, L., Erhardt, A., Kromer, 
S. A., Varadarajulu, J., Targosz, B. S., Sayan-Ayata, E. F., Holsboer, F., Landgraf, R. 
and Turck, C. W. (2006): Protein biomarkers in a mouse model of extremes in trait 
anxiety. Mol Cell Proteomics 5(10): 1914-1920. 
 
Dopman, E. B. and Hartl, D. L. (2007): A portrait of copy-number polymorphism in 
Drosophila melanogaster. Proc Natl Acad Sci U S A 104(50): 19920-19925. 
 
Draghici, S., Khatri, P., Eklund, A. C. and Szallasi, Z. (2006): Reliability and 
reproducibility issues in DNA microarray measurements. Trends Genet 22(2): 101-109. 
 
Du, J., McEwen, B. and Manji, H. K. (2009a): Glucocorticoid receptors modulate 
mitochondrial function: A novel mechanism for neuroprotection. Commun Integr Biol 
2(4): 350-352. 
Bibliography 
154 
 
Du, J., Wang, Y., Hunter, R., Wei, Y., Blumenthal, R., Falke, C., Khairova, R., Zhou, R., 
Yuan, P., Machado-Vieira, R., McEwen, B. S. and Manji, H. K. (2009b): Dynamic 
regulation of mitochondrial function by glucocorticoids. Proc Natl Acad Sci U S A 106(9): 
3543-3548. 
 
Earnheart, J. C., Schweizer, C., Crestani, F., Iwasato, T., Itohara, S., Mohler, H. and 
Luscher, B. (2007): GABAergic control of adult hippocampal neurogenesis in relation to 
behavior indicative of trait anxiety and depression states. J Neurosci 27(14): 3845-3854. 
 
El Yacoubi, M., Bouali, S., Popa, D., Naudon, L., Leroux-Nicollet, I., Hamon, M., 
Costentin, J., Adrien, J. and Vaugeois, J. M. (2003): Behavioral, neurochemical, and 
electrophysiological characterization of a genetic mouse model of depression. Proc Natl 
Acad Sci U S A 100(10): 6227-6232. 
 
El Yacoubi, M. and Vaugeois, J. M. (2007): Genetic rodent models of depression. Curr 
Opin Pharmacol 7(1): 3-7. 
 
Endo, M., Ohashi, K., Sasaki, Y., Goshima, Y., Niwa, R., Uemura, T. and Mizuno, K. 
(2003): Control of growth cone motility and morphology by LIM kinase and Slingshot via 
phosphorylation and dephosphorylation of cofilin. J Neurosci 23(7): 2527-2537. 
 
Erhardt, A., Czibere, L., Roeske, D., Lucae, S., Unschuld, P. G., Ripke, S., Specht, M., 
Kohli, M. A., Kloiber, S., Ising, M., Heck, A., Pfister, H., Zimmermann, P., Lieb, R., Putz, 
B., Uhr, M., Weber, P., Deussing, J. M., Gonik, M., Bunck, M., Kebler, M. S., Frank, E., 
Hohoff, C., Domschke, K., Krakowitzky, P., Maier, W., Bandelow, B., Jacob, C., Deckert, 
J., Schreiber, S., Strohmaier, J., Nothen, M., Cichon, S., Rietschel, M., Bettecken, T., 
Keck, M. E., Landgraf, R., Muller-Myhsok, B., Holsboer, F. and Binder, E. B. (2010): 
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse 
studies. Mol Psychiatry 16(6): 647-663. 
 
Fanselow, M. S. and Dong, H. W. (2010): Are the dorsal and ventral hippocampus 
functionally distinct structures? Neuron 65(1): 7-19. 
 
Feldker, D. E., Datson, N. A., Veenema, A. H., Meulmeester, E., de Kloet, E. R. and 
Vreugdenhil, E. (2003): Serial analysis of gene expression predicts structural differences 
in hippocampus of long attack latency and short attack latency mice. Eur J Neurosci 
17(2): 379-387. 
 
Filiou, M. D., Zhang, Y., Teplytska, L., Reckow, S., Gormanns, P., Maccarrone, G., 
Frank, E., Kessler, M. S., Hambsch, B., Nussbaumer, M., Bunck, M., Ludwig, T., 
Yassouridis, A., Holsboer, F., Landgraf, R. and Turck, C. W. (2011): Proteomics and 
metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial 
pathways. Biol Psychiatry 70(11): 1074-1082. 
 
Finn, D. A., Rutledge-Gorman, M. T. and Crabbe, J. C. (2003): Genetic animal models of 
anxiety. Neurogenetics 4(3): 109-135. 
 
Franz, C. E., York, T. P., Eaves, L. J., Mendoza, S. P., Hauger, R. L., Hellhammer, D. H., 
Jacobson, K. C., Levine, S., Lupien, S. J., Lyons, M. J., Prom-Wormley, E., Xian, H. and 
Kremen, W. S. (2010): Genetic and environmental influences on cortisol regulation 
across days and contexts in middle-aged men. Behav Genet 40(4): 467-479. 
 
Freeborough, A. and Kimpton, J. (2011): Discovering new genetic and psychosocial 
pathways in Major Depressive Disorder: the NewMood project. Psychiatr Danub 23 
Suppl 1: S138-141. 
Bibliography 
 
155 
 
Garg, P., Verma, R., Cook, L., Soofi, A., Venkatareddy, M., George, B., Mizuno, K., 
Gurniak, C., Witke, W. and Holzman, L. B. (2010): Actin-depolymerizing factor cofilin-1 is 
necessary in maintaining mature podocyte architecture. J Biol Chem 285(29): 22676-
22688. 
Gelenberg, A. J. (2010): The prevalence and impact of depression. J Clin Psychiatry 
71(3): e06. 
 
Gershon, E. S., Alliey-Rodriguez, N. and Liu, C. (2011): After GWAS: searching for 
genetic risk for schizophrenia and bipolar disorder. Am J Psychiatry 168(3): 253-256. 
 
Gille, G. and Reichmann, H. (2011): Iron-dependent functions of mitochondria--relation 
to neurodegeneration. J Neural Transm 118(3): 349-359. 
 
Goate, A., Chartier-Harlin, M. C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, 
L., Haynes, A., Irving, N., James, L. and et al. (1991): Segregation of a missense 
mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 
349(6311): 704-706. 
 
Gold, P. W. and Chrousos, G. P. (1999): The endocrinology of melancholic and atypical 
depression: relation to neurocircuitry and somatic consequences. Proc Assoc Am 
Physicians 111(1): 22-34. 
 
Gold, P. W. and Chrousos, G. P. (2002): Organization of the stress system and its 
dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol 
Psychiatry 7(3): 254-275. 
 
Gold, P. W., Goodwin, F. K. and Chrousos, G. P. (1988): Clinical and biochemical 
manifestations of depression. Relation to the neurobiology of stress (1). N Engl J Med 
319(6): 348-353. 
 
Gonzalez-Lima, F. and Garrosa, M. (1991): Quantitative histochemistry of cytochrome 
oxidase in rat brain. Neurosci Lett 123(2): 251-253. 
 
Gregory, G. D., Vakoc, C. R., Rozovskaia, T., Zheng, X., Patel, S., Nakamura, T., 
Canaani, E. and Blobel, G. A. (2007): Mammalian ASH1L is a histone methyltransferase 
that occupies the transcribed region of active genes. Mol Cell Biol 27(24): 8466-8479. 
 
Grippo, A. J. and Johnson, A. K. (2009): Stress, depression and cardiovascular 
dysregulation: a review of neurobiological mechanisms and the integration of research 
from preclinical disease models. Stress 12(1): 1-21. 
 
Groeneweg, F. L., Karst, H., de Kloet, E. R. and Joels, M. (2011a): Mineralocorticoid and 
glucocorticoid receptors at the neuronal membrane, regulators of nongenomic 
corticosteroid signalling. Mol Cell Endocrinol. 
 
Groeneweg, F. L., Karst, H., de Kloet, E. R. and Joels, M. (2011b): Rapid non-genomic 
effects of corticosteroids and their role in the central stress response. J Endocrinol 
209(2): 153-167. 
 
Gross, C., Santarelli, L., Brunner, D., Zhuang, X. and Hen, R. (2000): Altered fear circuits 
in 5-HT(1A) receptor KO mice. Biol Psychiatry 48(12): 1157-1163. 
 
Gurniak, C. B., Perlas, E. and Witke, W. (2005): The actin depolymerizing factor n-cofilin 
is essential for neural tube morphogenesis and neural crest cell migration. Dev Biol 
278(1): 231-241. 
Bibliography 
156 
 
Guryev, V., Saar, K., Adamovic, T., Verheul, M., van Heesch, S. A., Cook, S., Pravenec, 
M., Aitman, T., Jacob, H., Shull, J. D., Hubner, N. and Cuppen, E. (2008): Distribution 
and functional impact of DNA copy number variation in the rat. Nat Genet 40(5): 538-
545. 
 
Hambsch, B., Chen, B. G., Brenndorfer, J., Meyer, M., Avrabos, C., Maccarrone, G., Liu, 
R. H., Eder, M., Turck, C. W. and Landgraf, R. (2010): Methylglyoxal-mediated anxiolysis 
involves increased protein modification and elevated expression of glyoxalase 1 in the 
brain. J Neurochem 113(5): 1240-1251. 
 
Hamet, P. and Tremblay, J. (2005): Genetics and genomics of depression. Metabolism 
54(5 Suppl 1): 10-15. 
 
Han, X. J., Tomizawa, K., Fujimura, A., Ohmori, I., Nishiki, T., Matsushita, M. and Matsui, 
H. (2011): Regulation of mitochondrial dynamics and neurodegenerative diseases. Acta 
Med Okayama 65(1): 1-10. 
 
Hanukoglu, I. (2006): Antioxidant protective mechanisms against reactive oxygen 
species (ROS) generated by mitochondrial P450 systems in steroidogenic cells. Drug 
Metab Rev 38(1-2): 171-196. 
 
Haqq, A. M., Rene, P., Kishi, T., Khong, K., Lee, C. E., Liu, H., Friedman, J. M., 
Elmquist, J. K. and Cone, R. D. (2003): Characterization of a novel binding partner of the 
melanocortin-4 receptor: attractin-like protein. Biochem J 376(Pt 3): 595-605. 
 
Hard, M. L., Abdolell, M., Robinson, B. H. and Koren, G. (2005): Gene-expression 
analysis after alcohol exposure in the developing mouse. J Lab Clin Med 145(1): 47-54. 
 
Harro, J., Kanarik, M., Matrov, D. and Panksepp, J. (2011): Mapping patterns of 
depression-related brain regions with cytochrome oxidase histochemistry: Relevance of 
animal affective systems to human disorders, with a focus on resilience to adverse 
events. Neurosci Biobehav Rev 35(9): 1876-1889. 
 
Heinzmann, J. M., Thoeringer, C. K., Knapman, A., Palme, R., Holsboer, F., Uhr, M., 
Landgraf, R. and Touma, C. (2010): Intrahippocampal corticosterone response in mice 
selectively bred for extremes in stress reactivity: a microdialysis study. J Neuroendocrinol 
22(11): 1187-1197. 
 
Heitzer, M. D., Wolf, I. M., Sanchez, E. R., Witchel, S. F. and DeFranco, D. B. (2007): 
Glucocorticoid receptor physiology. Rev Endocr Metab Disord 8(4): 321-330. 
 
Henderson, N. D., Turri, M. G., DeFries, J. C. and Flint, J. (2004): QTL analysis of 
multiple behavioral measures of anxiety in mice. Behav Genet 34(3): 267-293. 
 
Henrichsen, C. N., Chaignat, E. and Reymond, A. (2009a): Copy number variants, 
diseases and gene expression. Hum Mol Genet 18(R1): R1-8. 
 
Henrichsen, C. N., Vinckenbosch, N., Zollner, S., Chaignat, E., Pradervand, S., Schutz, 
F., Ruedi, M., Kaessmann, H. and Reymond, A. (2009b): Segmental copy number 
variation shapes tissue transcriptomes. Nat Genet 41(4): 424-429. 
 
Hettema, J. M., Neale, M. C., Myers, J. M., Prescott, C. A. and Kendler, K. S. (2006): A 
population-based twin study of the relationship between neuroticism and internalizing 
disorders. Am J Psychiatry 163(5): 857-864. 
 
Bibliography 
 
157 
 
Hettema, J. M., Webb, B. T., Guo, A. Y., Zhao, Z., Maher, B. S., Chen, X., An, S. S., 
Sun, C., Aggen, S. H., Kendler, K. S., Kuo, P. H., Otowa, T., Flint, J. and van den Oord, 
E. J. (2011): Prioritization and association analysis of murine-derived candidate genes in 
anxiety-spectrum disorders. Biol Psychiatry 70(9): 888-896. 
 
Hevner, R. F. and Wong-Riley, M. T. (1990): Regulation of cytochrome oxidase protein 
levels by functional activity in the macaque monkey visual system. J Neurosci 10(4): 
1331-1340. 
 
Higuchi, R., Fockler, C., Dollinger, G. and Watson, R. (1993): Kinetic PCR analysis: real-
time monitoring of DNA amplification reactions. Biotechnology (N Y) 11(9): 1026-1030. 
 
Hillman, J. B., Dorn, L. D., Loucks, T. L. and Berga, S. L. (2011): Obesity and the 
hypothalamic-pituitary-adrenal axis in adolescent girls. Metabolism. 
 
Hogart, A., Leung, K. N., Wang, N. J., Wu, D. J., Driscoll, J., Vallero, R. O., Schanen, N. 
C. and LaSalle, J. M. (2009): Chromosome 15q11-13 duplication syndrome brain reveals 
epigenetic alterations in gene expression not predicted from copy number. J Med Genet 
46(2): 86-93. 
 
Hogg, S. (1996): A review of the validity and variability of the elevated plus-maze as an 
animal model of anxiety. Pharmacol Biochem Behav 54(1): 21-30. 
 
Holsboer, F. (2001): Stress, hypercortisolism and corticosteroid receptors in depression: 
implications for therapy. J Affect Disord 62(1-2): 77-91. 
 
Hu, C. A., Donald, S. P., Yu, J., Lin, W. W., Liu, Z., Steel, G., Obie, C., Valle, D. and 
Phang, J. M. (2007): Overexpression of proline oxidase induces proline-dependent and 
mitochondria-mediated apoptosis. Mol Cell Biochem 295(1-2): 85-92. 
 
Hu, D., Xu, X. and Gonzalez-Lima, F. (2005): Hippocampal cytochrome oxidase activity 
of rats in easy and difficult visual discrimination learning. Int J Neurosci 115(5): 595-611. 
 
Huang da, W., Sherman, B. T. and Lempicki, R. A. (2009): Systematic and integrative 
analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1): 44-
57. 
 
Huttemann, M., Pecina, P., Rainbolt, M., Sanderson, T. H., Kagan, V. E., Samavati, L., 
Doan, J. W. and Lee, I. (2011): The multiple functions of cytochrome c and their 
regulation in life and death decisions of the mammalian cell: From respiration to 
apoptosis. Mitochondrion 11(3): 369-381. 
 
Insel, T. R. and Charney, D. S. (2003): Research on major depression: strategies and 
priorities. Jama 289(23): 3167-3168. 
 
Iwamoto, K., Bundo, M. and Kato, T. (2005): Altered expression of mitochondria-related 
genes in postmortem brains of patients with bipolar disorder or schizophrenia, as 
revealed by large-scale DNA microarray analysis. Hum Mol Genet 14(2): 241-253. 
 
Jacobson, L. H. and Cryan, J. F. (2007): Feeling strained? Influence of genetic 
background on depression-related behavior in mice: a review. Behav Genet 37(1): 171-
213. 
 
Jia, P., Wang, L., Meltzer, H. Y. and Zhao, Z. Pathway-based analysis of GWAS 
datasets: effective but caution required. Int J Neuropsychopharmacol 14(4): 567-572. 
Bibliography 
158 
 
Jia, P., Wang, L., Meltzer, H. Y. and Zhao, Z. (2010): Pathway-based analysis of GWAS 
datasets: effective but caution required. Int J Neuropsychopharmacol 14(4): 567-572. 
 
Jiao, H., Arner, P., Hoffstedt, J., Brodin, D., Dubern, B., Czernichow, S., van't Hooft, F., 
Axelsson, T., Pedersen, O., Hansen, T., Sorensen, T. I., Hebebrand, J., Kere, J., 
Dahlman-Wright, K., Hamsten, A., Clement, K. and Dahlman, I. (2011): Genome wide 
association study identifies KCNMA1 contributing to human obesity. BMC Med 
Genomics 4: 51. 
 
Joachim, H. (1890). Papyros Ebers: Das älteste Buch über Heilkunde. Berlin, Reimer. 
 
Jou, S. H., Chiu, N. Y. and Liu, C. S. (2009): Mitochondrial dysfunction and psychiatric 
disorders. Chang Gung Med J 32(4): 370-379. 
 
Karssen, A. M., Li, J. Z., Her, S., Patel, P. D., Meng, F., Evans, S. J., Vawter, M. P., 
Tomita, H., Choudary, P. V., Bunney, W. E., Jr., Jones, E. G., Watson, S. J., Akil, H., 
Myers, R. M., Schatzberg, A. F. and Lyons, D. M. (2006): Application of microarray 
technology in primate behavioral neuroscience research. Methods 38(3): 227-234. 
 
Kempf, L., Nicodemus, K. K., Kolachana, B., Vakkalanka, R., Verchinski, B. A., Egan, M. 
F., Straub, R. E., Mattay, V. A., Callicott, J. H., Weinberger, D. R. and Meyer-Lindenberg, 
A. (2008): Functional polymorphisms in PRODH are associated with risk and protection 
for schizophrenia and fronto-striatal structure and function. PLoS Genet 4(11): 
e1000252. 
 
Kendler, K. S., Kalsi, G., Holmans, P. A., Sanders, A. R., Aggen, S. H., Dick, D. M., 
Aliev, F., Shi, J., Levinson, D. F. and Gejman, P. V. (2011): Genomewide association 
analysis of symptoms of alcohol dependence in the molecular genetics of schizophrenia 
(MGS2) control sample. Alcohol Clin Exp Res 35(5): 963-975. 
 
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. 
J., Walters, E. E. and Wang, P. S. (2003): The epidemiology of major depressive 
disorder: results from the National Comorbidity Survey Replication (NCS-R). Jama 
289(23): 3095-3105. 
 
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Liu, J., Swartz, M. and Blazer, D. G. 
(1996): Comorbidity of DSM-III-R major depressive disorder in the general population: 
results from the US National Comorbidity Survey. Br J Psychiatry Suppl(30): 17-30. 
 
Kiewe, P., Gueller, S., Komor, M., Stroux, A., Thiel, E. and Hofmann, W. K. (2009): 
Prediction of qualitative outcome of oligonucleotide microarray hybridization by 
measurement of RNA integrity using the 2100 Bioanalyzer capillary electrophoresis 
system. Ann Hematol 88(12): 1177-1183. 
 
Klamt, F., Zdanov, S., Levine, R. L., Pariser, A., Zhang, Y., Zhang, B., Yu, L. R., 
Veenstra, T. D. and Shacter, E. (2009): Oxidant-induced apoptosis is mediated by 
oxidation of the actin-regulatory protein cofilin. Nat Cell Biol 11(10): 1241-1246. 
 
Knapman, A., Heinzmann, J. M., Hellweg, R., Holsboer, F., Landgraf, R. and Touma, C. 
(2010a): Increased stress reactivity is associated with cognitive deficits and decreased 
hippocampal brain-derived neurotrophic factor in a mouse model of affective disorders. J 
Psychiatr Res 44(9): 566-575. 
 
 
Bibliography 
 
159 
 
Knapman, A., Heinzmann, J. M., Holsboer, F., Landgraf, R. and Touma, C. (2010b): 
Modeling psychotic and cognitive symptoms of affective disorders: Disrupted latent 
inhibition and reversal learning deficits in highly stress reactive mice. Neurobiol Learn 
Mem 94(2): 145-152. 
 
Knapman, A., Kaltwasser, S. F., Martins-de-Souza, D., Holsboer, F., Landgraf, R., Turck, 
C. W., Czisch, M. and Touma, C. (in press): Increased stress reactivity is associated with 
reduced hippocampal activity and neuronal integrity along with changes in energy 
metabolism. European Journal of Neuroscience. 
 
Komori, T. (2011): Signaling networks in RUNX2-dependent bone development. J Cell 
Biochem 112(3): 750-755. 
 
Kousaka, K., Kiyonari, H., Oshima, N., Nagafuchi, A., Shima, Y., Chisaka, O. and 
Uemura, T. (2008): Slingshot-3 dephosphorylates ADF/cofilin but is dispensable for 
mouse development. Genesis 46(5): 246-255. 
 
Kromer, S. A., Kessler, M. S., Milfay, D., Birg, I. N., Bunck, M., Czibere, L., Panhuysen, 
M., Putz, B., Deussing, J. M., Holsboer, F., Landgraf, R. and Turck, C. W. (2005): 
Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait 
anxiety. J Neurosci 25(17): 4375-4384. 
 
Kuhn, T. B., Meberg, P. J., Brown, M. D., Bernstein, B. W., Minamide, L. S., Jensen, J. 
R., Okada, K., Soda, E. A. and Bamburg, J. R. (2000): Regulating actin dynamics in 
neuronal growth cones by ADF/cofilin and rho family GTPases. J Neurobiol 44(2): 126-
144. 
 
Kulic, L., Wollmer, M. A., Rhein, V., Pagani, L., Kuehnle, K., Cattepoel, S., Tracy, J., 
Eckert, A. and Nitsch, R. M. (2011): Combined expression of tau and the Harlequin 
mouse mutation leads to increased mitochondrial dysfunction, tau pathology and 
neurodegeneration. Neurobiol Aging 32(10): 1827-1838. 
 
Kurian, S. M., Le-Niculescu, H., Patel, S. D., Bertram, D., Davis, J., Dike, C., Yehyawi, 
N., Lysaker, P., Dustin, J., Caligiuri, M., Lohr, J., Lahiri, D. K., Nurnberger, J. I., Jr., 
Faraone, S. V., Geyer, M. A., Tsuang, M. T., Schork, N. J., Salomon, D. R. and 
Niculescu, A. B. (2011): Identification of blood biomarkers for psychosis using 
convergent functional genomics. Mol Psychiatry 16(1): 37-58. 
 
Kuure, S., Cebrian, C., Machingo, Q., Lu, B. C., Chi, X., Hyink, D., D'Agati, V., Gurniak, 
C., Witke, W. and Costantini, F. (2010): Actin depolymerizing factors cofilin1 and destrin 
are required for ureteric bud branching morphogenesis. PLoS Genet 6(10): e1001176. 
 
Lamprianou, S., Chatzopoulou, E., Thomas, J. L., Bouyain, S. and Harroch, S. (2011): A 
complex between contactin-1 and the protein tyrosine phosphatase PTPRZ controls the 
development of oligodendrocyte precursor cells. Proc Natl Acad Sci U S A 108(42): 
17498-17503. 
 
Landgraf, R., Kessler, M. S., Bunck, M., Murgatroyd, C., Spengler, D., Zimbelmann, M., 
Nussbaumer, M., Czibere, L., Turck, C. W., Singewald, N., Rujescu, D. and Frank, E. 
(2007): Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: focus on 
vasopressin and glyoxalase-I. Neurosci Biobehav Rev 31(1): 89-102. 
 
Levinson, D. F. (2005): Meta-analysis in psychiatric genetics. Curr Psychiatry Rep 7(2): 
143-151. 
 
Bibliography 
160 
 
Li, H. and Durbin, R. (2009): Fast and accurate short read alignment with Burrows-
Wheeler transform. Bioinformatics 25(14): 1754-1760. 
Lifschytz, T., Broner, E. C., Zozulinsky, P., Slonimsky, A., Eitan, R., Greenbaum, L. and 
Lerer, B. (2011): Relationship between Rgs2 gene expression level and anxiety and 
depression-like behaviour in a mutant mouse model: serotonergic involvement. Int J 
Neuropsychopharmacol: 1-12. 
 
Lightman, S. L. and Conway-Campbell, B. L. (2010): The crucial role of pulsatile activity 
of the HPA axis for continuous dynamic equilibration. Nat Rev Neurosci 11(10): 710-718. 
 
Lister, R. G. (1987): The use of a plus-maze to measure anxiety in the mouse. 
Psychopharmacology (Berl) 92(2): 180-185. 
 
Livak, K. J. and Schmittgen, T. D. (2001): Analysis of relative gene expression data 
using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4): 
402-408. 
 
Livesey, F. J. (2003): Strategies for microarray analysis of limiting amounts of RNA. Brief 
Funct Genomic Proteomic 2(1): 31-36. 
 
Lo, C. P., Hsu, L. J., Li, M. Y., Hsu, S. Y., Chuang, J. I., Tsai, M. S., Lin, S. R., Chang, N. 
S. and Chen, S. T. (2008): MPP+-induced neuronal death in rats involves tyrosine 33 
phosphorylation of WW domain-containing oxidoreductase WOX1. Eur J Neurosci 27(7): 
1634-1646. 
 
Lohoff, F. W. (2010): Overview of the genetics of major depressive disorder. Curr 
Psychiatry Rep 12(6): 539-546. 
 
Lydall, G. J., Bass, N. J., McQuillin, A., Lawrence, J., Anjorin, A., Kandaswamy, R., 
Pereira, A., Guerrini, I., Curtis, D., Vine, A. E., Sklar, P., Purcell, S. M. and Gurling, H. M. 
(2011): Confirmation of prior evidence of genetic susceptibility to alcoholism in a 
genome-wide association study of comorbid alcoholism and bipolar disorder. Psychiatr 
Genet 21(6): 294-306. 
 
Mammucari, C. and Rizzuto, R. (2010): Signaling pathways in mitochondrial dysfunction 
and aging. Mech Ageing Dev 131(7-8): 536-543. 
 
Maoz, H. (2007): Failure of first SSRI for depression--what is the next step? Isr J 
Psychiatry Relat Sci 44(4): 327-329. 
 
Matthews, K., Christmas, D., Swan, J. and Sorrell, E. (2005): Animal models of 
depression: navigating through the clinical fog. Neurosci Biobehav Rev 29(4-5): 503-513. 
 
Maxwell, S. A. and Rivera, A. (2003): Proline oxidase induces apoptosis in tumor cells, 
and its expression is frequently absent or reduced in renal carcinomas. J Biol Chem 
278(11): 9784-9789. 
 
McBride, H. M., Neuspiel, M. and Wasiak, S. (2006): Mitochondria: more than just a 
powerhouse. Curr Biol 16(14): R551-560. 
 
McCormick, C. M. and Mathews, I. Z. (2010): Adolescent development, hypothalamic-
pituitary-adrenal function, and programming of adult learning and memory. Prog 
Neuropsychopharmacol Biol Psychiatry 34(5): 756-765. 
 
 
Bibliography 
 
161 
 
McEwen, B. S. (2007): Physiology and neurobiology of stress and adaptation: central 
role of the brain. Physiol Rev 87(3): 873-904. 
 
Mehmeti, I., Gurgul-Convey, E., Lenzen, S. and Lortz, S. (2011): Induction of the intrinsic 
apoptosis pathway in insulin-secreting cells is dependent on oxidative damage of 
mitochondria but independent of caspase-12 activation. Biochim Biophys Acta 1813(10): 
1827-1835. 
 
Melmed, S., Polonsky, K. S., Larsen, P. R. and Kronenberg, H. M. (2011). Williams 
Textbook of Endocrinology, Saunders Elsevier. 
 
Minamide, L. S., Striegl, A. M., Boyle, J. A., Meberg, P. J. and Bamburg, J. R. (2000): 
Neurodegenerative stimuli induce persistent ADF/cofilin-actin rods that disrupt distal 
neurite function. Nat Cell Biol 2(9): 628-636. 
 
Moffitt, T. E., Caspi, A., Harrington, H., Milne, B. J., Melchior, M., Goldberg, D. and 
Poulton, R. (2007): Generalized anxiety disorder and depression: childhood risk factors 
in a birth cohort followed to age 32. Psychol Med 37(3): 441-452. 
 
Mormede, P., Foury, A., Barat, P., Corcuff, J. B., Terenina, E., Marissal-Arvy, N. and 
Moisan, M. P. (2011): Molecular genetics of hypothalamic-pituitary-adrenal axis activity 
and function. Ann N Y Acad Sci 1220: 127-136. 
 
Mourier, A. and Larsson, N. G. (2011): Tracing the trail of protons through complex I of 
the mitochondrial respiratory chain. PLoS Biol 9(8): e1001129. 
 
Muller, M. B. and Holsboer, F. (2006): Mice with mutations in the HPA-system as models 
for symptoms of depression. Biol Psychiatry 59(12): 1104-1115. 
 
Murphy, K. C., Jones, L. A. and Owen, M. J. (1999): High rates of schizophrenia in adults 
with velo-cardio-facial syndrome. Arch Gen Psychiatry 56(10): 940-945. 
 
Murray, F., Smith, D. W. and Hutson, P. H. (2008): Chronic low dose corticosterone 
exposure decreased hippocampal cell proliferation, volume and induced anxiety and 
depression like behaviours in mice. Eur J Pharmacol 583(1): 115-127. 
 
Muzzi, P., Camera, P., Di Cunto, F. and Vercelli, A. (2009): Deletion of the citron kinase 
gene selectively affects the number and distribution of interneurons in barrelfield cortex. 
J Comp Neurol 513(3): 249-264. 
 
Neumann, I. D., Wegener, G., Homberg, J. R., Cohen, H., Slattery, D. A., Zohar, J., 
Olivier, J. D. and Mathe, A. A. (2011): Animal models of depression and anxiety: What 
do they tell us about human condition? Prog Neuropsychopharmacol Biol Psychiatry 
35(6): 1357-1375. 
 
Nosjean, A., Franc, B. and Laguzzi, R. (1995): Increased sympathetic nerve discharge 
without alteration in the sympathetic baroreflex response by serotonin3 receptor 
stimulation in the nucleus tractus solitarius of the rat. Neurosci Lett 186(1): 41-44. 
 
O'Keefe, L. V. and Richards, R. I. (2006): Common chromosomal fragile sites and 
cancer: focus on FRA16D. Cancer Lett 232(1): 37-47. 
 
Oleinik, N. V., Krupenko, N. I. and Krupenko, S. A. (2010): ALDH1L1 inhibits cell motility 
via dephosphorylation of cofilin by PP1 and PP2A. Oncogene 29(47): 6233-6244. 
 
Bibliography 
162 
 
Omura, T. (2010): Structural diversity of cytochrome P450 enzyme system. J Biochem 
147(3): 297-306. 
 
Ott, M., Gogvadze, V., Orrenius, S. and Zhivotovsky, B. (2007): Mitochondria, oxidative 
stress and cell death. Apoptosis 12(5): 913-922. 
 
O'Tuathaigh, C. M., Babovic, D., O'Meara, G., Clifford, J. J., Croke, D. T. and 
Waddington, J. L. (2007): Susceptibility genes for schizophrenia: characterisation of 
mutant mouse models at the level of phenotypic behaviour. Neurosci Biobehav Rev 
31(1): 60-78. 
 
Pacher, P. and Kecskemeti, V. (2004): Trends in the development of new 
antidepressants. Is there a light at the end of the tunnel? Curr Med Chem 11(7): 925-
943. 
 
Pagliarini, D. J., Calvo, S. E., Chang, B., Sheth, S. A., Vafai, S. B., Ong, S. E., Walford, 
G. A., Sugiana, C., Boneh, A., Chen, W. K., Hill, D. E., Vidal, M., Evans, J. G., Thorburn, 
D. R., Carr, S. A. and Mootha, V. K. (2008): A mitochondrial protein compendium 
elucidates complex I disease biology. Cell 134(1): 112-123. 
 
Parker, G., Graham, R., Hadzi-Pavlovic, D., Friend, P., Synnott, H. and Barrett, M. 
(2011): Does testing for bimodality clarify whether the bipolar disorders are categorically 
or dimensionally different to unipolar depressive disorders? J Affect Disord. 
 
Patel, S. D., Le-Niculescu, H., Koller, D. L., Green, S. D., Lahiri, D. K., McMahon, F. J., 
Nurnberger, J. I., Jr. and Niculescu, A. B., 3rd (2010): Coming to grips with complex 
disorders: genetic risk prediction in bipolar disorder using panels of genes identified 
through convergent functional genomics. Am J Med Genet B Neuropsychiatr Genet 
153B(4): 850-877. 
 
Pego, J. M., Morgado, P., Pinto, L. G., Cerqueira, J. J., Almeida, O. F. and Sousa, N. 
(2008): Dissociation of the morphological correlates of stress-induced anxiety and fear. 
Eur J Neurosci 27(6): 1503-1516. 
 
Pellow, S., Chopin, P., File, S. E. and Briley, M. (1985): Validation of open:closed arm 
entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 
14(3): 149-167. 
 
Petit-Demouliere, B., Chenu, F. and Bourin, M. (2005): Forced swimming test in mice: a 
review of antidepressant activity. Psychopharmacology (Berl) 177(3): 245-255. 
 
Petrov, A., Pirozhkova, I., Carnac, G., Laoudj, D., Lipinski, M. and Vassetzky, Y. S. 
(2006): Chromatin loop domain organization within the 4q35 locus in 
facioscapulohumeral dystrophy patients versus normal human myoblasts. Proc Natl 
Acad Sci U S A 103(18): 6982-6987. 
 
Phillips, T. J., Belknap, J. K., Hitzemann, R. J., Buck, K. J., Cunningham, C. L. and 
Crabbe, J. C. (2002): Harnessing the mouse to unravel the genetics of human disease. 
Genes Brain Behav 1(1): 14-26. 
 
Pillai, A., de Jong, D., Krugers, H., Knapman, A., Heinzmann, J. M., Holsboer, F., 
Landgraf, R., Joels, M. and Touma, C. (in preparation): Morphology of hippocampal and 
amygdalar neurons in young-adult mice is resilient to genetic differences in stress 
reactivity. PLoS One. 
 
Bibliography 
 
163 
 
Pinto, D., Darvishi, K., Shi, X., Rajan, D., Rigler, D., Fitzgerald, T., Lionel, A. C., 
Thiruvahindrapuram, B., Macdonald, J. R., Mills, R., Prasad, A., Noonan, K., Gribble, S., 
Prigmore, E., Donahoe, P. K., Smith, R. S., Park, J. H., Hurles, M. E., Carter, N. P., Lee, 
C., Scherer, S. W. and Feuk, L. (2011): Comprehensive assessment of array-based 
platforms and calling algorithms for detection of copy number variants. Nat Biotechnol 
29(6): 512-520. 
 
Porsolt, R. D., Bertin, A. and Jalfre, M. (1977): Behavioral despair in mice: a primary 
screening test for antidepressants. Arch Int Pharmacodyn Ther 229(2): 327-336. 
 
Porsolt, R. D., Bertin, A. and Jalfre, M. (1978): "Behavioural despair" in rats and mice: 
strain differences and the effects of imipramine. Eur J Pharmacol 51(3): 291-294. 
 
Prut, L. and Belzung, C. (2003): The open field as a paradigm to measure the effects of 
drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463(1-3): 3-33. 
 
Rezin, G. T., Amboni, G., Zugno, A. I., Quevedo, J. and Streck, E. L. (2009): 
Mitochondrial dysfunction and psychiatric disorders. Neurochem Res 34(6): 1021-1029. 
 
Riddle, D. R. and Forbes, M. E. (2005): Regulation of cytochrome oxidase activity in the 
rat forebrain throughout adulthood. Neurobiol Aging 26(7): 1035-1050. 
 
Roussos, P., Giakoumaki, S. G. and Bitsios, P. (2009): A risk PRODH haplotype affects 
sensorimotor gating, memory, schizotypy, and anxiety in healthy male subjects. Biol 
Psychiatry 65(12): 1063-1070. 
 
Ruegg, J., Holsboer, F., Turck, C. and Rein, T. (2004): Cofilin 1 is revealed as an 
inhibitor of glucocorticoid receptor by analysis of hormone-resistant cells. Mol Cell Biol 
24(21): 9371-9382. 
 
Rust, M. B., Gurniak, C. B., Renner, M., Vara, H., Morando, L., Gorlich, A., Sassoe-
Pognetto, M., Banchaabouchi, M. A., Giustetto, M., Triller, A., Choquet, D. and Witke, W. 
(2010): Learning, AMPA receptor mobility and synaptic plasticity depend on n-cofilin-
mediated actin dynamics. Embo J 29(11): 1889-1902. 
 
Rybnikova, E., Karkkainen, I., Pelto-Huikko, M. and Huovila, A. P. (2002): 
Developmental regulation and neuronal expression of the cellular disintegrin ADAM11 
gene in mouse nervous system. Neuroscience 112(4): 921-934. 
 
Sandvig, A., Berry, M., Barrett, L. B., Butt, A. and Logan, A. (2004): Myelin-, reactive 
glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and 
correlation with axon regeneration. Glia 46(3): 225-251. 
 
Sarmiere, P. D. and Bamburg, J. R. (2004): Regulation of the neuronal actin 
cytoskeleton by ADF/cofilin. J Neurobiol 58(1): 103-117. 
 
Sato, H., Takahashi, T., Sumitani, K., Takatsu, H. and Urano, S. (2010): Glucocorticoid 
Generates ROS to Induce Oxidative Injury in the Hippocampus, Leading to Impairment 
of Cognitive Function of Rats. J Clin Biochem Nutr 47(3): 224-232. 
 
Sato, S., Cerny, R. L., Buescher, J. L. and Ikezu, T. (2006): Tau-tubulin kinase 1 
(TTBK1), a neuron-specific tau kinase candidate, is involved in tau phosphorylation and 
aggregation. J Neurochem 98(5): 1573-1584. 
 
Bibliography 
164 
 
Sato, S., Xu, J., Okuyama, S., Martinez, L. B., Walsh, S. M., Jacobsen, M. T., Swan, R. 
J., Schlautman, J. D., Ciborowski, P. and Ikezu, T. (2008): Spatial learning impairment, 
enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in 
transgenic mice expressing tau-tubulin kinase 1. J Neurosci 28(53): 14511-14521. 
 
Schmidt, M. V., Enthoven, L., van der Mark, M., Levine, S., de Kloet, E. R. and Oitzl, M. 
S. (2003): The postnatal development of the hypothalamic-pituitary-adrenal axis in the 
mouse. Int J Dev Neurosci 21(3): 125-132. 
 
Schulze, T. G. (2010): Genetic research into bipolar disorder: the need for a research 
framework that integrates sophisticated molecular biology and clinically informed 
phenotype characterization. Psychiatr Clin North Am 33(1): 67-82. 
 
Sharp, A. J. (2009): Emerging themes and new challenges in defining the role of 
structural variation in human disease. Hum Mutat 30(2): 135-144. 
 
Shaw, C. J. and Lupski, J. R. (2004): Implications of human genome architecture for 
rearrangement-based disorders: the genomic basis of disease. Hum Mol Genet 13 Spec 
No 1: R57-64. 
 
She, X., Cheng, Z., Zollner, S., Church, D. M. and Eichler, E. E. (2008): Mouse 
segmental duplication and copy number variation. Nat Genet 40(7): 909-914. 
 
Shen, Q., Lal, R., Luellen, B. A., Earnheart, J. C., Andrews, A. M. and Luscher, B. 
(2010): gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-
adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic 
forms of depression. Biol Psychiatry 68(6): 512-520. 
 
Shyn, S. I., Shi, J., Kraft, J. B., Potash, J. B., Knowles, J. A., Weissman, M. M., Garriock, 
H. A., Yokoyama, J. S., McGrath, P. J., Peters, E. J., Scheftner, W. A., Coryell, W., 
Lawson, W. B., Jancic, D., Gejman, P. V., Sanders, A. R., Holmans, P., Slager, S. L., 
Levinson, D. F. and Hamilton, S. P. (2011): Novel loci for major depression identified by 
genome-wide association study of Sequenced Treatment Alternatives to Relieve 
Depression and meta-analysis of three studies. Mol Psychiatry 16(2): 202-215. 
 
Silberstein, S., Vogl, A. M., Bonfiglio, J. J., Wurst, W., Holsboer, F., Arzt, E., Deussing, J. 
M. and Refojo, D. (2009): Immunology, signal transduction, and behavior in 
hypothalamic-pituitary-adrenal axis-related genetic mouse models. Ann N Y Acad Sci 
1153: 120-130. 
 
Simon, N. M. (2009): Generalized anxiety disorder and psychiatric comorbidities such as 
depression, bipolar disorder, and substance abuse. J Clin Psychiatry 70 Suppl 2: 10-14. 
 
Simon-Sanchez, J. and Singleton, A. (2008): Genome-wide association studies in 
neurological disorders. Lancet Neurol 7(11): 1067-1072. 
 
Siu, H., Zhu, Y., Jin, L. and Xiong, M. (2011): Implication of next-generation sequencing 
on association studies. BMC Genomics 12: 322. 
 
Stark, Z., Bruno, D. L., Mountford, H., Lockhart, P. J. and Amor, D. J. (2010): De novo 
325 kb microdeletion in chromosome band 10q25.3 including ATRNL1 in a boy with 
cognitive impairment, autism and dysmorphic features. Eur J Med Genet 53(5): 337-339. 
 
 
Bibliography 
 
165 
 
Steiner, M. A., Marsicano, G., Nestler, E. J., Holsboer, F., Lutz, B. and Wotjak, C. T. 
(2008): Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 
signaling coincide with exaggerated corticosterone secretion in mice. 
Psychoneuroendocrinology 33(1): 54-67. 
 
Sterner, E. Y. and Kalynchuk, L. E. (2010): Behavioral and neurobiological 
consequences of prolonged glucocorticoid exposure in rats: relevance to depression. 
Prog Neuropsychopharmacol Biol Psychiatry 34(5): 777-790. 
 
Steru, L., Chermat, R., Thierry, B. and Simon, P. (1985): The tail suspension test: a new 
method for screening antidepressants in mice. Psychopharmacology (Berl) 85(3): 367-
370. 
 
Stevens, A., Begum, G. and White, A. (2011): Epigenetic changes in the hypothalamic 
pro-opiomelanocortin gene: a mechanism linking maternal undernutrition to obesity in the 
offspring? Eur J Pharmacol 660(1): 194-201. 
 
Sullivan, P. F. (2010): The psychiatric GWAS consortium: big science comes to 
psychiatry. Neuron 68(2): 182-186. 
 
Tarantino, L. M., Sullivan, P. F. and Meltzer-Brody, S. (2011): Using animal models to 
disentangle the role of genetic, epigenetic, and environmental influences on behavioral 
outcomes associated with maternal anxiety and depression. Front Psychiatry 2: 44. 
 
Tecott, L. H. (2003): The genes and brains of mice and men. Am J Psychiatry 160(4): 
646-656. 
 
Teplyuk, N. M., Zhang, Y., Lou, Y., Hawse, J. R., Hassan, M. Q., Teplyuk, V. I., Pratap, 
J., Galindo, M., Stein, J. L., Stein, G. S., Lian, J. B. and van Wijnen, A. J. (2009): The 
osteogenic transcription factor runx2 controls genes involved in sterol/steroid 
metabolism, including CYP11A1 in osteoblasts. Mol Endocrinol 23(6): 849-861. 
 
Touma, C., Bunck, M., Glasl, L., Nussbaumer, M., Palme, R., Stein, H., Wolferstatter, M., 
Zeh, R., Zimbelmann, M., Holsboer, F. and Landgraf, R. (2008): Mice selected for high 
versus low stress reactivity: a new animal model for affective disorders. 
Psychoneuroendocrinology 33(6): 839-862. 
 
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., 
Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., Shores-Wilson, K., Biggs, M. 
M., Balasubramani, G. K. and Fava, M. (2006): Evaluation of outcomes with citalopram 
for depression using measurement-based care in STAR*D: implications for clinical 
practice. Am J Psychiatry 163(1): 28-40. 
 
Trumbach, D., Graf, C., Putz, B., Kuhne, C., Panhuysen, M., Weber, P., Holsboer, F., 
Wurst, W., Welzl, G. and Deussing, J. M. (2010): Deducing corticotropin-releasing 
hormone receptor type 1 signaling networks from gene expression data by usage of 
genetic algorithms and graphical Gaussian models. BMC Syst Biol 4: 159. 
 
Varadarajulu, J., Lebar, M., Krishnamoorthy, G., Habelt, S., Lu, J., Bernard Weinstein, I., 
Li, H., Holsboer, F., Turck, C. W. and Touma, C. (2011): Increased anxiety-related 
behaviour in Hint1 knockout mice. Behav Brain Res 220(2): 305-311. 
 
Vaswani, M., Linda, F. K. and Ramesh, S. (2003): Role of selective serotonin reuptake 
inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol 
Biol Psychiatry 27(1): 85-102. 
Bibliography 
166 
 
Vreeburg, S. A., Hoogendijk, W. J., van Pelt, J., Derijk, R. H., Verhagen, J. C., van Dyck, 
R., Smit, J. H., Zitman, F. G. and Penninx, B. W. (2009): Major depressive disorder and 
hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen 
Psychiatry 66(6): 617-626. 
 
Walker, W. P., Aradhya, S., Hu, C. L., Shen, S., Zhang, W., Azarani, A., Lu, X., Barsh, G. 
S. and Gunn, T. M. (2007): Genetic analysis of attractin homologs. Genesis 45(12): 744-
756. 
 
Walsh, R. N. and Cummins, R. A. (1976): The Open-Field Test: a critical review. Psychol 
Bull 83(3): 482-504. 
 
Wang, L., Jia, P., Wolfinger, R. D., Chen, X. and Zhao, Z. (2011): Gene set analysis of 
genome-wide association studies: methodological issues and perspectives. Genomics 
98(1): 1-8. 
 
Williams, J. W., Jr., Slubicki, M. N., Tweedy, D. S., Bradford, D. W., Trivedi, R. B. and 
Baker, D. (2009a): Evidence Synthesis for Determining the Responsiveness of 
Depression Questionnaires and Optimal Treatment Duration for Antidepressant 
Medications. 
 
Williams, R. t., Lim, J. E., Harr, B., Wing, C., Walters, R., Distler, M. G., Teschke, M., 
Wu, C., Wiltshire, T., Su, A. I., Sokoloff, G., Tarantino, L. M., Borevitz, J. O. and Palmer, 
A. A. (2009b): A common and unstable copy number variant is associated with 
differences in Glo1 expression and anxiety-like behavior. PLoS One 4(3): e4649. 
 
Wirtz, S. and Schuelke, M. (2011): Region-specific expression of mitochondrial complex I 
genes during murine brain development. PLoS One 6(4): e18897. 
 
Wust, S., Federenko, I. S., van Rossum, E. F., Koper, J. W., Kumsta, R., Entringer, S. 
and Hellhammer, D. H. (2004): A psychobiological perspective on genetic determinants 
of hypothalamus-pituitary-adrenal axis activity. Ann N Y Acad Sci 1032: 52-62. 
 
Xu, J., Sato, S., Okuyama, S., Swan, R. J., Jacobsen, M. T., Strunk, E. and Ikezu, T. 
(2010): Tau-tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron 
degeneration in P301L FTDP-17 tau-mutant mice. Faseb J 24(8): 2904-2915. 
 
Yalcin, B., Nicod, J., Bhomra, A., Davidson, S., Cleak, J., Farinelli, L., Osteras, M., 
Whitley, A., Yuan, W., Gan, X., Goodson, M., Klenerman, P., Satpathy, A., Mathis, D., 
Benoist, C., Adams, D. J., Mott, R. and Flint, J. (2010): Commercially available outbred 
mice for genome-wide association studies. PLoS Genet 6(9). 
 
Yang, H., Ding, Y., Hutchins, L. N., Szatkiewicz, J., Bell, T. A., Paigen, B. J., Graber, J. 
H., de Villena, F. P. and Churchill, G. A. (2009): A customized and versatile high-density 
genotyping array for the mouse. Nat Methods 6(9): 663-666. 
 
Yen, Y., Anderzhanova, E., Kleinknecht, K., Bunck, M., Micale, V., Landgraf, R. and 
Wotjak, C. (2011): Inbred low anxiety-related behavior (LAB) mice - a mouse model of 
attention-deficit hyperactivity disorder (ADHD)? Pharmacopsychiatry 44: 312. 
 
Zdanov, S., Klamt, F. and Shacter, E. (2010): Importance of cofilin oxidation for oxidant-
induced apoptosis. Cell Cycle 9(9): 1675-1677. 
 
Bibliography 
 
167 
 
Zhang, L. F., Shi, L., Liu, H., Meng, F. T., Liu, Y. J., Wu, H. M., Du, X. and Zhou, J. N. 
(2011): Increased hippocampal tau phosphorylation and axonal mitochondrial transport 
in a mouse model of chronic stress. Int J Neuropsychopharmacol: 1-12. 
 
Zhou, X. and Tuck, D. P. (2007): MSVM-RFE: extensions of SVM-RFE for multiclass 
gene selection on DNA microarray data. Bioinformatics 23(9): 1106-1114. 
 
Zhu, P., Sang, Y., Xu, H., Zhao, J., Xu, R., Sun, Y., Xu, T., Wang, X., Chen, L., Feng, H., 
Li, C. and Zhao, S. (2005): ADAM22 plays an important role in cell adhesion and 
spreading with the assistance of 14-3-3. Biochem Biophys Res Commun 331(4): 938-
946.
 
168 
 
 
Acknowledgements 
 
169 
 
9  Acknowledgements 
First of all, I´d like to thank Prof. Rainer Landgraf for giving me the opportunity to conduct 
this thesis in his research group. He allowed the freedom to take my own decisions and 
to make my own mistakes and at the same time kept his door open and patiently listened 
to all the problems I discovered when testing this freedom. At this point, I am not going to 
praise his scientific achievements. Whoever is interested in that can search for his name 
in Pubmed. Throughout my time as a Ph.D. student in his group, I was impressed by his 
personal integrity and his political incorrectness, which I mean as positive as can be. 
This allows him an analytical and unvarnished view to the world. I think he doesn´t know, 
but these characters made him a ´doctoral father` in the purest sense of the word. 
 
I cordially thank Prof. Grupe and all the members of the committee for their willingness to 
act as referees for this thesis.  
 
I´d further like to thank Dr. Chadi Touma for the opportunity to work with animals of the 
SR mouse model and for his kind introduction into the topic of stress reactivity and HPA 
axis dysfunction. 
 
In addition to a ´doctoral father` I was so lucky to have a ´doctoral family`. In particular 
my supervisor Dr. Ludwig Czibere (´doctoral brother`) who supported my work with 
practical hints, encouraging words, creative chaos and great ideas. As the Landgraf 
department is a huge one, I can´t name everyone. But I´d like to thank all the members – 
present and former ones – for their support and for creating an atmosphere, which made 
going to the Institute something to look forward to every day.       
 
Furthermore, I´d like to stress out the friendly and collaborative atmosphere within the 
Institute which allowed working in several collaborative projects. Without these 
collaborations, the methodological diversity presented in this study would never have 
been possible. I very much thank Dr. Alana Knapman, who was my collaboration partner 
in the neurodevelopmental study and the Cofilin-1 project; Kathrin Henes for showing to 
me how to do CO staining; Dr. Peter Weber, Dr. Benno Pütz, Dr. André Altmann, and 
Monika Rex-Haffner who contributed to microarray and SAGE experiments; the 
department of Prof. Turck who showed me how to do mitochondrial proteomics; the 
department of Prof. Müller-Myhsok which helped with the association study, the PCAs, 
and the analysis of CNV data; Dr. Dietrich Trümbach and Regina Augustin from the 
Acknowledgements 
170 
 
Helmholtz Zentrum who were kindly supporting me with GO term and multivariate 
analyses of microarray data; Dr. Angelika Erhardt-Lehmann and Darina Czamara who 
supported my work with the down-sized analysis of the TMEM132D study. I also want to 
thank the friendly people from RGs Touma, Deussing, Refojo, Eder, Rein, and Almeida 
for their support in coping with every day lab problems. 
 
Last, but not at all least, I´d like to thank the IMPRS program for having me as a 
member. The IMPRS curriculum was a more than stimulating add on program. I´d also 
like to thank the members of my thesis advisory committee - Prof. Chris Turck, Dr. Ilona 
Kadow, and Dr. Ulrike Schmidt - for their valuable input to my thesis. Many thanks go to 
the program coordinator Hans-Jörg Schäffer and to his colleagues from the IMPRS 
coordination office, who always have an open ears for Ph.D. student´s issues.    
  
Curriculum vitae 
 
171 
 
10 Curriculum vitae 
 
Name     Regina Andrea Widner-Andrä 
Date of birth    March 22nd 1976  
Place of birth    Benediktbeuern  
 
 
Since October 2008 Ph.D. student at the Ludwig Maximilian University in 
Munich, Faculty of Biology  
Research group of Prof. Dr. Rainer Landgraf, Max 
PIanck Institute of Psychiatry 
´Assignment of functional impact on genetic data in 
two mouse models of affective disorders` 
 
October 2003 - July 2008 Studies of Molecular Medicine, University in 
Erlangen 
 
September 2001 - July 2003 Second-change education, Berufsoberschule in 
Miesbach 
 
April 1994 - September 2001 Employments as PTA (´Pharmazeutisch-technische 
Assistentin`) 
 
September 1992 - March 1994 Apprenticeship as PTA  
 
July 1992  Graduation from ´Realschule`  
 
172 
 
 
 
 
  
 
Declaration/Erklärung 
 
173 
 
11 Declaration/Erklärung 
Hiermit versichere ich, die vorliegende Arbeit selbstständig und nur mit den 
angegebenen Hilfsmitteln und Quellen angefertigt zu haben. Ausführungen, die wörtlich 
oder sinngemäß übernommen wurden, sind als solche gekennzeichnet. Ich versichere 
ebenfalls, nicht anderweitig versucht zu haben, eine Dissertation einzureichen oder mich 
einer Doktorprüfung zu unterziehen.  
 
 
München, 25. Mai 2012 
 
 
 
 
 
Regina Widner-Andrä 
